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DNA is regularly subjected to endogenous and exogenous reagents that cause mutations 
that can be detrimental to a cell if they are not repaired. One class of enzymes responsible 
for DNA repair is the family of DNA glycosylases and their role is to remove damaged 
bases.  Uracil DNA Glycosylase (UDG) is a member of this family and is highly specific, 
removing  only  uracil,  an  RNA  base,  from  DNA.  Uracil  arises  in  DNA  through 
misincorporation of deoxyuridine monophosphate (dUMP) creating an A.U base pair, or 
through deamination of cytosine resulting in a G.U base pair. Though UDG acts on A.U 
pairs, this is not it’s primarily role as A.U pairings are not mutagenic. However the G.U 
mispair is highly mutagenic and leads to a G.C to A.T transition on subsequent rounds of 
replication. UDG only reacts with uracil and has no activity at thymine since the 5-methyl 
group on the base is excluded from the active site. This thesis examines mutants of UDG 
that can cleave cytosine but not 5-methylcytosine. Methylation of cytosine at CpG sites 
leads to gene silencing and is an important epigenetic signal. Knowing the methylation 
state of cytosines will therefore be important for understanding gene control and may be 
beneficial for treating many diseases. The most common method for detecting cytosine 
methylation uses a bisulphite reaction followed by normal DNA sequencing methods. This 
process has several drawbacks and the aim of this work is to create an enzyme that is 
capable of distinguishing between5-methylcytosine and cytosine. It has been reported that 
mutation  of  a  critical  asparagine  in  UDG  to  an  aspartate  allows  the  enzyme  to 
accommodate cytosine into its active site; generating a cytosine DNA glycosylase (CDG). 
Using the natural ability of UDG to distinguish between uracil and thymine due to the 
presence of the 5-methyl group, we hypothesised that the mutant enzyme should be able to 
discriminate  between5-methylcytosine  and  cytosine,  which  differ  by  the  presence  or 
absence of a methyl group in the same position. E. coli and human CDGs were prepared 
and their ability to remove cytosine or 5-methylcytosine examined when placed in different 
sequence  contexts.  hCDG  was  generated  through  complete  gene  synthesis  of  hUDG 
followed  by  the  N204D  mutation.  The  corresponding  mutation  in  E.coli  (N123D) 
generates a highly cytotoxic enzyme that cannot even be cloned in pUC19. As L191 aids 
base flipping, mutation to alanine (L191A) renders the enzyme inactive; activity can then 
be rescued using a bulky synthetic nucleoside that occupies the base pair and forces the 
target  base  into  an  extrahelical  conformation.  The  L191A  mutation  was  followed  by 
N123D to generate an expressible and functional eCDG, denoted eCYDG. We demonstrate 
that these mutants have cytosine glycosylase activity when the cytosine is mispaired or 
unpaired, but not when paired with guanine, and show no activity against5-methylcytosine 
in any context. The activity of these CDGs varies with the stability of the base pair, with 
the fastest cleavage rates being obtained with the least stable base pairs, and also varies 
with the local sequence context. As CDGs are able to discriminate between cytosine and 5-
methylcytosine  we  began  development  of  a  real-time  PCR  assay  for  detection  of  5-
methylcytosine. This employed a hexaethylene glycol (HEG) linker opposite the target 
cytosine, as this produces one of the fastest cleavage rates and cannot be read by a DNA 
polymerase.   ii 
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Chapter 1: General Introduction 
1.1 DNA and Epigenetics 
DNA  is  the  molecule  that  is  responsible  for  the  storage  of  genetic  information.  Gene 
expression is regulated by many cellular processes that usually involve protein interaction. 
This  can  cause  up-  or  down-regulation  of  a  specific  gene  leading  to  alterations  in  its 
expression. One way in which gene expression is regulated is through the methylation of 
cytosine bases within DNA, a form of epigenetics, which usually results in gene silencing. 
Errors in this have been implicated in diseases such as cancer (Jones and Baylin, 2002). 
Cytosine methylation most commonly occurs at CpG sites that are found in high density 
around promoter regions of genes, and are hotspots for mutations (Shen et al., 1992) as5-
methylcytosine can be deaminated to create thymine, producing a G.T mismatch (Sartori et 
al., 2002). Alterations to the methylation patterns of these regions can therefore affect gene 
expression and regulation. It has been found that methylation of cytosines inhibits gene 
expression through two main mechanisms. The first is whereby the methylation of cytosine 
itself prevents the binding of DNA binding proteins (Figure 1.1A), such as transcription 
factors (Watt and Molloy, 1988). This is because sequence recognition is disrupted by the 
methyl  group  protruding  into  the  major  groove.  The  second,  and  probably  the  most 
important,  occurs  through  the  binding  of  methyl-CpG-binding  proteins  (MBPs),  to 
methylated cytosines. MBPs can either repress gene expression directly by occupying the 
binding domains of DNA binding proteins (Figure 1.1A), or recruit other repressor proteins 
to cause gene silencing through chromatin remodelling (Figure 1.1B) (Jones et al., 1998). 
One such class of protein that is recruited by MBPs are histone deacetylases (HDACs). 
The recruitment causes the HDACs to come into close proximity to the N-terminal tail of 
histone 3 that is part of a nucleosome around which the DNA is wound. The HDACs are 
then  able  to  cause  deacetylation  of  lysine  4  and  9  (Figure  1.1B)  and  its  subsequent 
methylation by a histone methyltransferase (HMT), also recruited by MBPs, which restores 
the positive charge on the lysine. This increases the affinity of DNA for the nucleosome 
due to charge interactions, causing stronger DNA binding and chromatin remodelling into 
a condensed and thus repressed form (Nan et al., 1998). 2 
 
 
Figure 1.1 Gene regulation by cytosine methylation. A) Binding of methyl binding proteins (MBPs; blue) 
prevent the binding of transcription factors (TF; orange). B) MBPs recruit histone deacetylases (HDACS; 
green) that deacetylate lysines in the N-terminal tail of histones (red). This restores the lysines positive 
charge, increasing the affinity for DNA (black lines) creating a condensed chromatin form. 
More  recently  a  new  “6
th”  base  has  been  found  that  could  also  play  a  role  in  gene 
regulation, 5-hydroxymethylcytosine (Kriaucionis and Heintz, 2009, Tahiliani et al., 2009). 
This base is generated through the addition of a hydroxyl group to 5-methylcytosine via 
Ten  Eleven  Translocation  (TET)  proteins.  As  no  cytosine  demethylation  enzymes  are 
known it has been proposed that this acts as an intermediate in the demethylation of5-
methylcytosine or possibly to act as another epigenetic marker (Tahiliani et al., 2009). 
More recent studies seem to suggest that it is indeed an intermediate in demethylation (He 
et al., 2011, Jin et al., 2014) and further support comes from the role of thymine DNA 
glycosylases (Hashimoto et al., 2012, Muller et al., 2014). These are specific for uracil and 
thymine substrates when  they are  mispaired  with  guanine, but  has  no  activity towards 
cytosine,  even  though  5-carboxylcytosine  is  a  substrate  for  mammalian  thymine  DNA 
glycosylase (He et al., 2011). They are therefore able to excise the deaminated products of 
cytosine,  5-methylcytosine  and  5-hydroxymethylcytosine  (i.e.  uracil,  thymine  and  5-
hydroxymethyluracil respectively) (Hashimoto et al., 2012, Morera et al., 2012). It is not 
surprising that this seems to be the route for demethylation as a DNA glycosylase capable 
of  excising  5-methlycytosine  and  5-hydroxymethylcytosine,  might  also  be  able  to 3 
 
accommodate cytosine, which would result in constant genome lesions, generating a high 
mutation rate. 
The inclusion of 5-methylcytosine within the genome does not only affect gene expression 
regulation; it also has potent mutagenic properties, as deamination of this base generates 
thymine, which upon subsequent DNA replication results in a transition mutation (G.
MC to 
A.T). Since the resulting G.T mispair is made from canonical bases it would then not be 
obvious which is the incorrect base that should be excised. The high rate of deamination 
of5-methylcytosine, and its slow repair rate, accounts for the high mutation and relatively 
low  abundance  of  CpG  sites.  It  is  for  this  reason  that  the  dinucleotide  CpG  is 
underrepresented  in  all  mammalian  genomes  (Lindahl,  1993,  Mol  et  al.,  1995b). 
Deamination of unmethylated cytosine is also common at CpG sites generating UpG. This 
can also lead to a transition mutation, but uracil, unlike thymine, is not a standard DNA 
base and so can be recognised as a lesion to be repaired. The generation of uracil in DNA 
can arise from both enzymatic and spontaneous deamination (Mol et al., 1995b). 
Tools for the detection of5-methylcytosine are important for assessing the epigenetic status 
of any CpG sites, and might be useful for identifying the cause of some diseases. The main 
method  currently  used  in  the  detection  of  5-methylcytosine  is  bisulphite  sequencing 
(discussed  in  section  1.4).  Although  this  is  routinely  used,  it  suffers  from  several 
drawbacks  and  requires  DNA  sequencing.  We  therefore  plan  to  design  an  enzymatic 
approach for the detection of5-methylcytosine that will prove to be accurate and reliable. 
The  aim  of  this  project  is  to  generate  an  enzyme  capable  of  discriminating  between 
cytosine and5-methylcytosine. This will be achieved by selective mutation of the enzyme 
Uracil DNA glycosylase (UDG; also known as UNG). In order to do this we must first 
understand  how  UDG  discriminates  between  uracil  and  thymine,  and  apply  it  for  the 
discrimination between cytosine and5-methylcytosine (Figure 1.2). 4 
 
 
Figure 1.2 DNA bases. A: adenine, G: guanine, U: uracil, T: thymine, C: cytosine, 
MC:5-methylcytosine and 
hmC: hydroxymethylcytosine, dR: deoxyribose. 
1.2 DNA Glycosylases 
DNA is constantly under attack from endogenous and exogenous reagents, which cause 
damage through incorporation or formation  of cytotoxic and mutagenic  bases,  that are 
either analogues or adducts of the four Watson-Crick bases (Lindahl, 1993). Surprisingly, 
endogenous agents cause the most damage, such as oxygen that creates 8-oxoguanine via 
hydroxyl radicals, and water that causes deamination of cytosine and 5-methylcytosine to 
uracil and thymine respectively (Lindahl, 1993, Sartori et al., 2002). These reactions can 
be accelerated by higher temperatures (Lindahl and Nyberg, 1974) and by mutagens such 
as nitrous acid (Savva et al., 1995). In eukaryotes, this can cause temporary cell-cycle 
arrest that then allows DNA repair to take place before replication begins (Krokan et al., 
1997). A list of common glycosylases and their substrates are displayed in Table 1.1. 
Glycosylases that have broad substrate specificity are able to recognise the damaged base 
itself as it no longer forms hydrogen bonds to its complement or does not stack correctly 
within the duplex, enabling the base to be flipped out of dsDNA more easily into the 
enzyme’s active site (Berdal et al., 1998). Some of these glycosylases also admit normal, 
undamaged bases into their active site such as the E. coli enzyme 3-methyladenine DNA 
glycosylase  II  (ALKA)  that  admits  adenine  (Drohat  et  al.,  2002).  Interestingly  its 
counterpart  3-methyladenine  DNA  glycosylase  I  is  specific  for  only  3-methyladenine 
(Berdal et al., 1998). 5 
 
The thermostability of DNA containing a damaged base may also affect the efficiency of 
the  repair  process,  especially  if  this  alters  its  ability  to  hydrogen  bond  with  its 
complementary base or stack with the neighbouring bases. This is because many repair 
proteins work by flipping the damaged base out from the duplex into their active site; the 
greater  the  destabilisation  of  the  lesion  the  less  energy  will  be  required  for  this  step, 
thereby facilitating repair (Sagi et al., 2000). Increased thermostability of DNA can be 
advantageous to thermophilic glycosylases that require high DNA melting temperatures to 
aid repair (Sagi et al., 1999). The thermostability of damaged DNA can also be dependent 
on its flanking sequence (Sagi et al., 2000), by influencing the base pair conformation 
and/or base stacking (Singer and Hang, 1997). 
Glycosylase  Species  Substrates 
UDG  E. coli, human  U 
TDG  Human (MBD4), E. coli (MUG)  T.G, U.G 
SMUG1  Human  U, hoU, hmU 
ALKA  E. coli, human (MPG)  3-meA, hypoxanthine 
OGG1  Human, E. coli (Fpg)  8-oxoG 
MUTY  E. coli, human (NYH)  A.8-oxoG 
 
Table 1.1 Common DNA glycosylases. Homologues for the different species are given in brackets. hoU: 
hydroxyuracil, hmU: hydroxymethyluracil, 3-meA: 3-methyladenine, 8-oxoG: 8-oxoguanine. 
1.2.1 Repair of Damaged DNA 
DNA repair is therefore crucial for maintaining the integrity of the genome. The simplest 
form of repair is through direct dealkylation in a one-step mechanism; i.e. the removal of 
alkyl groups from O6-methylguanine (O6-meG) by Ada (Volkert, 1988). The other forms 
of  repair  are  more  complicated  and  require  the  excision  of  a  nucleotide;  nucleotide 
excision repair (NER), or just the damaged base itself; base excision repair (BER). NER is 
the most complex system that involves around 30 proteins (Krokan et al., 1997) and is 
responsible  for  removing  long  stretches  of  DNA  as  an  oligonucleotide  and  works  by 
recognising the large distortions produced upon the DNA duplex, for example by XPA 
(Robins et al., 1991). New DNA is then incorporated into the unpaired excised region 
using  the  complementary  strand  as  a  template  to  complete  repair.  The  BER  pathway, 
however, removes only the base, and not the nucleotide as in the NER pathway. DNA 6 
 
glycosylases in the BER pathway remove damaged, cytotoxic or mutagenic bases through 
cleavage of the N-glycosidic bond between the target base and the deoxyribose sugar; thus 
releasing the base and leaving an abasic (AP) site (Pearl, 2000). The base is only excised 
when it is in an extrahelical conformation (Jiang and Stivers, 2002) in which it is able to 
access  the  active  site  of  the  glycosylase.  Glycosylases  do  not  cause  major  helical 
distortions to DNA, though some distortions are inevitable in order to aid formation of the 
extrahelical  conformation  (Pearl,  2000).  DNA  glycosylases  stay  tightly  bound  to  their 
target,  to  protect  the  abasic  site  after  base  excision,  until  the  next  repair  enzyme,  an 
apurinic endonuclease, displaces the glycosylase in order for a polymerase to incorporate 
the correct base (Hoseki et al., 2003).  This is to prevent further mutations from occurring. 
A  glycosylase  that  has  been  extensively  studied  is  UDG,  of  which  five  families  have 
currently been identified. This glycosylase excises uracil from DNA and is an enzyme 
involved in the BER pathway (Krokan et al., 2001). 
1.2.2 How Uracil Arises in DNA 
Uracil can arise in DNA through misincorporation of dUMP, though this causes no adverse 
effects as it is replicated in exactly the same way as thymine. Though not mutagenic, the 
incorporation of uracil can affect the interaction of some DNA binding proteins (Handa et 
al., 2002) thereby affecting regulatory DNA processes. Uracil also arises in DNA from 
deamination of cytosine, producing a guanine:uracil mismatch that results in a transition 
mutation (Figure 1.3). The role of UDG is therefore to excise uracil so that the correct base 
can be incorporated thereby preventing a transition mutation of G.C to A.T (Pearl, 2000). 
The importance of UDG is apparent when looking at a genome of 10
10 base pairs (Pearl, 
2000), in which up to 500 uracil bases per cell will be produced by deamination every day 
(Lindahl,  1993).  Deamination  is  also  approximately  4000  times  faster  in  ssDNA, 
explaining why it is enhanced during transcription and replication (Mosbaugh, 1988). 
   7 
 
 
Figure 1.3 The transition mutation from G.C to A.T, caused by cytosine deamination. 
UDG is responsible for protecting the genome and has a much higher enzymatic rate than 
other glycosylases (Boiteux et al., 1990, Bjelland et al., 1994, Neddermann and Jiricny, 
1994, Roy et al., 1994). This is probably due to its high selectivity for uracil and to the 
tight and specific active site that allows for quick catalysis. It may also be because most 
other glycosylases have activity towards two or more substrates and therefore have a lower 
specificity per substrate in comparison to uracil and UDG. This would result in weaker 
binding and a lower rate of catalysis and excision (Kavli et al., 1996). 
Uracil is a natural component of RNA, though this is not excised by UDG as the 2′OH 
group prevents admission into the active site (Mol et al., 1995b, Slupphaug et al., 1996), 
where there would be a steric clash with a phenylalanine (Savva et al., 1995), in a similar 
fashion to the way that the methyl group that excludes thymine (Kavli et al., 1996). 
1.3 Uracil DNA Glycosylases 
1.3.1 Family 1 UDGs 
UDG found in humans, E. coli and Herpes Simplex Virus 1 (HSV1) belongs to Family 1 of 
the  UDG  superfamily.  Within  humans  there  are  two  forms  of  UDG  created  from 
alternative  splicing  of  the  UDG  gene,  UNG1  and  UNG2;  UNG1  is  targeted  to  the 
mitochondria and UNG2 the nucleus (Nilsen et al., 1997, Haug et al., 1998). This family 
of enzymes acts on uracil in both single stranded DNA (ssDNA) and double stranded DNA 
(dsDNA), but has no detectable activity towards dUMP, deoxyuridine or uridine (Lindahl, 
1974). They are able to recognise uracil in an extrahelical conformation and cause excision 
of the base through cleavage of the N-glycosidic bond (Mol et al., 1995b). 
C
G 
C
G 
U
A 
C
G 
T
A 
U
G 8 
 
 
Figure 1.4 Cartoon alignment for comparison of human and  E. coli UDGs. The human forms contain a 
nuclear localisation signal (NLS) or mitochondrial  targeting peptide (MTP) at their N-terminals. Critical 
residues (black boxes) and motifs 1 and 2 (purple boxes) highlighted. 
1.3.1.1 Recognition of Uracil by UDG 
It is still unclear as to how UDG locates its substrate but the first stage is non-specific 
DNA binding (Dong et al., 2000). So far three models have been suggested. The first is the 
inherent extrahelicity model that suggests that uracil has weak binding with its opposing 
base and spontaneously flips out from the helix, enabling enzyme binding. This seems 
unlikely as the mismatch pairing of G.U, or even A.U, is very similar to the correct base 
pairings with similar bond energies, suggesting that spontaneous base flipping is highly 
unlikely to occur (Pearl, 2000). The two-stage recognition is a hybrid model whereby UDG 
recognises uracil in DNA and then causes the base to flip into an extrahelical conformation 
(Pearl, 2000). This is similar to the mechanism of  methyltransferases, which recognise a 
specific DNA sequence via major groove interactions of the fully stacked base-paired B-
DNA  conformation,  resulting  in  the  flipping  out  of  the  base  so  that  it  can  undergo 
methylation (Klimasauskas et al., 1994). UDG has an approximately 20,000 fold larger 
rate of activity than methyltransferases, suggesting that it plays an active role in flipping of 
the nucleotide (Slupphaug et al., 1996). A G:U pair has a “wobble” structure (Figure 1.5) 
as  the  N7  and  O6  of  guanine  and  the  O4  of  uracil  protrude  into  the  major  groove; 
suggesting a means for recognition (Pearl, 2000). The “wobble” created from abnormal 
base stacking may be more easily recognised from the minor groove that has less variation, 
as UDG has most contact with the minor groove. This is because most base modifications, 
i.e. methylation, protrude out of the major groove making detection of changes harder to 
recognise.  Minor  groove  interactions  by  UDG  may  be  an  important  factor  in  the 
recognition of a damaged and/or mismatch base (Slupphaug et al., 1996). The A.U pair 
also has a distinct major groove conformation, which is different to that of G.U. This 9 
 
makes the two stage recognition model also unlikely to be sufficient as the enzyme would 
have to have multiple recognition processes in order to recognise uracil opposite guanine, 
adenine or in ssDNA. 
 
Figure 1.5 A G.U wobble base pair. Above the red line, indicating the axis of the pair, are the three hydrogen 
bond acceptors protruding into the major groove: guanine’s N7 and O6, uracil’s O4. dR: deoxyribose. 
The base sampling model on the other hand suggests that UDG samples bases along the 
DNA and flips them out in order to check their interaction within the active site (Pearl, 
2000). From this, the mechanism suggested for UDG is stochastic “hopping” (Slupphaug et 
al., 1996, Jiang and Stivers, 2002, Rowland et al., 2014) whereby it slides along the DNA 
via a charge interaction between the negative phosphate backbone (Friedman and Stivers, 
2010, Zharkov et al., 2010, Schonhoft et al., 2013) of the DNA and the positive face 
(Figure 1.6) of UDG, where the active site is located. 10 
 
 
Figure 1.6 Space filled model of showing the positive face of hUDG (arrow) next to its active site. (PDB 
1AKZ) (Parikh et al., 1998). Positive charge: red, neutral; white and negative; blue. (Diagram created using 
Chimera V1.5.3.) 
UDG scans for uracil bases in sections  in a distributive manner (Purmal et al., 1994), 
which is affected by the context of uracil distribution (Schonhoft and Stivers, 2013). UDG 
has a scan range of approximately 1.5 – 2 kb before dissociating (Higley and Lloyd, 1993). 
This means that UDG is not able to sample every base, as the time it spends in contact with 
the DNA is very short (Panayotou et al., 1998, Jiang and Stivers, 2002). UDG therefore 
acts in a selective manner and would have to dissociate after excision in order to release 
the free uracil base (Slupphaug et al., 1996). This mechanism is possible provided UDG 
does not completely detach from the DNA and maintains its active site orientation in order 
to excise uracil once it has been located. The scanning process is halted when UDG arrives 
at a mismatch, such as a G.U. The displacement caused by this wobble base pair causes a 
clash  with  a  leucine  residue  (Leu275  in  hUDG)  on  the  surface  of  UDG.  This  in  turn 
produces a rotation in the side chain of a tyrosine (Tyr275 in hUDG) causing UDG to halt 
and allow insertion of the leucine residue (Parikh et al., 1998). The enzyme therefore acts 11 
 
through what is known as a “Pinch, Push, Plug and Pull” mechanism (Jiang and Stivers, 
2002). UDG has a preference for cleaving uracil in ssDNA as there is no opposing base 
and  it  can  easily  be  disrupted  and  flipped  into  the  active  site.  Base  pairing  stability 
determines the efficiency of substrate interaction in dsDNA (Krosky et al., 2004, Krosky et 
al., 2005); a uracil paired with guanine is less stable than uracil paired with an adenine. 
This is because an A.U pair is most similar to standard Watson-Crick base pair stacking. 
This makes disrupting the base pair interactions more difficult, hindering the flipping of 
the base into an extrahelical conformation. A guanine opposite uracil would be favoured by 
UDG  due  to  its  weaker  base  pair  interactions  within  the  DNA  duplex.  This  has  been 
supported by experimental data and provides the substrate preference for UDG as ssU > 
dsG.U >> dsA.U (Panayotou et al., 1998, Pearl, 2000). 
UDG  therefore  recognises  DNA  in  three  stages:  (i)  weak  non-specific  binding,  (ii) 
destabilisation of uracil into an extrahelical conformation, and (iii) rapid docking of the 
uracil into the active site. This was first shown through the use of a deoxyuridine analogue, 
2′-fluorouridine  (2′-FU),  positioned  adjacent  to  2-aminopurine  (2-AP).  A  change  in 
fluorescence is seen by 2-AP when 2′-FU substitute is flipped out into an extrahelical state 
(Stivers et al., 1999), due to changes in local base stacking. This mechanism has since been 
shown using natural deoxyuridine (Wong et al., 2002). 
1.3.1.2 Structure of UDG 
The crystal structure of UDG (Figure 1.4) has shown that it contains no disulphide bridges 
and has its C and N-termini on opposite sides of the enzyme. It has an α/β fold that creates 
a groove with an approximate diameter of 21 Å. This also happens to be the approximate 
width of a DNA duplex, and hence suitable as its binding site. The groove narrows to about 
10 Å and suggests that the DNA duplex does not fit entirely and that a conformational 
change  is  required.  However,  the  10  Å  end  has  three  loops  that  are  proline  rich  and 
provides  the  groove  with  a  rigid  structure,  suggesting  that  a  conformational  change  is 
unlikely (Mol  et  al., 1995b). The  active site appears to  be flexible as  there is  an  11° 
difference  in  the  plane  of  uracil  between  eUDG  and  hUDG  (Werner  et  al.,  2000). 
Therefore this is a perfect site for DNA binding due to its shape, size and charge, which is 
created by the basic amino acids that line the groove and provide a positive electrostatic 
potential in which to complement the DNA and allow for binding of duplex DNA (Mol et 
al., 1995b). 12 
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Figure 1.7 Structure of hUDG bound to dsDNA (PDB 1SSP) (Parikh et al., 1998). A) Stereo view of UDG 
bound to uracil containing DNA. B) Stereo view of uracil bound in the active site of UDG with the critical 
residues highlighted. Oxygen atoms coloured red and nitrogen atoms coloured blue. eUDG counterparts for 
the critical residues are Tyr66, Phe77, Asn123 and His187.  (Diagrams created using Chimera V1.5.3.) 
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1.3.1.3 DNA-Enzyme Binding 
UDG only has a weak interaction with non-uracil containing DNA and upon addition of 
uracil  into  DNA  the  enzyme’s  affinity  increases;  favouring  a  model  in  which  uracil 
recognition is due to recognition of the base itself (Panayotou et al., 1998). This is shown 
through  the  first  stage  of  DNA  recognition  whereby  UDG  recognises  the  DNA  non-
specifically,  upstream  of  a  mispaired  uracil,  causing  distortion  of  the  phosphodiester 
backbone and consequently helical strain (Parikh et al., 1998). Binding of UDG to DNA 
results in DNA bending, which is important as the binding of undamaged DNA would 
result in steric clashes with the serine loops (described below), if it were not to be bent 
(Parikh et al., 1998). This is because the 3′ end of the DNA binds tightly to the enzyme and 
stays in a stacked conformation. This would result in the 5′ end clashing with leucine 191 
(which acts as a wedge), the nucleotide and the critical asparagine. As a result UDG is 
unable to excise uracil at the 3′ end of a DNA fragment, but is able to excise uracil at the 5′ 
end, provided it is phosphorylated (Krokan and Wittwer, 1981, Varshney and van de Sande, 
1991). This mechanism is conserved throughout the UDG superfamily. 
1.3.1.3.1 Serine Interactions 
It has been demonstrated with E. coli UDG that once the uracil has been located, three 
important  conserved serine residues, Ser88, 189 and 192,  bind  via their hydroxyl  side 
chains to the +1, -1, -2 and -5 phosphates of the uracil base (reading 5′ to 3′) (Werner et al., 
2000, Handa et al., 2002). The binding of Ser88 and Ser189 to the flanking  5′ and 3′ 
phosphates causes a decrease of 4 Å in the phosphate-phosphate distance, which is the 
approximate distance caused by the unwinding of a single nucleotide (Jiang and Stivers, 
2002). The decrease in distance causes compression of the DNA around the area in which 
the  uracil  base  is  located.  DNA  torsion,  caused  by  the  serine  interaction,  is  relieved 
through the bending of the DNA by approximately 45° towards the major groove (Parikh et 
al., 1998, Jiang and Stivers, 2002), causing disruption of duplex stacking. This causes 
flipping of the mismatched uracil nucleotide into an extrahelical conformation (van Aalten 
et al., 1999) that is then able to be admitted into the highly specific active site of UDG 
(Werner  et  al.,  2000),  resulting  in  excision  of  the  base.  This  binding  around  the 
deoxyuridine is referred to as the pinching mechanism (Parikh et al., 1998, Stivers et al., 
1999, Jiang and Stivers, 2002). Substrate binding brings about a clamping motion of the 
serine loops which aid positioning of the substrate within the active site (Werner et al., 15 
 
2000). Mutation of Ser88 and Ser189 results in decreased binding, as also seen with the 
removal  of  the  hydroxyl  of  Ser88,  while  mutation  of  both  Ser88  and  Ser189  reduces 
UDG’s  binding  affinity  significantly.  The  conformational  change  of  UDG  is  the  rate 
limiting  step  for  these  mutants  showing  that  their  role  is  in  the  formation  of  uracil’s 
extrahelical conformation. These mutants have no effect on the enzyme’s ability to flip the 
base into an extrahelical conformation or the ability of UDG to clamp around the base to 
form the final conformation before excision occurs. Thus, the serines play a crucial role in 
the early stages of UDG’s excision mechanism. 
It  has  also  been  suggested  that  the  serines  help  to  attain  the  final  conformation  after 
glycosidic bond cleavage, through cooperatively acting together (Jiang and Stivers, 2002). 
Their importance is also highlighted through a decrease in enzyme activity when they are 
mutated to alanine. Serine interactions with the 5′ phosphodiester of uracil was shown to 
be most important in binding and catalysis while surprisingly having no significant effect 
on lowering the activation energy (Werner et al., 2000). Though upstream of the target 
uracil base, the 5′ phosphodiester of the -5 nucleotide contributes significantly to uracil 
excision (Handa et al., 2002). The phosphodiester pinching caused by the serine residues 
contributes to the bending of the N-glycosidic bond along with aromatic stacking forces. 
This therefore weakens this bond and suggests that these residues may play an important 
role  in  lowering  the  activation  energy  for  N-glycosidic  bond  cleavage,  independent  of 
DNA sequence effects (Werner et al., 2000). These serines therefore play a role in the later 
stages of the cleavage mechanism, as well as initial binding of UDG. 
1.3.1.3.2 Effect of Flanking Regions 
As well as the flanking phosphates the flanking bases themselves also affect catalysis and 
excision.  Uracil  is  best  excised  when  the  -2,  -1,  +1  and  +2  bases  are  adenines.  The 
efficiency is greatly reduced when these flanking bases are guanines (Slupphaug et al., 
1995).  Complete  disruption  of  the  preferred  sequence  for  optimal  excision  activity  by 
UDG found that the -1 and -2 5′ flanking bases have interactions that are most important 
for catalysis. However, the +1 base is not crucial for catalysis and only contributes to 
decreasing the activation energy (Jiang and Stivers, 2001). Therefore sequence specificity 
is important for excision and it has been shown that local and global interactions, such as 
DNA bound to histones, can greatly affect excision rates irrespective of sequence (Ye et al., 
2012). 16 
 
1.3.1.3.3 Rate Limiting Factor of Excision  
The flipping of the base is the rate limiting step as the rate of dissociation of UDG is 
similar for ssDNA and dsDNA, though ssDNA cleavage of uracil is three times faster than 
that of dsDNA. This is the same for different base pairings as the association of uracil in a 
G.U mismatch is approximately 15-fold faster than that of an A.U (Panayotou et al., 1998). 
This is due to base pair stability whereby uracil is most similar to thymine and therefore 
has better binding with its natural partner, adenine. It is of note that UDG has a similar 
association  rate  (kon)  of  recognition  with  both  G.U  and  A.U  (Parikh  et  al.,  1998), 
suggesting that the faster rate for G.U mismatches is not due to extrahelical recognition 
and that uracil spends more time in this conformation in a G.U mismatch than an A.U. This 
is also seen in enzymes from different species, which have different rates of excision for 
dsDNA but have similar rates for ssDNA (Eftedal et al., 1993, Krokan et al., 1997). The 
rate of uracil displacement from dsDNA can be affected by its surrounding sequence (Jiang 
and Stivers, 2002), most notably the adjacent 5′ nucleotide (discussed previously) (Abu 
and Waters, 2003). The rate of excision can also be affected by the chain length suggesting 
that some interactions occur at a distance from the uracil base whereby longer 5′ flanks of 
oligonucleotides facilitate uracil release (Handa et al., 2002). 
1.3.1.4 The Role of Leucine 
Since flipping of the base by UDG is more frequent than spontaneous base flipping, it has 
been suggested that Leu191 (eUDG) protrudes into the minor groove and acts as a wedge 
to facilitate the extrahelical conformation. The leucine then acts as a plug to occupy the 
space left by the extrahelical base thereby increasing the time for the enzyme to act on the 
uracil,  through  maintaining  its  extrahelical  conformation.  In  this  way  the  leucine  also 
serves to prevent reinsertion and the flipping back of uracil into the DNA duplex (Krokan 
et al., 1997, Parikh et al., 1998). Mutation of this leucine to alanine affects the enzyme’s 
ability to bind and flip the base. This is because it loses the ability to “push” out the base 
and “plug” the space created and thus, this leucine is involved throughout UDG’s excision 
mechanism (Jiang and Stivers, 2002). 
1.3.1.4.1 Introduction of Pyrene into the Substrate 
It was proposed that the introduction of a pyrene (Pn) residue (Figure 1.8D) opposite uracil 
(instead of a natural base) would force the uracil into an extrahelical formation, while not 17 
 
compromising duplex stability. Due to the bulk of pyrene it is able occupy the space of the 
opposing base as well as its own (Jiang et al., 2001). The pyrene thus acts like a wedge and 
is able to rescue the mutational effects of L191A/G (Figure 1.8).  
 
Figure 1.8 The “Push and Plug” roles of leucine. A) A.U base pair. B) Leucine acts as a wedge to force uracil 
into an extrahelical conformation, occupying the AP site. C) L191A mutation causes inhibition of UDG by 
preventing cytosine flipping. D) Incorporation of a pyrene (Pn) nucleotide to act as a wedge to force the 
uracil into an extrahelical conformation, rescuing the effects of the L191A mutation. dR: deoxyribose. 
The L191G mutant shows a 60-fold decrease in activity, which is recovered by placing 
pyrene opposite uracil. Furthermore, UDG is rapidly able to  attain the final state with 
uracil, as shown by a near 4-fold increase in catalytic rate of Pn.U compared to A.U. This 
is because the pyrene maintains the uracil in its extrahelical conformation thus increasing 
the stability (Jiang et al., 2001, Jiang and Stivers, 2002). Fluorescence studies using 2′-FU 
have confirmed that pyrene acts as a surrogate for the leucine side chain  (Jiang et al., 
2002b).  This  confirms  that  leucine  has  an  important  role  in  the  pushing  and  plugging 
stages of the flipping process. 
Pyrene is also able to rescue serine mutations involved with initial uracil recognition by 
preorganising the uracil into an extrahelical conformation. Though pyrene is able to rescue 
the effects of L191A by providing the driving force to deliver uracil in the active site, it is 
unable to rescue the effects of N123G or serine mutations. This is because it does not play 
a role in the stabilisation of uracil when bound in the active site (Jiang et al., 2002b). This 18 
 
is expected as pyrene is used purely as a substitute for leucine and forms no active site 
interactions  (Mol  et  al.,  1995b,  Parikh  et  al.,  1998).  This  therefore  suggests  that  this 
asparagine binds late in the flipping process and only once the uracil is in the active site 
(Jiang et al., 2002b). 
1.3.1.5 Active Site Composition and Mechanism of UDG 
Two short sequence motifs are conserved in the active site of Family 1 UDGs, even though 
some UDGs such as hUDG are larger enzymes. hUDG contains an extra 81 residues at the 
N-terminal that act as a signal sequence for post translational translocation to either the 
nucleus (UNG2) or mitochondria (UNG1) (Nilsen et al., 1997, Krokan et al., 2001). Motif 
1  (also  referred  to  as  motif  A)  has  the  sequence  GQDPY  that  contains  the  catalytic 
aspartate residue, Asp64, which activates a water molecule to form a nucleophile, and a 
tyrosine, Tyr66, that assists in active site specificity (Figure 1.9). Motif 2 (also referred to 
as  motif  B)  has  the  sequence  HPSPLSA  and  is  responsible  for  complex  stabilisation 
through minor groove interactions. 
                                              Motif 1 
eUDG            RQSGVTIYPPQKDVFNAFRFTELGDVKVVILGQDPYHGPGQAHGLAFSVR 80 
hUDG            RK-HYTVYPPPHQVFTWTQMCDIKDVKVVILGQDPYHGPNQAHGLCFSVQ 131 
hsv1UDG         C-QTEEVLPPREDVFSWTRYCTPDEVRVVIIGQDPYHHPGQAHGLAFSVR 194 
                      : ** .:**.  :     :*:***:****** *.*****.***: 
 
eUDG            PGIAIPPSLLNMYKELENTIPGFTRPNHGYLESWARQGVLLLNTVLTVRA 130 
hUDG            RPVPPPPSLENIYKELSTDIEDFVHPGHGDLSGWAKQGVLLLNAVLTVRA 181 
hsv1UDG         ANVPPPPSLRNVLAAVKNCYPEARMSGHGCLEKWARDGVLLLNTTLTVKR 244 
                  :. **** *:   :..       ..** *. **::******:.***:  
 
eUDG            GQAHSHASLGWETFTDKVISLINQHREGVVFLLWGSHAQKKGAIIDKQRH 180 
hUDG            HQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRH 231 
hsv1UDG         GAAASHSRIGWDRFVGGVIRRLAARRPGLVFMLWGTHAQNA-IRPDPRVH 293 
                  * **   **: *.. *:  :  .  *:**:***::**:     * : * 
                      Motif 2 
eUDG            HVLKAPHPSPLSAHRGFFGCNHFVLANQWLEQRGETPIDWMPVLPAESE  229 
hUDG            HVLQTAHPSPLSVYRGFFGCRHFSKTNELLQKSGKKPIDWK------EL  274 
hsv1UDG         CVLKFSHPSPLSKV-PFGTCQHFLVANRYLETRSISPIDW-------SV  315 
                 **: .******    *  *.**  :*. *:  . .****       .  
 
Figure 1.9 Partial ClustalW sequence alignment for the three commonly studied Family 1 UDGs. Active site 
residues are highlighted in red; motif 1 and 2 are boxed. * indicates positions which have a single, fully 
conserved residue; : indicates conservation between groups of strongly similar properties (scoring > 0.5 in 
the Gonnet PAM 250 matrix); . indicates conservation between groups of weakly similar properties (scoring 
=< 0.5 in the Gonnet PAM 250 matrix). 
Motif 2 also contains a critical histidine, His187, responsible for stabilising the negative 
charge of uracil (Sartori et al., 2002) in its anionic intermediate state (Werner and Stivers, 
2000) upon cleavage of the glycosidic bond (Figure 1.10). 19 
 
 
Figure 1.10 The critical residues lining the active site of E. coli uracil-DNA glycosylase. DNA highlighted in 
red and the water molecule in blue. 
The energy gained upon UDG binding, through the serine and proline interactions with the 
DNA and uracil, starts an autocatalytic mechanism (Dinner et al., 2001). Binding causes 
disruption of a hydrogen bond between Asp64 and His134 which allows the aspartate to 
rotate  by  approximately  120
o  (Parikh  et  al.,  1998,  Xiao  et  al.,  1999).  Asp64  is  then 
correctly positioned to bind a water molecule between its side chain carboxyl and main 
chain carbonyl, (Dodson et al., 1994, Savva et al., 1995) which subsequently allows for the 
deprotonation of the water molecule to occur (Lindahl, 1974, Werner et al., 2000) forming 
an OH
- nucleophile, which is then able to undergo nucleophilic attack on the C1’ atom 
(Mol et al., 1995b, Werner et al., 2000, Jiang and Stivers, 2002) of the N-glycosidic bond. 
This is the bond that connects the base to the deoxyribose sugar of the DNA backbone, 
thus releasing the uracil base and creating an AP site (Pearl, 2000). 
Cleavage  of  the  glycosidic  bond  results  in  protonation  of  the  O2  of  uracil,  thereby 
increasing the leaving ability of the base (Savva et al., 1995) and creating the transition 
state (Mol et al., 1995b, Drohat et al., 1999b) that is stabilised by His187 (His268 in 
hUDG). His187 interacts with the 3′ phosphate of uridine, enabling it to transfer a charged 
hydrogen bond to the O2 of uracil, after moving approximately 2 Å to be in a position to 
interact  with  the  O2,  and  thus  aiding  cleavage  of  the  N-glycosidic  bond  through 
stabilisation of the transition state oxyanion (Slupphaug et al., 1996, Krokan et al., 1997, 
Drohat  and Stivers, 2000, Werner  and Stivers,  2000)  (Figure  1.11). The movement  of 
His187  by  2  Å  is  restricted  by  the  2′OH  and  3′  endo  sugar  pucker  of  RNA  uracil, 20 
 
preventing excision (Slupphaug et al., 1996). Asp64 has also been shown to bind to the 
extrahelical conformation of uracil suggesting, that along with His187, it plays a role in 
transition state stabilisation (Drohat et al., 1999a, Jiang et al., 2002a, Jiang and Stivers, 
2002).  
The flanking phosphates -2, -2, +1 and +2 of the uracil, that are involved in serine pinching, 
considerably lower the activation barrier for catalysis while also stabilising the transition 
state through interactions with the cationic sugar and repulsion of the oxyanion. It is of 
note that these phosphates also bind strongly to the ground state (Jiang et al., 2003).  
The N2 and O1 of Asn123′s side chain binds to the O4 and N3 of the uracil base via 
donation  and  acceptance  of  a  hydrogen  bond  respectively.  This  acts  as  the  “pulling” 
mechanism to aid formation of the extrahelical state and the stability of the transition state. 
It is also possible for the backbone carbonyl of Asp64 and the backbone amides of Asp64 
and Gln63 to form hydrogen bonds with the N3 and O2 of the uracil respectively to aid 
stability  (Mol  et  al.,  1995b,  Slupphaug  et  al.,  1996).  The  hydrogen  bonds  formed  by 
Asn123 are critical as its mutation results in the enzyme being unable to actively flip the 
base due to the lack of binding stability (Jiang and Stivers, 2002). 
His187 also has a large effect on lowering the activation barrier and is another critical 
residue for catalysis (Kavli et al., 1996, Drohat et al., 1999b, Xiao et al., 1999), showing 
the importance of the hydrogen bonds formed by these residues (Xiao et al., 1999, Jiang 
and Stivers, 2002). His187 and Asp64, along with Gln63, do not affect the stability of the 
active site-bound uracil, or the affinity of UDG for binding and flipping the uracil base. 
When mutated they show a decrease in activity, suggesting they have a role in glycosidic 
bond cleavage. Mutation of Asp64 to asparagine results in an increase in binding (Mol et 
al., 1995b, Drohat et al., 1999a, Jiang and Stivers, 2002) but this is most likely due to the 
more favourable interactions of the asparagine with the phosphodiester backbone (Jiang et 
al., 2001). Other active site mutations have a large detrimental effect lowering the activity  
by 93-99.9% (Kavli et al., 1996). 
Once the uracil has been flipped from the helix and entered the active site, UDG undergoes 
a conformational change and envelops the base. (Parikh et al., 1998, Stivers et al., 1999, 
Werner  et  al.,  2000).  This  mechanism  of  closing  around  the  uracil  is  probably  a 
contributing factor in the specificity, forming the correct hydrogen bonds with Asn123 
(Mol et al., 1995b, Savva et al., 1995), which keep the uracil in the correct orientation for 21 
 
cleavage and are essential for leaving group activity (Drohat et al., 1999a, Drohat et al., 
1999b). Only uracil-containing DNA produces a decrease in tryptophan fluorescence as 
this base is the only one that is able to induce the conformational change in UDG (Stivers 
et  al.,  1999).  Asn123,  Leu191,  Ser88  and  Ser189  play  important  roles  in  the 
conformational change that occurs after the base has been flipped out, as seen with mutants 
that are defective in this mechanism (Mol et al., 1995b, Savva et al., 1995, Jiang et al., 
2002b). 
Mutants of Asn123, Leu191, Ser88 and Ser189 acting against 2′-FU arrest with uracil in an 
extrahelical conformation without clamping and active site docking, and in turn prevent 
cleavage. A decrease in tryptophan fluorescence is not observed, but an increase in 2-AP 
(located adjacently 5′ to the 2′-FU) fluorescence is still seen. This is because the enzyme is 
incapable of undergoing the conformational changes that are required to close around the 
base; a mechanism that alters the position and thus fluorescence of the tryptophan residue. 
It therefore appears that either the active site has become larger, allowing access by 2′-FU, 
or that the DNA is distorted, changing the base stacking and so producing an increase in 2-
AP fluorescence (Jiang and Stivers, 2002). These observations show the importance of the 
critical asparagine in the later stages of UDG’s mechanism. 
The Asn123 in eUDG (and N204 in hUDG) could theoretically form hydrogen bonds with 
cytosine as well as uracil by rotating the amino acid side chain, since this does not interact 
with any other part of the protein. In order to maintain the correct orientation, the side 
chain amide of the asparagine makes a hydrogen bond with a water molecule, that in turn 
bonds with a further two water molecules. These molecules make further connections with 
the main chain  carbonyls  and peptide  nitrogen’s, and therefore  fix its orientation.  The 
opposite orientation would produce a repulsive force between the water and amide, and so 
would  be  energetically  unfavourable.  This  water  molecule  also  interacts  with  another 
group of water molecules that bind to the O4 of uracil. If this was a cytosine then a second 
repulsive interaction would occur between the protons. Fixing the orientation of asparagine 
by interaction with these water molecules is therefore critical for the enzyme’s specificity 
(Pearl, 2000). 22 
 
 
Figure 1.11 N-Glycosidic bond cleavage mechanism. A) Asp64 deprotonates a water molecule to create an 
OH
- nucleophile. B) The nucleophile attacks the C1’ of the ribose ring. C) The N-Glycosidic bond is cleaved 
and the transition state of the free uracil is stabilised by His187. D) The uracil base in its native form due to 
rearrangement of electrons that also allows the regeneration of the catalytic Asp64. DNA highlighted in red 
and the water molecule/OH nucleophile in blue. 
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1.3.1.6 Events after Excision 
Dissociation  of  the  released  base  is  the  major  rate-limiting  step  of  the  reaction,  and 
requires reversal of the conformational change that clamped the base (Jiang and Stivers, 
2002). Dissociation of the base is also delayed if the next enzyme in the BER pathway is 
not available, as UDG stays bound to protect the AP site (Parikh et al., 1998) in order to 
prevent misincorporation of another base. UDG also has nanomolar affinity for AP-DNA 
and is thus inhibited by its presence (Parikh et al., 1998). 
UDG  can  be  inhibited  by  its  product,  free  uracil,  but  this  only  occurs  at  millimolar 
concentrations (Slupphaug et al., 1996). It is also inhibited by the Bacillus subtilis uracil 
DNA  glycosylase  inhibitor  (Ugi)  (Bennett  and  Mosbaugh,  1992),  and  other  peptide 
inhibitors including ssDNA binding (SSB) proteins (Handa et al., 2001) that are involved 
in  DNA  replication,  repair  and  recombination.  These  peptide  inhibitors  mimic  the 
interaction of UDG with DNA and in turn prevent binding of DNA or a polynucleotide 
(Mol et al., 1995a, Savva and Pearl, 1995). 
Once  the  free  base  has  dissociated,  the  next  enzyme  in  the  BER  pathway,  apurinic 
endonuclease (APE), which has been suggested to directly interact with UDG (Pettersen et 
al., 2007), removes the abasic sugar and the 3′ phosphate. The correct nucleotide is then 
inserted by a DNA polymerase and finally the DNA backbone is sealed by DNA ligase 
(Krokan et al., 1997, Pearl, 2000) (Figure 1.12). 
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Figure 1.12 The mechanism of the BER pathway (Adapted from Lindahl, 1993). Uracil DNA glycosylase 
recognises the G.U mismatch in DNA and removes uracil. An AP Endonuclease breaks the phosphodiester 
backbone  allowing  the  removal  of  the  ribose  and  phosphate  associated  with  the  excised  uracil  base 
generating an abasic site. DNA polymerase then inserts cytosine (to correctly base pair with guanine) and 
DNA ligase seals the backbone completing repair.  
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1.3.1.7 The Role of Phenylalanine 77 and Tyrosine 66 in Thymine Exclusion 
A conserved phenylalanine, Phe77, sits at the bottom of the active site (Mol et al., 1995b) 
and stacks with uracil through van der Waals interactions (Savva et al., 1995). This mimics 
the stacking of the pyrimidine ring and helps to stabilise the docked state (Mol et al., 
1995b, Krokan et al., 1997). The phenylalanine’s carbonyl oxygen forms a hydrogen bond 
with the OH of Tyr66, and both these residues are highly conserved in Family 1 UDGs. 
Phe77 and Tyr66 assist in shape complementarity, whilst Tyr66 also prevents thymine 
from entering the active site of UDG (Mol et al., 1995b, Kavli et al., 1996). Initial base 
sampling does not discriminate between uracil and thymine and it is only upon docking 
into the active site that discrimination occurs through Tyr66 (Parker et al., 2007). This is 
because Tyr66 acts as a barrier preventing entry of thymine, since there would be a steric 
clash between the aromatic ring of tyrosine and the methyl group of thymine (Mol et al., 
1995b, Kavli et al., 1996) (Figure 1.13).  
 
Figure  1.13  Thymine  exclusion  by  UDG.  A)  Normal  binding  of  uracil  (red)  within  the  active  site.  B) 
Exclusion mechanism of thymine (red) whereby if bound a steric clash (broken blue circle) occurs between 
thymine and Tyr66. dR: deoxyribose. 
This is important in specificity as the 5-methyl group is the only difference between uracil 
and thymine. Tyr66 is kept in place via its H-bond with Phe77 and also through van der 
Waals interactions with Val160 and Pro167 (Mol et al., 1995a). The tyrosine also excludes 
the  larger  purine  bases,  as  their  rings  would  also  clash  with  the  side  chain  of  Tyr66. 
Although cytosine is also a pyrimidine it is excluded by repulsive interactions with the 
polar groups that line the active site, which would also interact unfavourably with purines. 
Thymine may also be excluded through favourable hydrophobic interactions with its ring 
and methyl group at the mouth of the active site. This may act as a “trap” that prevents 26 
 
thymine  from  entering  the  active  site.  In  order  for  thymine  to  bind  it  would  have  to 
displace  the  nucleophilic  water  molecule,  which  would  result  in  the  catalytic  Asp64 
rotating away from the substrate, and thus inhibiting the enzyme (Savva et al., 1995). 
1.3.1.8 Tyrosine 66 Mutations 
The mutation of tyrosine at position 66 (eUDG) to a phenylalanine (Y66F) only causes a 
small  reduction  in  UDG  activity  (Kavli  et  al.,  1996).  These  residues  only  differ  by  a 
hydroxyl group and both contain an aromatic ring that blocks the entry of thymine (Mol et 
al., 1995a). However, mutation of Tyr66 to a smaller residue such as alanine (eUDG Y66A; 
hUDG Y147A) creates a larger space in the active site that is able to accommodate the 5-
methyl group of thymine. This mutant is therefore able to excise thymine as well as uracil, 
generating a thymine DNA glycosylase (TDG) (Kavli et al., 1996). Mutation of Y66 to 
cysteine  or serine (Y66S/C), results in minimal uracil activity and a decrease in  TDG 
activity in comparison to Y66A. This contradicts with the notion that the tyrosine’s sole 
role is to provide a steric block towards thymine (Handa et al., 2002). Though these TDGs 
have reduced activity, they still have a higher turnover rate than most other glycosylases 
(Kavli  et  al.,  1996,  Handa  et  al.,  2002).  This  then  suggests  that  Y66  plays  a  role  in 
catalysis, possibly by stabilising the transition state through van der Waals interactions 
with Y66 and C5 of uracil (Handa et al., 2002). 
The  weaker  TDG  activity  of  the  Y66A/S/C  mutants  led  to  a  4-fold  higher  mutation 
frequency within E. coli in comparison to wild type UDG (Kavli et al., 1996). Addition of 
wild type UDG decreased the mutation frequency in an UDG
- background (Kavli et al., 
1996), highlighting its importance in DNA repair. It is of note that these Y66 mutants are 
extremely cytotoxic and can only be produced in vitro (Handa et al., 2002). 
Interestingly, though still active towards uracil, mutation to tryptophan (Y66W) reduces its 
inhibition by either uracil or DNA containing an AP site (AP-DNA) (Acharya et al., 2003). 
It has been proposed that a UDG deficient in its ability to bind AP-DNA could leave the 
site open, increasing mutation  frequency  (Bharti and Varshney, 2010). The tryptophan 
causes a widening of the uracil binding pocket  and does not prevent  access by uracil. 
However, free uracil does not inhibit this mutant in contrast to UDG or its Y66F/H/L 
mutants. It has been suggested that uracil may also bind to a second site resulting in non-
competitive inhibition (Acharya et al., 2003). As might be expected this mutant has no 27 
 
TDG activity as entry of thymine into the active site would cause a steric clash between the 
5-methyl group of thymine and the tryptophan’s side chain (Bharti and Varshney, 2010). 
These mutant UDGs with TDG activity are able to excise both uracil and thymine opposite 
either  adenine  or  guanine,  whereas  natural  TDGs,  belonging  to  Family  2  (Waters  and 
Swann, 1998), are only able to recognise the bases mismatched with guanine (Kavli et al., 
1996). 
1.3.1.9 Properties of Cytosine DNA Glycosylases 
UDG discriminates between uracil and cytosine, which only differ in hydrogen bonding at 
the C4 and N3 positions of the pyrimidine ring. A cytosine DNA glycosylase (CDG) can 
be created by mutating the critical asparagine to an aspartate (N123D for eUDG). This 
alters the hydrogen bond donor and acceptor pattern, allowing recognition of cytosine as 
well as uracil; shown by red hydrogen bonds in Figure 1.14. This occurs through hydrogen 
bonding between the carboxylate of aspartate and the 4-amino group of cytosine (Kavli et 
al., 1996). 
 
Figure 1.14 Alteration of the hydrogen bond pattern for N123D. dR: deoxyribose. 
N123D is highly cytotoxic, as with Y66A (which has greater activity) as they excise the 
natural bases cytosine and thymine respectively. This will destroy the DNA and result in 
death of the host cell when expressing the proteins within a bacterial cell. When mutating 
hUDG, hCDG could only be produced in a recA
+ strain of E. coli in which, in the absence 
of the IPTG inducer, the turnover rate of the enzyme was low enough for the host cell to 
repair the DNA damage (Kavli et al., 1996). DNA degradation was still observed, and over 
time the DNA became too damaged and affected the survival of the host cell. The E. coli 
variant, eCDG appears to be even more cytotoxic in E. coli than the human counterpart as 28 
 
no transformants were produced (Kwon et al., 2003 and results presented in this thesis). 
eCDG can be produced through an in vitro transcription translation system (Handa et al., 
2002) and has only been produced in E.coli as a double mutant with L191A. As previously 
stated the leucine mutation prevents base flipping and excision, as the base is not in an 
extrahelical conformation and so cannot enter the active site of the enzyme. This renders 
the asparagine mutation inactive, though CDG activity is restored by placing the cytosine 
opposite a pyrene (Kwon et al., 2003). 
CDG still retains excision activity on uracil, which could be due to protonation of the 
aspartate’s  side  chain,  causing  a  change  in  the  hydrogen  bonding  pattern,  which  is 
observed around a pKa of 6-7 (Kwon et al., 2003). However, this residual uracil activity is 
most likely caused by the opposite rotamer of aspartate (Pearl, 2000). This could occur 
through the water molecules, which anchor the original asparagine in place, not acting in 
the same way towards the aspartate substitute. This allows the aspartate’s side group to 
rotate and reverse its hydrogen bonding pattern, and thus be in the correct position to 
hydrogen bond to uracil. 
It has been shown that the optimum pH for cytosine excision is approximately 6.2; this 
allows for protonation of Asp123 and for Asp64 to be deprotonated. This was due to a 
pronounced bell-shape pH-rate profile whereby it was suggested that the ascending limb 
represents the deprotonation of Asp64, and the descending limb the protonation of Asp123 
(Kwon  et  al.,  2003).  This  neutralises  the  positive  charge  on  the  base  in  its  anionic 
intermediate state during catalysis (Werner and Stivers, 2000). Protonation of Asp123 may 
be important in hydrogen bonding to the H4 and the donation of a proton to the N3 of 
cytosine, which aids release of the base from its transition state (Kwon et al., 2003). This is 
consistent with protonation of the N3 that aids catalysis of the non-enzymatic hydrolysis of 
cytosine (Shapiro and Danzig, 1972). 
Using the L191A and pyrene rescue (as mentioned in 1.3.1.4) it is possible to create a 
Cytosine/Pyrene DNA glycosylase (CYDG) (Kwon et al., 2003).  As with UDG, pyrene 
(Pn) is able to rescue the effects of the leucine mutation through mimicry (Figure 1.15). 
CYDG is able to excise cytosine from a Pn.C base pair but not a G.C pair. This is because 
the mutant enzyme is unable to flip the base without the bulky pyrene residue. The activity 
of CYDG is comparable to that of other DNA glycosylases, though it has 10
12 fold lower 
catalytic power than UDG and 10
4 fold less than thymine DNA glycosylase (TDG) (Kwon 29 
 
et al., 2003), a member of Family 2 UDGs (Waters and Swann, 1998, Abner et al., 2001). 
CYDG has minimal G.C activity, 2600 fold less than Pn.C, as it is unable to perform the 
push and plug mechanism (Kwon et al., 2003). 
 
Figure 1.15 Pyrene rescue of CDG. A) Normal mechanism of CDG using Leu191 to force cytosine into an 
extrahelical  conformation.  B)  L191A  mutation  causing  inhibition  of  UDG  through  preventing  cytosine 
flipping.  C)  Incorporation  of  a  pyrene  (Pn)  nucleotide  to  act  as  a  wedge  to  force  the  cytosine  into  an 
extrahelical conformation; rescuing the effects of the L191A mutation. dR: deoxyribose. 
Y66A has also been created as a double mutant with L191A. In a similar fashion to that of 
CYDG,  this  creates  a  thymine/pyrene  DNA  glycosylase  (TYDG)  that  is  100  fold  less 
active  than  CYDG.  TYDG  has  no  activity  towards  A:T  and  is  therefore  specific  for 
excision of thymine from Pn.T base pairs (Kwon et al., 2003). 
1.3.2 Family 2 UDGs 
Mismatch-specific uracil DNA glycosylase (MUG) and thymine DNA glycosylase (TDG) 
are similar enzymes that have the ability to excise thymine and are the two members of 
Family 2 UDGs. Both  enzymes  also have uracil excision activity, but only when it is 
mismatched opposite guanine (Neddermann and Jiricny, 1994); its activity is determined 30 
 
by how easily the base pair can be disrupted. This is due to insertion of a leucine residue 
into the space left by the flipped out base (that is more extensive than Family 1) and 
intercalation of an arginine (Figure 1.16) into the distal strand that also provides selectivity 
towards G.U (Gallinari and Jiricny, 1996, Barrett et al., 1998a, Barrett et al., 1998b, Pearl, 
2000).  These  enzymes  show  no  ssDNA  activity  and  are  not  greatly  inhibited  by  Ugi 
(Gallinari  and Jiricny, 1996,  Lutsenko and  Bhagwat,  1999, Waters et  al., 1999). They 
possess high affinity for the AP site produced (O'Neill et al., 2003) that is most likely due 
to it not retaining uracil in the active site post excision (Pearl, 2000). The strong affinity for 
AP sites also means that it is only able to process one thymine at a time (Waters and 
Swann, 1998), and it is unable to move on to the next reaction until it has been displaced 
by APE1 (Waters et al., 1999, Fitzgerald and Drohat, 2008), which increases the turnover 
rate of TDG. However, Deinococcus radiodurans MUG is able to excise uracil from G.U, 
A.U base pairs and from ssDNA (Moe et al., 2006). 
 
Figure 1.16 The ability of MUG to hydrogen bond with the opposing widowed guanine base, mimicking that 
of the flipped out uracil base. DNA highlighted in red and the water molecule in blue. 
Unlike other UDGs, Family 2 enzymes function as dimers (Maiti et al., 2008, Grippon et 
al., 2011, Morgan et al., 2011) and have slightly different residues within the conserved 
motifs  of  Family  1  UDGs  resulting  in  lower  activity  and  a  different  recognition  and 
catalytic mechanism (Pearl, 2000). The lower activity is due to a lack of ability to activate 
a  water  molecule  for  nucleophilic  attack  of  the  N-glycosidic  bond,  and  cleavage  only 
occurs through a dissociative mechanism (Mol et al., 1995b, Barrett et al., 1998b, Barrett 31 
 
et  al.,  1999,  Bennett  et  al.,  2006).  This  explains  why  MUG  has  only  10%  sequence 
homology to Family 1 UDGs but retains good structural homology (Barrett et al., 1998b). 
MUG is less able to excise thymine from G.T mismatches, than TDG. It has 120 fewer 
residues at its N-terminus (Gallinari and Jiricny, 1996), suggesting that thymine excision is 
not solely due to active site selectivity (Liu et al., 2008). MUG also contains a serine 
(Ser23) that clashes with the 5-methyl group of thymine causing its weak thymine excision 
activity (Hardeland et al., 2000, Moe et al., 2006). TDG contains an alanine (Ala145 in 
hTDG), in the position of the critical tyrosine in Family 1 UDGs, and thymine can more 
easily be accommodated in the active site (Barrett et al., 1999). It has been shown that the 
TDGs thymine activity is related to the balance of substrate interaction and the activation 
energy required for cleavage (Hardeland et al., 2000). This also confirms the importance of 
tyrosine in Family 1 for thymine  exclusion (Gallinari and Jiricny, 1996, Barrett et al., 
1998b). Both MUG and TDG are able to excise the cytosine adduct 3,N4-ethenocytosine 
(created through reaction with vinyl chloride (Hang et al., 1998, Saparbaev and Laval, 
1998), ethyl carbamate (Leithauser et al., 1990), and also via lipid peroxidation (Borys-
Brzywczy et al., 2005)) with greater affinity than uracil and forms the same “wobble” 
pairing as G:T (Abu and Waters, 2003). Unlike G.T, 3,N4-ethenocytosine is displaced 
towards the major  groove while the  guanine  remains  stacked within the DNA duplex, 
though both are displaced vertical as well as horizontally (Cullinan et al., 1997).  It is able 
to excise 3,N4-ethenocytosine due to its larger active site (Hang et al., 1998, Saparbaev 
and Laval, 1998, Lutsenko and Bhagwat, 1999, O'Neill et al., 2003) producing greater 
destabilisation  of  the  duplex  requiring  less  energy  to  force  it  into  an  extrahelical 
conformation (Sagi et al., 2000).  
More recently hTDG (and MUG) have been shown to excise 7,8-dihydro-8-oxoadenine 
(8oxoA) when opposite any of the three standard bases (Talhaoui et al., 2013), and like 8-
hydroxyguanine  (8oxoG),  it  is  generated  from  reactive  oxygen  species;  e.g.  hydroxyl 
radicals (OH•) (Lindahl, 1993). hTDG excises 8oxoA with similar efficiency to thymine 
and  3,N4-ethenocytosine  (Talhaoui  et  al.,  2013)  further  emphasising  the  role  of  these 
enzymes for repairing mutagenic base adducts. 
As with Family 1 the rate of excision is dependent on the flanking sequences that alter the 
stability of the base pair (Hang et al., 1998), most notably the nature of the 5′ base (Abu 
and Waters, 2003). This is because the 5′ base aids stabilisation of the transition state for 32 
 
thymine but is able to stabilise both the transition state and enzyme-substrate complex for 
3,N4-ethenocytosine. 
In summary, Family 2 enzymes’ main role appears to be the removal of cytosine adducts, 
as UDGs are far more active than MUG and are sufficient for excision of uracil for DNA 
repair. This is also supported by the observation that MUG does not affect the number of5-
methylcytosine  to  thymine  or  cytosine  to  uracil  transition  mutations  (Lutsenko  and 
Bhagwat, 1999). The primary role of TDG is most likely the removal of thymine from G.T 
mismatches that arise at CpG sites (Waters and Swann, 1998, Sagi et al., 2000), as these 
are hotspots for mutations (Shen et al., 1992) as5-methylcytosine can be deaminated to 
create thymine, producing a G.T mismatch (Sartori et al., 2002). 
1.3.3 Family 3 UDGs 
A third Family of UDGs was first identified in Xenopus (Haushalter et al., 1999) and was 
first  thought  to  be  exclusive  to  eukaryotes  but  was  later  found  in  numerous  bacteria 
(Pettersen et al., 2007, Mi et al., 2009). They are able to excise uracil from ssDNA with 
their affinity being only slightly lower affinity than that of Family 1 enzymes, with their 
affinity for G.U being considerably lower, resembling that of Family 2. It therefore appears 
to have hybrid properties of UDGs and TDG/MUGs (Pettersen et al., 2007). Due to its 
greater preference for ssDNA in comparison to Family 1 UDGs, it was given the name 
Single-strand-selective mono-functional uracil DNA glycosylase (SMUG1) (Pearl, 2000), 
even though SMUG1 is up to 700 times more active against ds than ssDNA substrates 
(Wibley et al., 2003) under physiological conditions (Doseth et al., 2012). It is therefore 
essentially  a  double-strand-selective  DNA  glycosylase.  It  also  shows  activity  towards 
xanthine (X) but has no activity towards hypoxanthine and oxanine; deaminated analogues 
of adenine and guanine respectively (Mi et al., 2009). 
As  with  Family  1  the  asparagine  (N58)  is  critical  for  catalysis  and  if  mutated  to  an 
aspartate results in a loss of activity (Mi et al., 2009), while it utilises another asparagine 
for the activation of  the  water molecule (Mol et al., 1995b, Savva et al., 1995). In contrast 
to the other families, SMUG1 has an arginine instead of leucine for plugging the space left 
by the flipped out  base. This  substitution  does not affect  the ability of the enzyme to 
occupy the space and an L191R mutation in UDGs only serve to increase the affinity for 
the abasic product (Slupphaug et al., 1996). 33 
 
1.3.4 Family 4 UDGs 
Family 4 UDGs were initially discovered through homology screening of MUG in the 
thermophilic bacterium Thermotoga maritima. Studies on this class of enzyme have shown 
heat stability of up to 75°C and for up to 15 minutes at 85°C without the loss of activity, 
giving  them  the  name  “thermophilic  UDGs”.  This  was  designated  as  a  new  class  of 
enzyme  as  no  homologues  have  been  found  in  eukaryotes,  though  others  have  been 
identified in other thermophilic bacteria (Sandigursky and Franklin, 1999, Sandigursky et 
al.,  2001).  Despite  low  homology  they  are  most  similar  to  MUG  (Sandigursky  and 
Franklin, 1999), as they too do not contain asparagine or aspartate as the catalytic residue 
within the active site (Pearl, 2000), though they do contain a conserved asparagine which 
could  support  a  water  molecule  for  attack  of  the  C1’  of  uracil  (Kosaka  et  al.,  2007). 
Glycosidic bond cleavage occurs via a dissociative mechanism (Figure 1.17) (Hoseki et al., 
2003); DNA distortion causes strain on the glycosidic bond that weakens it and provides 
the required energy to aid cleavage  (Parikh et  al., 2000). These thermophilic enzymes 
recognise uracil in the same manner as Family 1 and act on dsDNA regardless of the 
opposing base, and ssDNA through a positively charged active site (Hoseki et al., 2003) 
while showing no activity towards thymine (Sandigursky et al., 2001, Hoseki et al., 2003). 
 
Figure 1.17 Dissociative mechanism of N-Glycosidic bond cleavage by Family 4 UDGs. 
The majority of these thermophilic UDGs have a quartet of cysteine residues that form a 
loop structure and are thought to act as ligands for an iron-sulphur cluster (4Fe-4S). Since 
this is located away from the active site and the binding groove, it is presumed to have no 
effect  on  the  binding  or  activity  of  the  enzyme  (Hoseki  et  al.,  2003).  The  metal  ion 
coordination of the cluster, along with salt bridges, ion pairs and proline residues within 34 
 
the loop region, may account for a balance between stability and flexibility required by a 
thermostable enzyme (Hoseki et al., 2003, Engstrom et al., 2012). It is also conceivable 
that the cluster may play a role in protein-protein interactions. 
The  first  archaeal  UDG  to  be  discovered  was  from  Archaeoglobus  fulgidus  and  was 
designated a member of Family 4 due to its thermophilic properties.  A. fulgidus UDG 
(afUDG) is most similar to T. maritima in sequence and enzymatic ability, and therefore 
suggests a similarity between BER in thermophilic bacteria and Achaea (Sandigursky and 
Franklin, 2000). The main similarity is that they have two conserved residues; a glutamate 
at positions 2 and 5 and a leucine at positions 4 and 7 for afUDG and tmUDG respectively. 
These could be important for their folding and thus their thermostability, though these 
residues are not conserved in any other thermophilic UDG’s (Sandigursky et al., 2001). As 
with other UDGs it is able to excise uracil when paired with either guanine or adenine and 
is able to act on ssDNA, whilst having no activity for excising thymine (Sandigursky and 
Franklin, 2000). 
1.3.5 Family 5 UDGs 
This family of enzymes is similar to Family 4, and also contain four cysteine residues that 
are highly conserved and are ligands for an iron-sulphur (4Fe-4S) cluster (Hoseki et al., 
2003). However they do not contain a polar residue in motif 1. The absence of a polar 
residue suggests that glycosidic bond cleavage occurs through a dissociative mechanism 
(Figure 1.17) that does not require water (Sartori et al., 2002, Starkuviene and Fritz, 2002). 
Cleavage is therefore thought to occur via the energy that is gained from the unfavourable 
extrahelical conformation of the base, weakening the glycosidic bond (Parikh et al., 2000), 
as well as by interactions between the negative phosphate backbone and the positive C1’ 
atom (Dinner et al., 2001). These enzymes have weak uracil excision activity that is most 
likely due to their broad substrate specificity (Kosaka et al., 2007). The broad specificity 
may be due to their ability to distort the DNA by 60° (Kosaka et al., 2007), which is 
greater than the 45° of UDGs and having a larger DNA binding region (Jiang and Stivers, 
2002).  As  well  as  uracil  they  are  able  to  excise  thymine  (Hoseki  et  al.,  2003),  5′-
hydroxymethyluracil  and  5′-fluorouracil  (Starkuviene  and  Fritz,  2002),  εC  and 
hypoxanthine (Sartori et al., 2002). 
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1.4 5-Methylcytosine Detection 
The detection of 5-methylcytosine within the genome is important in the understanding of 
gene regulation. Many techniques have been developed to detect 5-methylcytsoine though 
they  are  limited  by  either  sequence  context  or  can  generate  false  positives  through 
incomplete chemical reactions. The most commonly used methods are hereby described. 
1.4.1 Bisulphite Sequencing 
The gold standard for 5-methylcytosine detection is bisulphite sequencing. The reaction of 
DNA  with  bisulphite,  shown  in  Figure  1.19  (Baylin  et  al.,  2001,  Arand  et  al.,  2012, 
Hackett et al., 2012, Su et al., 2013), causes the conversion of cytosine to uracil while 
bisulphite is unreactive towards 5-methylcytosine (Shapiro et al., 1973).  
 
Figure 1.18 The bisulphite reaction mechanism (Adapted from Clark et al., 1994). dR: deoxyribose. 
The reaction products can then be sequenced and, since all the cytosines are converted to 
uracil,  they  appear  as  thymines  in  the  sequence.  In  contrast  any5-methylcytosines  are 
unreactive and still appear as cytosines in the sequencing reaction. The result, when run 36 
 
alongside the sequence of an unreacted sample, detects the location of any methylated 
cytosines. 
Though the bisulphite method is successful and is widely used, it has many limitations 
(Grunau et al., 2001). The first is incomplete reaction of all the unmethylated cytosines, 
which then still appear in the cytosine sequencing lane, giving a false positive for cytosine 
methylation. The second is DNA degradation due to the bisulphite reaction itself resulting 
in a loss of the amount of DNA available for sequencing. The final problem is incomplete 
desulphonation  during  the  bisulphite  reaction,  which  can  inhibit  the  sequencing 
polymerase (Clark et al., 1994). To try and reduce the effects of these problems many 
different analysis methods have been developed; such as pyrosequencing (Colella et al., 
2003), methylation-sensitive single-strand conformation analysis (MS-SSCA) (Bianco et 
al., 1999), high resolution melting analysis (HRM) (Wojdacz and Dobrovic, 2007) and 
microarray based methods (Adorjan et al., 2002). 
Variations  of  bisulphite sequencing have been  developed to  enable the detection of 5-
hydroxymethylcytosine known as TAB-seq (Tet-assisted bisulphite sequencing) (Yu et al., 
2012)  and  OxBS-seq  (Oxidative  bisulphite  sequencing)  (Booth  et  al.,  2012).  TAB-seq 
works through glycosylation of 5-hydroxymethylcytosine by β-glucosyltransferase (βGT) 
followed by reaction with TET that converts any 5-methylcytosines to 5-carbonylcytosines 
while being unreactive towards cytosine and the glucosylated 5-hydroxymethylcytosine. 
Upon bisulphite treatment cytosines and 5-carbonylcytosines are converted to thymine and 
appear so when sequenced and analysed while the glucosylated 5-hydroxymethylcytosine 
is unreacted and appears as cytosine; revealing sites of  hydroxymethylation. OxBS-seq 
also  detects  the  presence  of  5-hydroxymethylcytosine  through  reaction  with  KRuO4 
followed  by  bisulphite  treatment.  5-hydroxymethylcytosines  are  converted  to  5-
formylcytosines and like 5-methylcytosine are unaffected by reaction with bisulphite. The 
resultant products can then be compared to the same sample treated with bisulphite without 
having undergone a reaction with KRuO4. Additional cytosines shown upon sequencing 
analysis indicates sites of hydroxymethylation. 
1.4.2 Bisulphite and UDG 
Similar to bisulphite sequencing, UDG has been used in conjunction with the bisulphite 
reaction to detect 5-methylcytosine (Huang et al., 2013). As cytosine is converted to uracil 
during  bisulphite  treatment  the  product  can  then  be  reacted  with  UDG  under  limiting 37 
 
conditions, to remove the uracil and fragment the DNA. The resultant products can then be 
analysed by PAGE in comparison with a control sequence containing no 5-methylcytosines 
to determine which cytosines are methylated. 
1.4.3 Methylation Sensitive Enzyme Restriction 
Some restriction enzymes are methylation sensitive and will not digest DNA if methylated. 
The enzymes HpaII and MspI (Cedar et al., 1979, McClelland et al., 1994) are commonly 
used as they both recognise the sequence CCGG, with the former not being able to cleave 
if the central cytosine is methylated. Methylation can then be determined depending on 
which enzymes are able to cleave the DNA of interest, depending upon which cytosine and 
whether both strands of the DNA are methylated. Though this method detects methylation 
at CpG sites it has a major disadvantage in that it is limited to the restriction site sequence. 
Therefore the methylation state of cytosines at CpG sites that are not in a CCGG context or 
any other cytosine of interest not in a CpG context cannot be determined. 
1.4.4 Nanopores 
Nanopore sequencing (Kasianowicz et al., 1996, Manrao et al., 2011, Manrao et al., 2012) 
has  shown  the  ability  to  not  only  sequence  DNA  but  also  provide  a  way  to  detect 
methylation. Sequencing works by dividing a solution in two via a membrane containing a 
nanopore. A voltage is then applied across the membrane to generate a current that allows 
the DNA to  enter  and transcend the pore. The  DNA  causes a  change in the potential 
difference, depending on its composition, allowing discrimination of bases. This technique 
can  be  further  exploited  to  detect  the  presence  of  5-methylcytosine  (and  5-
hydroxymethylcytosine)  as  the  presence  of  5-methylcytosine  causes  a  local  change  in 
current compared to cytosine. The difference in current can then be used to detect the 
presence of 5-methylcytosine (Laszlo et al., 2013). 
1.4.5 Triplexes 
Most  recently  it  has  been  shown  that  triplexes  can  be  used  in  the  detection  of  5-
methylcytosine (and other cytosine modifications), most notably at CpA sites (Johannsen 
et  al.,  2014).  The  technique  works  through  determining  the  stability  of  the  triplex  by 
measuring its melting temperature. It was shown that the incorporation of 5-methylcytosine 
dramatically effects the binding of the third strand and thus reduces its stability, providing 
discrimination.  Though  this  method  is  non-destructive  towards  DNA  it  is  unable  to 38 
 
determine  methylation  at  the  more  relevant  CpG  site,  while  also  showing  sequence 
dependency (it is restricted to sequences in which one strand is mainly purines); a common 
limitation with triplexes (Rusling et al., 2005).  
1.4.6 Small Molecules 
Small  molecules  have  also  been  used  to  detect  the  presence  of  5-methylcytosine.  The 
naphthyridine  dimer  (ND)  analogue,  NCD,  binds  to  GG  mismatches  in  the  sequence 
context CGG/CGG in a 2:1 stoichiometry. The binding of NCD causes disruption and 
breakage of the flanking GC base pairs resulting in the cytosines being flipped out of the 
duplex. The exposed cytosines can then be reacted with hydroxylamine-sodium bisulphite 
and  cleaved  at  these  sites  by  piperidine.  5-methylcytosine  does  not  react  with 
hydroxylamine-sodium bisulphite but does with potassium permanganate and so cytosine 
and 5-methylcytosine can be distinguished in a CGG/CGG context (where C is cytosine or 
5-methylcytosine) (Oka et al., 2008, Oka et al., 2009). 
1.4.7 Other Methods 
Thin layer chromatography (TLC) and mass spectrometry (MS) can be used to detect 5-
methylcytosine,  but  these  methods  only  allow  for  the  detection  of  the  presence  of  5-
methylcytosine, and not its specific location within DNA (Tahiliani et al., 2009). 
Immunoprecipitation (IP) with antibodies can also be used to detect the presence of 5-
methylcytosine;  once  bound  the  DNA  can  be  prepared  for  sequencing  or  microarray 
analysis (Weber et al., 2005, Down et al., 2008), providing an estimate to the degree of 
methylation  within  a  region  of  interest.  As  the  antibodies  require  more  than  one  5-
methylcytosine for efficient binding, it requires 5-methylcytosines to be in close proximity 
to each other (Sano et al., 1980, Sano et al., 1988). Therefore this method does not allow 
for  specific  detection  of  5-methylcytosine  and  only  provides  global  and/or  local 
methylation mapping. 
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1.5 Purpose of this Research 
The purpose of this research was to find an alternative way of detecting the presence of 5-
methylcytosine,  by  creating  an  enzyme  that  was  able  to  discriminate  between  it  and 
cytosine. The enzyme was created by mutating uracil DNA glycosylase (UDG) to generate 
a cytosine DNA glycosylase (CDG). Since UDG is able to exclude thymine from its active 
site as a result of steric clash with its 5-methyl group, we predicted that the mutant CDG 
should be able to exclude 5-methylcytosine by the same principle, since 5-methylcytosine 
is related to cytosine in the same way that thymine is related to uracil. Thus, CDG should 
be able to discriminate between cytosine and5-methylcytosine. 
This thesis therefore describes the production and characterisation of a series of mutants of 
E. coli and human UDG. The cleavage activity of these mutants is then examined using a 
range of radiolabelled synthetic oligonucleotides that contain different mismatches. 
1.5.1 Selection of Enzyme 
Initially all experiments were performed using the E. coli variant of UDG (eUDG), as the 
gene  was  easily  obtained  through  PCR  of  the  E.  coli  genome  using  appropriate  UDG 
specific  primers.  This  was  subsequently  cloned  into  a  cloning/expression  vector  for 
mutagenesis  purposes.  In  addition  it  was  thought  that  any  mutants  produced,  being 
derivatives  of  E.  coli enzymes,  would produce greater protein  yields  when  grown  and 
expressed in E. coli. We anticipated that the enzymes would be expressed more efficiently 
by  having  optimal  codon  usage  selecting  for  the  most  abundant  tRNAs  for  a  specific 
residue. Due to problems of cytotoxicity we were unable to obtain eCDG, but worked with 
eCYDG instead (Kwon et al., 2003). We then progressed onto using hUDG as it has been 
shown that this  is  more easily expressed in  E.coli (Kavli et  al., 1996).  As eukaryotes 
contain introns within their DNA a human variant of UDG cannot be obtained simply from 
PCR using genomic DNA as with eUDG. A clone of hUDG was therefore produced via 
complete gene synthesis with the N-terminal domain removed as this merely acts as a 
signal sequence for localisation to either the nucleus or mitochondria (Nilsen et al., 1997). 
We were able to generate both hCDG and hCYDG.   40 
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Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Oligonucleotides 
All  oligonucleotides  (Appendices  I,  II  and  III)  were  obtained  from  ATDBio  Ltd 
(Southampton, UK). They were diluted in dH2O and stored at -20°C until required. The 
anthraquinone  pyrrolidine  phosphoramidite  (Figure  2.1)  was  obtained  from  Berry  & 
Associates (Michigan, USA). 
 
Figure 2.1 The structure of anthraquinone pyrrolidine phosphoramidite. 
2.1.2 Enzymes 
All restriction enzymes were purchased from either Promega (Southampton, UK) or New 
England Biolabs (NEB) (Herts, UK). Pfu DNA polymerase and thermosensitive alkaline 
phosphatase (TSAP) were also purchased from Promega. T4 polynucleotide kinase (PNK) 
and T4 DNA ligase were also purchased from NEB. All enzymes were stored at -20°C.
 
2.1.3 Chemicals 
Radioactive  [γ-
32P]ATP  was  purchased  from  Perkin  Elmer  (Cambridgeshire,  UK)  at  a 
concentration of 3000 Ci/mmol and stored at 4°C. The vectors pUC18, pUC19 and pET28a 
were purchased from Sigma-Aldrich (Dorset, UK), and Merck Chemicals (Nottingham, 
UK)  respectively.  The  QIAprep  plasmid  purification  kit  was  purchased  from  Qiagen 
(Crawley, UK). UreaGel (20% acrylamide:bisacrylamide 19:1 containing 8 M urea) and 
Accugel  (40%  (w/v)  acrylamide:bisacrylamide  19:1)  were  purchased  from  National 
Diagnostics (Hull, UK). The SYBR Green was purchased from Life Technologies (Paisley, 
UK). The GenomeLab™ DTCS Quick Start Kit, containing the master mix (composed of 42 
 
the polymerase, buffer, dNTPs and fluorescent ddNTPs), and sample loading solution (SLS) 
were purchased from Beckman Coulter (High Wycombe, UK). 
2.1.4 Plasmids Generated in this Work 
Plasmid Name  Mutation  Notes 
pUC19eUDG    Original  construct  obtained  from  Prof.  K.  R. 
Fox.  Details  of  its  generation  are  given  in 
section 2.3.1. 
pUC19eUYDG  L191A   
pUC19eCYDG  N123D, L191A   
pUC18eUDG    Subcloned from pUC19eUDG. 
pUC18eCDG  N123D   
pUC18eUYDG  L191A   
pUC18eCYDG  N123D, L191A   
pETeUDG    Subcloned from pUC19eUDG into pET28a. 
pETUgi    Ugi  subcloned  into  pET28a  from  pRSETB; 
obtained  from  Dr.  Renos  Savva  (Birkbeck, 
University of London, UK). 
pETeUDGUgi    Fusion sequence of UDG and Ugi. 
pETeUDGUgiS    As  pETeUDGUgi,  but  with  the  internal  UDG 
(between UDG and Ugi) stop codons removed. 
pETeUDGUgiST    As  pETeUDGUgiS,  but  with  the  5′  thrombin 
cleavage site mutated. 
pETeUYDG  L191A  Inability to  flip  out  target  base due to  leucine 
mutation. 
pETeCYDG  N123D, L191A  As  above,  but  with  the  N123D  mutation  to 43 
 
CDG. 
pEThUDGΔ81    Created by total gene synthesis. 
pEThCDGΔ81  N204D   
pEThCYDGΔ81  N204D, L272A  Used for comparison with eCYDG. 
pUC19eUDGBXE    Contains  full length  linker of BglII, XhoI and 
EcoRV restriction sites (Figure 4.1A). 
pUC19eUDGBX    As  above,  but  with  removal  of  EcoRV 
restriction site (Figure 4.1B). 
pUC19eUDGB    As above, but with removal of EcoRV and XhoI 
restriction sites (Figure 4.1C). 
pUC19eUDGIF    Contains a stop codon upstream and  In Frame 
with UDG (Figure 4.2B). 
pUC19eUDGOF    Contains  a  stop  codon  upstream  and  Out  of 
Frame with UDG (and in frame with the LacZ; 
Figure 4.2C). 
 
Table 2.1 Plasmid constructs used and generated in this thesis. For pUC plasmids the UDG gene was inserted 
between the HindIII and EcoRI sites, while for pET plasmids it was inserted between the EcoRI and NdeI 
sites. Details on individual plasmid constructs are presented in appropriate places in this thesis. The wild type 
sequences for eUDG and hUDGΔ81 can be seen in Appendix V. 
2.2 Methods for Studying Base Excision 
2.2.1 Cleavage Studies and Rate of Reaction Determination 
The cleavage assay is a technique to study the ability of a DNA repair enzyme to act upon 
ds or ssDNA. In essence, the DNA is incubated with a repair enzyme to allow excision of a 
base or nucleotide. The DNA is then heated at 95°C, in the presence of 10% piperidine 
(Kwon et al., 2003), to cause a break in the phosphodiester backbone, creating a shorter 
DNA fragment, showing that excision and therefore cleavage of the DNA had occurred. 
The products of the reaction are then run on a denaturing polyacrylamide gel to separate 
the cleaved and intact DNA strands. This assay can provide a quantitative estimate of the 44 
 
enzyme’s  activity  by  comparing  the  intensities  of  the  bands  that  corresponds  to  the 
uncleaved DNA and the cleaved products. The rate of reaction is determined from the 
assumption that all the substrate is bound to enzyme as the enzyme is in excess of substrate. 
It is therefore assumed that the initial velocity represents the rate of reaction as the amount 
substrate turned over per unit time.  
2.3 Protocols 
2.3.1 Agarose Gel Electrophoresis 
Agarose gels of 0.7 – 1% (w/v) in 1x TBE buffer (unless stated otherwise) were prepared 
containing 0.1x GelRed, samples were ran in 1x TBE at 15 Vcm-1 for 1 hour and imaged 
under UV light. 
2.3.2 Site-Directed Mutagenesis 
The  wild  type  UDG  plasmid  was  constructed  by  Professor  K.  R.  Fox  (University  of 
Southampton) by PCR amplification of the E. coli UDG gene from genomic DNA and had 
been cloned into the multiple cloning site (MCS) of pUC19 between the HindIII and EcoRI 
sites using primers that included sites for NdeI and EcoRI. This was to allow the gene to be 
subcloned from pUC19 into pET28a as pUC19 doesn’t contain an NdeI site within its 
MCS. The UDG gene was then removed and inserted into the expression vector pET28a 
using the restriction enzymes and sites of NdeI and EcoRI (Figure 2.2). 
 
Figure 2.2 Plasmid maps. A) The structure of pUC19eUDG showing ampicillin resistance (red), origin of 
replication (blue), LacZα (green) and UDG (orange). B) The structure of pETeUDG showing kanamycin 
resistance (red), origin of replication (blue), LacI (green), T7 promoter (purple) and eUDG (orange). Arrows 
denote direction of transcription. 45 
 
The different mutants of eUDG were generated by site-directed mutagenesis (SDM) using 
the  QuikChange®  protocol  by  Stratagene  (Stratagene,  2004).  The  procedure,  which  is 
outlined in Figure 2.3, uses two complementary primers (Table 2.2) containing the bases to 
generate the mutation in the centre. These produce a mismatch when annealed with the 
target on the original plasmid. The mutagenic oligonucleotide primers must be of a suitable 
size  so  that  they  anneal  to  the  target  and  tolerate  the  presence  of  the  mismatch.  The 
supercoiled plasmid is first denatured at 98°C. The mutagenic primers then bind during the 
annealing stage, when the temperature is lowered to approximately 55°C. The temperature 
is then increased to approximately 70°C and the primers are extended around the plasmid 
by the polymerase. This reaction proceeds through 12 - 18 cycles of denaturing, annealing 
and  extension.  The  polymerase  should  have  3′  exonuclease  (proofreading)  activity  to 
greatly reduce the chance of secondary mutations occurring through misincorporation of an 
incorrect nucleotide. Unlike normal PCR, only linear amplification occurs as the products 
contain nicks (Figure 2.2) in the newly synthesised DNA, preventing the newly synthesised 
DNA from becoming a template in the next cycles of replication (usually 12 - 18). The 
parental/template plasmid is then removed by digestion with DpnI, as the enzyme acts only 
on methylated DNA. The newly synthesised, unmethylated annealed circular DNA can be 
transformed into competent E. coli . 
The PCR reaction solution contained 500 nM of each primer, 500 nM dNTPs, 3% DMSO, 
5  μl  of  10x  Pfu  buffer,  1  μl  of  Pfu  DNA  polymerase  (typically  2  -  3  u/μl)  and 
approximately 100 ng of DNA template in 0.5 ml PRC tubes. The sample was made up to 
final volume of 50 μl with dH2O. Samples were cycled using a TECHNE thermocycler 
using the following conditions: 
Segment 1: Cycles 01: 98°C for 2 min. 
Segment 2: Cycles 18: 98°C for 30 sec, 50°C for 30 sec and 72°C for 2 min per kb. 
Segment 3: Cycles 01: 72°C for 10 min and hold at 4°C. 
1 μl  of DpnI (Promega: typically 10 u/μl) was  added to  each sample and mixed. The 
samples were left at 37°C for a minimum of 1 hour to digest the template DNA. Finally the 
plasmids were transformed into competent E. coli XL1-Blue cells. 46 
 
 
Figure  2.3  QuikChange  site-directed  mutagenesis  (Stratagene,  2004).47 
 
Mutation  Primers 
N123D  5′-GCGTCAGGGCGTTCTGCTACTCGATACTGTGTTGACGGTACGCGC-3′ 
5′-GCGCGTACCGTCAACACAGTATCGAGTAGCAGAACGCCCTGACGC-3′ 
L191A  5′-GCACCGCATCCGTCGCCGGCGTCGGCGCATCGTGGATTC-3′ 
5′-GAATCCACGATGCGCCGACGCCGGCGACGGATGCGGTGC-3′ 
A191L  5′-GCACCGCATCCGTCGCCGCTTTCGGCGCATCGTGGATTC-3′ 
5′ GAATCCACGATGCGCCGAAAGCGGCGACGGATGCGGTGC 3′ 
N204D  5′-GGTGTTCTCCTTCTCGACGCTGTCCTCACGG-3′ 
5′-CCGTGAGGACAGCGTCGAGAAGGAGAACACC-3′ 
eUDGUgi 
Stop 
Codons 
5′-TTACCGGCAGAGAGTGAGGGAGGAGAATTCCTGGTGCCGCGC-3′ 
5′-GCGCGGCACCAGGAATTCTCCTCCCTCACTCTCTGCCGGTAA-3′ 
Thrombin  5′-AGCGGCCTGGTGCCGGGCGGCAGCCATATGG-3′ 
5′-CCATATGGCTGCCGCCCGGCACCAGGCCGCT-3′ 
 
Table  2.2  Sequences  of  oligonucleotide  primers  used  in  site-directed  mutagenesis.  Base  substitutions 
highlighted in red. 
2.3.3 Preparation of Competent Cells 
E.coli XL1-Blue cells were first grown on agar plates containing no antibiotic. A colony 
was selected and grown overnight at 37°C in 2YT media (16 g tryptone, 10 g yeast extract 
and 5 g NaCl per litre). 1 ml of these cells was transferred to 100 ml of 2YT media and 
grown to O.D. of 0.6 - 0.8, measured at 600 nm. The cells were transferred into 2 x 20 ml 
Sterilin tubes and centrifuged at 1950 x g for 10 minutes at 4°C. The supernatant was 
removed and the pellet resuspended in 20 ml of transformation buffer (50 mM CalCl2, 10 
mM Tris-HCl pH 7.4) and placed on ice for 30 minutes. The suspension was spun again, 
the supernatant was removed, and the pellet was resuspended in 5 ml of transformation 
buffer. Glycerol was added to the solution to give a final concentration of 15% (v/v) and 
made into 500 μl aliquots and stored at -80°C for future use when transforming plasmids. 
2.3.4 Transformation 
XL1-Blue competent cells (200 μl) were added to either 50 μl of the SDM reaction from 
the PCR mutagenesis, or 20 μl of the ligated construct. The solution was placed on ice for 
30 minutes, heat shocked for 1 minute at 42°C and placed back on ice for a further 2 
minutes. The bacteria were grown out with the addition of 500 μl of 2YT media to the 
solution and left at 37°C for 1 hour. The solution was plated onto blood agar (40 g blood 48 
 
agar per litre) plates containing the relevant antibiotic (Table 2.3) and grown overnight at 
37°C. Plates were stored at 4°C until required. 
Procedure  Plate Composition 
pET28a Mutagenesis/Cloning  30 μg/ml kanamycin 
pUC18/19 Mutagenesis  100 μg/ml carbenicillin 
pUC18  to  pUC19  Cloning 
(Blue/White Selection) 
100 μg/ml  carbenicillin,  0.5 mM  IPTG, 0.02% 
(w/v) X-Gal 
Protein Purification in pET28a 
vector 
30 μg/ml kanamycin, 50 μg/ml chloramphenicol 
 
Table 2.3 Composition of agar plates. 
2.3.5 Plasmid Purification 
Single colonies were picked from the agar plates and shaken overnight at 37°C in 5 ml of 
2YT media containing the same concentration of antibiotic as used in the agar plate that 
the colony had been taken from. The culture was transferred into 1.5 ml Eppendorf tubes 
and centrifuged at 6100 x g for 4 minutes. The plasmids were purified using a Qiagen 
QIAprep kit following the manufacturer’s protocol. The supernatant was removed from the 
Eppendorf tubes and the cells resuspended in a total of 250 μl buffer P1. The cells were 
lysed under alkali conditions by the addition of 250 μl buffer P2 and neutralised with 350 
μl  of  buffer  N3.  The  solution  was  centrifuged  at  17,900  x  g  for  10  minutes  and  the 
supernatant transferred into a spin column provided. The column was centrifuged at 17,900 
x g for 1 minute and the supernatant discarded. 0.5 ml of buffer PB was added to remove 
any  remaining  cellular  debris  and  centrifuged  again  at  17,900  x  g  for  1  minute.  The 
supernatant was again discarded and 0.75 ml of buffer PE was added to the column and 
centrifuged twice at 17,900 x g for 1 minute discarding the supernatant in between each 
centrifuge. This was to remove salt within the solution and any remaining contaminants. 
Finally the column was place into an Eppendorf tube and 50 μl of buffer EB was added. 
The solution was centrifuged for a final time at 17,900 x g for 1 minute and the flow-
through  containing  the  purified  plasmid  was  collected  in  an  Eppendorf  tube.  The 49 
 
concentration and quality of the plasmid was determined using a Nanodrop 2000c (Thermo 
Scientific) and stored at -20°C until required. 
2.3.6 DNA sequencing 
Sequencing  was  either  performed  by  MWG  Eurofins  (Germany)  or  manually  using  a 
Beckman Coulter CEQ8000 genetic analysis system. Chromatograms can be viewed in 
Appendix VI. 
The  samples  for  analysis  by  the  CEQ8000  were  prepared  by  first  undergoing  PCR. 
Between 100 - 195 ng pUC, or 260 - 390 ng of pET plasmids was taken and made up to 11 
μl with dH2O in 0.5 ml PCR tubes. The samples were heated at 95°C for 1 minute to 
denature the supercoiled DNA. 1 μl of 5 μM  of primer (5 pmoles  primer in  the final 
reaction) and 8 μl of master mix were added to make a final volume of 20 μl. Samples 
were then cycled using a TECHNE thermocycler using the following conditions: 
Segment 1: Cycles 30: 96°C for 20 sec, 50°C for 20 sec and 60°C for 4 min. 
Segment 2: Cycles 01: Hold at 4°C. 
The samples were cleaned-up by transferring into 1.5 ml Eppendorf tubes. 5 μl of stop 
solution (20 μl 3 M EDTA, 20 μl 100 mM NaOAc, 10 μl Glycogen and 60 μl 95% ethanol) 
was added to each sample and mixed thoroughly. The samples were centrifuged at 4°C for 
5 minutes at 13000 x g. The supernatant was removed and 200 μl of 70% ethanol added 
followed by centrifugation at 4°C for 5 minutes at 13000 x g. This step was then repeated 
and the samples vacuum dried using a SpeedVac to remove any residual ethanol. Each 
pellet was re-suspended in 40 μl of SLS and transferred to a 96 well plate with a drop of 
mineral oil put on top of each sample. The samples were loaded into the CEQ8000 and 
sequenced. 
2.3.7 Gene Amplification 
Gene  amplification was performed to  obtain  large amounts  of the  gene of interest  for 
cloning  purposes,  rather  than  direct  sub  cloning  of  one  plasmid  to  another.  Gene 
amplification was also used after N123D mutagenesis to generate a product that could be 
sent for sequencing. This was to confirm whether site-directed mutagenesis was working 
when determining the cytotoxicity of eCDG. The eUDG mutant variants were amplified 
from pUC18 using flanking primers that also included the restriction sites required for 
cloning  (Figure  2.4A).  Ugi,  obtained  with  thanks  from  Dr.  Renos  Savva  (Birkbeck, 50 
 
University of London, UK), was amplified using flanking primers designed to incorporate 
additional  unpaired  bases  at  the  5′  terminus  that  included  restriction  sites  required  for 
cloning or the addition of a thrombin cleavage site (Figure 2.4B). 
The  PCR  reaction  solution  was  prepared  in  the  same  manner  as  for  the  site-directed 
mutagenesis protocol but with different cycling conditions: 
Segment 1: Cycles 01: 98°C for 2 min. 
Segment 2: Cycles 30: 98°C for 30 sec, 50°C for 30 sec and 72°C for 2 min per kb. 
Segment 3: Cycles 01: 72°C for 10 min and hold at 4°C. 
The amplified genes were stored at -20°C until required. 
A 
 
5′-TGTAAAACGACGGCCAGT-3′ 
5′-TCACACAGGAAACAGCTATGAC-3′ 
 
B 
 
5′-TCAGCTGAATTCCTGGTGCCGCGCGGCAGCATGACAAATTTATCTGACATCATTG-3′ 
5′-TAGTACAAGCTTATAACATTTTAATT-3′ 
Figure 2.4 Oligonucleotides used in the amplification of genes investigated. A) Oligonucleotides used for the 
amplification  of  eUDG  mutant  variants  contained  within  pUC18.  B)  Oligonucleotides  used  for  the 
amplification  of  Ugi  cloned  in  the  vector  pRSETB.  Additional  unpaired  overhang  bases  containing  a 
thrombin cleavage and EcoRI site (red) and additional bases to allow for restriction enzyme docking (blue).  
2.3.8 Gene Synthesis 
hUDGΔ81  was  prepared  by  complete  gene  synthesis  using  18  oligonucleotides  (each 
approximately 60 bases long; see Appendix II  for sequences). These were designed to 
overlap  at  each  terminus  by  approximately  20  bp  (Figure  2.5)  with  the  terminal 
oligonucleotides also containing an NdeI (5′) and EcoRI (3′) site. The oligonucleotides 
were mixed in equimolar amounts to give a stock concentration of 1 μM that was diluted in 
the PCR reaction mix to a final concentration of 100 nM. The PCR reaction mix was 
prepared  as  follows:  100  nM  oligonucleotides,  an  additional  300  nM  of  the  terminal 
oligonucleotides, 500 nM  dNTPs,  3% DMSO, 5 μl  10x  Pfu buffer, 1 μl  of  Pfu  DNA 
polymerase (typically 2 - 3 u/μl) and made up to 50 μl with dH2O in 0.5 ml PRC tubes. 
Samples were cycled using a TECHNE thermocycler using the following conditions: 
Segment 1: Cycles 01: 98°C for 2 min. 
Segment 2: Cycles 55: 98°C for 30 sec, 50°C for 30secs and 72°C for 2 min. 
Segment 3: Cycles 01: 72°C for 10 min and hold at 4°C. 51 
 
This  produced a mixture of products, which included the desired full  length,  and was 
further amplified by PCR with the terminal oligonucleotides alone (Figure 5.1; see section 
4.2.1 and 4.3.1 for more detail). 300 nM terminal oligonucleotides, 500 nM dNTPs, 3% 
DMSO, 5 μl 10x Pfu buffer, 1 μl of Pfu DNA polymerase (typically 2 - 3 u/μl) was added 
to 3 μl of the PCR reaction into a new 0.5 ml PCR tube and underwent a further PCR 
reaction using the following cycling conditions. 
Segment 1: Cycles 01: 98°C for 2 min. 
Segment 2: Cycles 23: 98°C for 30 sec, 50°C for 30 sec and 72°C for 2 min.
 
Segment 3: Cycles 01: 72°C for 10 min and hold at 4°C. 
 
Figure 2.5 Protocol for hUDGΔ81 gene synthesis. A) The 60mer overlapping oligonucleotides anneal and the 
unpaired regions are filled with DNA polymerase. B) Intermediate products. C) Full length gene product 
produced. D) Addition of the external oligonucleotides to amplify up the full length gene. E) Amplified full 
length gene available for cloning. 
Each sample (2 μl) was mixed with 3 μl of ficoll loading solution (20% (w/v) ficoll, 10 
mM EDTA and 0.1% (w/v) bromophenol blue) and loaded on a 1% agarose gel containing 
0.1x GelRed, ran in 1x TBE buffer at 15 Vcm-1 for 1 hour and imaged under UV light. 52 
 
The resulting products underwent a PCR clean-up (QIAGEN) (see below) and stored at -
20°C until required. 
2.3.9 PCR clean-up 
PCR  reactions  were  cleaned-up  using  the  Qiagen  QIAquick  PCR  Purification  Kit 
following the manufacturer’s protocol. 5 volumes of Buffer PB to 1 volume of the PCR 
reaction was added and the solution mixed and transferred to spin column contained in a 2 
ml collection tube. The sample was centrifuged for 1 min at 17,900 x g. The flow through 
was  discarded  and  750  µl  Buffer  PE  was  added  to  the  spin  column  and  the  sample 
centrifuged as before for 1 min. Discard the flow through and centrifuge for a further 1 min. 
Transfer the spin column to a clean 1.5 ml Eppendorf tube and add 30 µl of Buffer EB and 
leave for 1 min followed by centrifugation as before for 1 min. The sample was then stored 
at -20°C until required. 
2.3.10 Cloning 
The eUDG mutant variants and the hUDGΔ81 constructs were cloned into their intended 
vector at an insert to vector ratio of 3 or 5:1. The insert and vector were double digested 
separately using 0.5 μl (Promega: typically 10 u/μl) of each enzyme; NdeI and EcoRI. 
Additionally 1 μl of 10x buffer D or B (Promega) respectively was added and made up to 
10 μl with dH2O and left at 37°C for 1 hour. An extra 0.5 μl of the appropriate buffer and 1 
μl of TSAP (Promega: typically 2 u/μl) was added to the vector solution and left for 1 hour 
at 37°C to remove the 5′ phosphates to prevent vector re-ligation. The insert was heated at 
65°C and the vector at 75°C for 20 minutes to inactivate the enzymes. The samples were 
mixed followed by the addition of 2.5 μl of 10x ligase buffer (NEB) and 1 μl of ligase 
(NEB: typically 400 u/μl). The samples were then left at 37°C for a minimum of 1 hour to 
ligate before transformation. 
2.3.11 Colony PCR 
Blue/white selection of (pUC) colonies was used to determine potential positive clones. 
Where  blue/white  selection  was  not  available  (pET  plasmids)  a  random  selection  of 
colonies were examined by colony PCR. Each colony was suspended in a PCR reaction 
mix containing 500 nM of each primer, 500 nM dNTPs, 3% DMSO, 10 μl of 5x GoTaq 
buffer, 0.2 μl of GoTaq DNA polymerase (typically 5 u/μl; Promega) and made up to final 53 
 
volume of 50 μl with dH2O in 0.5 ml PCR tubes. Samples were cycled using a TECHNE 
thermocycler using the following conditions: 
Segment 1: Cycles 01: 98°C for 2 min. 
Segment 2: Cycles 30: 98°C for 30 sec, 50°C for 30 sec and 72°C for 1 min per kb. 
Segment 3: Cycles 01: 72°C for 10 min and hold at 4°C. 
The  samples,  after  the  addition  of  3  μl  of  ficoll,  were  loaded  on  a  1%  agarose  gel  
containing 0.1x GelRed, ran in 1x TBE buffer at 15 Vcm-1 for 1 hour and imaged under 
UV light. An example can be seen in Figure 4.5. 
2.3.12 Taq
αI Digestion 
The N123D mutation generates an additional Taq
αI restriction site (TCGA) that would 
generate a different plasmid digestion pattern with Taq
αI; and which can be used as a 
diagnostic for successful mutagenesis. 1 μl of 10x buffer B (Promega) and 0.5 μl Taq
αI 
(NEB: typically 20 u/μl) was added to 1 μl of DNA (from a typical plasmid preparation; 
approximately 100 ng) and made up to 10 μl with dH2O. The sample was left at 65°C for 1 
hour for digestion to take place. 3 μl of ficoll was added to the sample and loaded on a 1% 
agarose gel containing 0.1x GelRed, ran in 1x TBE buffer at 15 Vcm-1 for 1 hour and 
imaged under UV light. 
2.3.13 Purification of Enzymes 
2.3.13.1 Cell Harvesting 
The  appropriate  plasmid  (100  ng)  was  transformed  into  100  μl  of  competent 
BL21(DE3)pLysS cells and plated onto blood agar (40 g blood agar per litre) plates as per 
the transformation protocol. A colony was selected and cultured overnight at 37°C in 5 ml 
2YT media containing 30 μg/ml kanamycin and 50 μg/ml chloramphenicol. The overnight 
culture  (5  ml)  was  transferred  into  500  ml  of  2YT  media,  containing  the  same 
concentrations of antibiotic, shaken at 37°C until an OD600 of 0.5 - 0.8 was obtained. 1 ml 
of 100 mM IPTG was added, to induce the protein of interest, and shaken at 37°C for 2.5 
hours. The solution was split into two 250 ml fractions and centrifuged at 5500 x g for 20 
minutes. The supernatant was discarded and the pellets transferred into a Sterilin tube and 
buffered with 5 - 10 ml of 1x PBS [pH 7.4], which were then be stored at -20°C until 
required. 54 
 
2.3.13.2 Sonication and Protein Preparation 
The cell pellet was thawed on ice and 1x PBS [pH 7.4] was further added to 20 - 25 ml. 
The solution was sonicated in an ice bath for 10 minutes with pulse times of 30 seconds on 
and 40 seconds off. The solution was centrifuged at 31000 x g for 20 minutes and the 
supernatant collected and stored in a Sterilin tube, at 4°C if required, ready for purification. 
2.3.13.3 Protein Purification 
Purification  was  performed  using  an  AKTA  Prime  (GE  Healthcare).  The  sample  was 
loaded in 1x PBS [pH 7.4], containing 20 mM imidazole and run through a His Trap FF 
Crude (GE Healthcare), to which the protein of interest binds, at a rate of 1 ml min
-1. The 
protein was eluted in 1x PBS [pH 7.4], containing 250 mM imidazole (see Figure 3.13) and 
the  collected  sample  was  subsequently  concentrated  using  a  20  ml  Vivaspin  (Fisher) 
column by centrifuging at 1850 x g for 10 minutes. A volume of 5 ml 1x PBS [pH 7.4] was 
added to the column and centrifuged again as previously. A volume of 5 ml 1x PBS [pH 
7.4] was again added and centrifuged at 1850 x g for 3 minutes cycles until approximately 
0.5 ml remained. 2.5 ml of 1x PBS [pH 7.4] was added and all 2.5 ml removed into a 
Sterilin tube. A further 2 ml of 1x PBS [pH 7.4] was added, to obtain as much protein as 
possible, and the remaining 2.5 ml removed into the same Sterilin tube. The concentration 
was  determined using  a Nanodrop 2000c (Thermo  Scientific) and  glycerol was  finally 
added to the solution to a concentration of 50% (v/v). The solution was divided into 500 μl 
aliquots that were stored at -20°C until required. 
2.3.13.4 SDS-PAGE 
The SDS-PAGE gel was comprised of two solutions denoted the “stacking” and “resolving” 
gels.  The  stacking  gel  contained  0.33  ml  acrylamide  (30%  acrylamide:  0.8%  bis-
acrylamide (37.5:1)), 1.45 ml dH2O, 0.62 ml gel buffer (3 M Tris, 0.3% (w/v) SDS pH 
8.45) and 5 μl TEMED. The running gel contained 1.665 ml acrylamide (30% acrylamide: 
0.8% bis-acrylamide (37.5:1)), 1.665 ml dH2O, 1.665 ml gel buffer and 5 μl TEMED. 25 
μl of 20% (w/v) ammonium persulphate was added to the running gel, which was applied 
first and allowed to set, and isopropanol was applied on top to prevent the formation of air 
bubbles. Once set, the isopropanol was removed and 12.5 μl ammonium persulphate was 
added to the stacking gel, which was applied on top of the running gel to create a complete 
gel. An example can be seen in Figure 3.10. 55 
 
1 ml samples of pre and post protein induction cultures were taken and centrifuged at 
17,900 x g for 3 minutes. 60 μl of 4x gel loading buffer (2.5 ml 1 M Tris pH 6.8, 4 ml 20% 
(w/v) SDS, 40 mg bromophenol blue, 2 ml glycerol, 1 ml dH2O, 860 μl β–mercaptoethanol) 
was added and heated at 95°C for 15 minutes. 5 μl of 4x gel loading buffer was added to 
15 μl samples of flow through, 250 mM imidazole protein elution and the protein solution 
after concentration. The samples were loaded and run in anode (200 mM Tris pH 8.9) and 
cathode (100 mM Tris, 100 mM Tricine, 0.1% SDS pH 8.2) buffers at 18 Vcm-
1 for 50 
minutes. The gel was stained in coomassie blue (1 g Coomassie, 100 ml glacial acetic acid, 
400 ml methanol, 500 ml dH2O) on a rocking table for 30 minutes and was left in destain 
(400 ml methanol, 100 ml glacial acetic acid, 500 ml dH2O) on a rocking table overnight. 
2.3.14 5′ Radiolabelling of oligonucleotides 
Oligonucleotides (60 pmoles; Table 2.2) were radiolabelled at its 5′-end using 1 μl of 10 
μCi/μl at 3000 Ci/mmol of [γ-
32P]ATP, 1 μl of PNK (NEB: typically 10 u/μl) and 2 μl of 
10x PNK buffer and made up to 20 μl using dH2O. The samples were left at 37°C for a 
minimum of 1 hour for the reaction to take place. The reaction was stopped using 20 μl 
stop  solution  (80%  (v/v)  formamide,  10  mM  EDTA,  2  mM  NaOH  and  0.1%  (w/v) 
bromophenol blue). The samples were run on a 12.5% denaturing polyacrylamide gel (20 
cm by 0.3 mm) at 30 Vcm
-1 for approximately 1 hour. The gel was then exposed to X-ray 
film for 2 minutes and the band corresponding to the labelled fragment was excised. The 
gel slice was put into a P1000 tip containing glass wool (with the tip sealed with parafilm) 
and the DNA was eluted from the gel by the addition of 400 μl of Tris-EDTA 10:1 (10 mM 
Tris-HCl [pH 7.5], 1 mM EDTA) and left overnight on a rocking table. The solution was 
removed from the tip using a P1000 pipette and pulsed centrifugation (≤6000 x g). The 
glass wool prevents the removal of the gel slice from the tip. The DNA was precipitated 
from the solution by adding 50 μl of 3 M NaOAc and 1ml of ethanol, leaving the sample 
on dry ice for a minimum of 1 hour. The solution was centrifuged at 17,900 x g for 10 
minutes and the supernatant was removed; leaving a pellet of DNA that can be traced using 
a Geiger counter. The pellet was washed with 200 μl of 70% ethanol and centrifuged at 
17,900 x g for 2 minutes. The solution was again removed to leave a pellet that was dried 
in  a  SpeedVac  to  remove  any  residual  ethanol.  The  pellet  was  finally  resuspended  in 
Buffer 1 (10 mM Tris-HCl, 25 mM NaCl, 2.5 mM MgCl2 [pH 8.0] (Drohat et al., 1999a)) 
or Buffer 2 (10 mM NaMES, 25 mM NaCl, 2.5 mM MgCl2 [pH 6.3] (Kwon et al., 2003)), 56 
 
for  UDG  and  UYDG  or  CYDG  respectively,  to  obtain  approximately  10  cps/μl  as 
estimated using a hand held Geiger counter.  
Oligonucleotide  Sequence 
U  5′-CCGAATCAGTGCGCAUAGTCGGTATTTAGCC-3′ 
T  5′-CCGAATCAGTGCGCATAGTCGGTATTTAGCC-3′ 
C  5′-CCGAATCAGTGCGCACAGTCGGTATTTAGCC-3′ 
MC  5′-CCGAATCAGTGCGCA
MCAGTCGGTATTTAGCC-3′ 
G  5′-GGCTAAATACCGACTGTGCGCACTGATTCGG-3′ 
A  5′-GGCTAAATACCGACTATGCGCACTGATTCGG-3′ 
AP  5′-GGCTAAATACCGACTAPTGCGCACTGATTCGG-3′ 
Z  5′-GGCTAAATACCGACTZTGCGCACTGATTCGG-3′ 
I  5′-GGCTAAATACCGACTITGCGCACTGATTCGG-3′ 
ssC(GAT)  5′-GGATAAATAGGGAGTCTGAGAAGTGATTAGG-3′ 
ssC(polyA)  5′-AAAAAAAAAAAAAAACAAAAAAAAAAAAAAA-3′ 
G2  5′-GCTAAATATATATATGTTATATAATTATTCG-3′ 
C2  5′-CGAATAATTATATAACATATATATATTTAGC-3′ 
MC2  5′-CGAATAATTATATAA
MCATATATATATTTAGC-3′ 
A2  5′-GGCTAAATACCGACCACGCGCACTGATTCGG-3′ 
C(G)  5′-CCGAATCAGTGCGCGCGGTCGGTATTTAGCC-3′ 
gap
  5′-GGCTAAATACCGACT-3′ 
5′-TGCGCACTGATTCGG-3′ 
long C  5′-CCGTACTGAATCAGTGCGCACAGTCGGTATTTACGATAGCC-3′ 
long gap  5′-GGCTATCGTAAATACCGACT-3′ 
5′-TGCGCACTGATTCAGTACGG-3′ 
HEG  5′-GGCTAAATACCGACCHEGCGCGCACTGATTCGG-3′ 
APHEG  5′-GGCTAAATACCGACAPHEGAPGCGCACTGATTCGG-3′ 
U(G)  5′-CCGAATCAGTGCGCGUGGTCGGTATTTAGCC-3′ 
C(AG)  5′-CCGAATCAGTGCGCACGGTCGGTATTTAGCC-3′ 
A(AG)  5′-GGCTAAATACCGACCATGCGCACTGATTCGG-3′ 
C(GA)  5′-CCGAATCAGTGCGCGCAGTCGGTATTTAGCC-3′ 
A(GA)  5′-GGCTAAATACCGACTACGCGCACTGATTCGG-3′ 
 
Table 2.4 Oligonucleotides used in excision assays. Central target base highlighted in bold. AP; abasic site, Z; 
anthraquinone pyrrolidine and gap; unpaired, HEG; hexethyleneglycol. 
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2.3.5 Excision Assays 
Each radiolabelled oligonucleotide (U, T, C, 
MC) was split into equal aliquots and paired 
with  1  μl  (45  to  60  μM;  approximately  2-fold  excess)  of  each  of  the  complementary 
oligonucleotides (G, A, AP), determined by their central base (highlighted in bold in Table 
2.4),  to give a maximum of 12 oligonucleotide pairings. The samples were placed in a 
heating block at 95°C 10 minutes; the block was then removed and left to cool  to ambient 
temperature overnight, allowing the strands to anneal and form a duplex. Occasionally the 
duplexes  formed  were  further  purified  to  remove  the  excess  complementary 
oligonucleotide.  This  was  performed  by  running  the  sample  on  a  16%  native 
polyacrylamide gel (20 cm by 0.3 mm) at 15 Vcm
-1 for approximately 3 hours. The DNA 
was then purified as stated above. 
2.3.15.1 Activity Assays 
To determine whether an enzyme could excise a specific base from a mismatched duplex, 
enzyme  activity  excision  assays  were  performed.  Enzyme  at  various  concentrations 
ranging from 3 - 3000 nM diluted in Buffer 2 (Buffer 1 was also used for eUDG and 
eUYDG) was added in equal volumes with 1 nM - 60 μM radiolabelled duplex substrates 
on ice. The samples were incubated at 37°C for between 1 minute and 24 hours. The assays 
were stopped under alkali conditions with 3 μl of stop solution (as previous) and heated at 
95°C  for  20  minutes.  This  causes  cleavage  of  the  ribose  sugar  and  subsequent 
phosphodiester backbone cleavage. 
2.3.15.2 Quantitative Assays 
Assays  were  performed  as  described  above  in  triplicate  except  that  the  reaction  was 
stopped using 10% (v/v) piperidine before heating at 95°C for 20 minutes. The samples 
were lyophilised to dryness and resuspended in 10 μl stop solution. Treatment with hot 
piperidine yielded single reaction products, while samples that were simply heated in stop 
solution  yielded  products  with  ragged  ends  and  multiple  bands  on  the  denaturing 
polyacrylamide gels (see Figure 3.15). 
2.3.15.3 Denaturing Polyacrylamide Gel Electrophoresis 
The products of the cleavage reactions were run on a 12.5% denaturing polyacrylamide 
gels containing 8 M urea. The gels were run at 30 Vcm
-1 for approximately 1 hour in 1x 58 
 
TBE and fixed in (v/v) 10% acetic acid. The gels were transferred onto Whatman 3MM 
paper, covered with Saran wrap and dried under vacuum at 86°C for 1 hour. The gels were 
exposed overnight to a phosphorimage screen and scanned using a Typhoon FLA 7000 
phosphorimager (GE Healthcare). 
2.3.15.4 Cleavage Quantification 
The intensity of the bands from each gel was estimated using ImageQuantTL software (GE 
Healthcare). The rate of reaction (initial velocity) was determined from plots of percentage 
cleaved against time, using SigmaPlot, by fitting each set of data to a single exponential 
rise to maximum and averaged (Appendix IV). The rate of cleavage of some substrates was 
very low and in these instances an estimate of the rate constant was obtained from the 
fraction cleaved at a given time, assuming a simple exponential process.  
2.3.16 Detection of 5-Methylcytosine 
2.3.16.1 DNA Probing 
An  80  mer  oligonucleotide  (Table  2.5)  was  designed  encompassing  a  cytosine  or  5-
methylcytosine in a CpG context in the centre with primer binding sites at either end. The 
sequences flanking the CpG site are the same as those used for the cleavage assays. This 
region was targeted by a probe oligonucleotide containing a hexaethylene glycol (HEG) 
linker  opposite  the  target  cytosine  or  5-methylcytosine  and  a  3′  propyl  to  prevent 
polymerase read through and extension (Table 2.5). HEG was also used as this was found 
to  provide one of the highest  cleavage rates  for the enzymes investigated (see section 
3.3.12). The target and probe oligonucleotide in excess were mixed, heated to 95°C and 
allowed to cool and run on a 16% native polyacrylamide gel at 15 Vcm
-1 for approximately 
3 hours. This was so that we could be certain that we had a fully annealed duplex and any 
excess oligonucleotides would be removed. The DNA was located using UV shadowing 
onto a TLC plate, eluted and purified as per 5′ labelling (section 2.3.12) giving a final 
concentration of ≤ 20 μM, and stocks of a maximum of 500 and 5 nM were made for 
experimental use. 
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Oligonucleotide  Sequence 
Target  5′-TAGCGTAGGGAGATATACCATGGGCAGCAGCCAGTGCGCAC/
MCG 
GTCGGTATTCTGAGATCCGGCTGCTAACAAAGTTGATCAT-3′ 
Probe  5′-GGCTAAATACCGACTHTGCGCACTGATTCGG-propyl-3′ 
Forward Primer 
(pET28a For) 
5′-GGAGATATACCATGGGCAGCAGC-3′ 
Reverse Primer 
(pET28a Rev) 
5′-CTTTGTTAGCAGCCGGATCTCAG-3′ 
 
Table 2.5 Oligonucleotides used in the cytosine detection assay. H; HEG. 
2.3.16.2 Incubation with eCYDG 
The 500 and 5 nM target-probe (TP) stocks were incubated with excess eCYDG for 24 
hours to allow cleavage if the target cytosine was unmethylated. The reaction product was 
then reacted with 10% (v/v) piperidine and heated at 95°C for 30 minutes to cleave the 
phosphodiester backbone, and lyophilised to dryness. 
2.3.16.3 Real-time PCR 
The lyophilised samples were resuspended in 13.6 μL of dH2O followed by the addition of 
1 μL of 10 μM primers, 1 μL of 10 mM dNTPs, 4 μL of 5x GoTaq buffer, 0.2 μl of GoTaq 
DNA polymerase (typically 5 u/μl; Promega) and 0.2 μL 10X SYBR Green. The reactions 
were transferred to glass capillaries for use in a Roche LightCycler 1.5 qPCR machine. The 
cycling conditions are as follows: 
Segment 1: Cycles 01: 98°C for 2 min. 
Segment 2: Cycles 30: 98°C for 10 sec, 55°C for 10 sec and 72°C for 10s. 
Segment 3: Cycles 01: 72°C for 4 min and hold at 4°C. 
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Chapter 3: Production and Properties of eCYDG 
3.1 Introduction 
Generating  a  glycosylase  that  has  the  ability  to  excise  a  normal  DNA  base  might  be 
expected to generate a protein that is cytotoxic to the host organism. This has previously 
been noted for eCDG (Kavli et al., 1996, Kwon et al., 2003). human CDG (hCDG) has 
previously been prepared using recA
+ E. coli cells (Kavli et al., 1996), while it has only 
been possible to express E. coli CDG using in vitro transcription and translation (Handa et 
al., 2002). An alternative solution to expressing  eCDG is to mutate leucine 191 to  an 
alanine (L191A), that renders the enzyme inactive (Jiang et al., 2001), followed by the 
N123D mutation allowing expression and purification of the enzyme (Kwon et al., 2003). 
As described in the introduction (section 1.3.1.4) L191A disables the enzyme’s ability to 
flip the target base into an extrahelical conformation. The enzyme’s activity can then be 
restored by incorporating a bulky synthetic nucleoside  (i.e. pyrene)  opposite the target 
cytosine base. Pyrene, being planar, can stack within the DNA duplex while its large size 
causes it to encroach upon the cytosine’s space, forcing it into an extrahelical conformation 
for  enzyme  binding  and  base  excision.  This  enzyme  was  previously  denoted  a 
cytosine/pyrene DNA glycosylase (eCYDG) (Kwon et al., 2003). 
 
Figure 3.1 Recognition of cytosine and uracil by the 180° rotation of Asp123′s side chain. 
eCYDG excises cytosine at an optimal pH of 6.3 at which D123 and not D64 is in a 
protonated state (Handa et al., 2002, Kwon et al., 2003). This should also be applicable to 
any CDG in order to optimise its activity. In the wild type UDG asparagine 123 is held in a 
fixed conformation by a triad of water molecules that enables it to be specific for uracil 
recognition. Aspartate does not form these bonds with the water molecules and it is able to 62 
 
freely rotate around its side chain (Figure 3.1), allowing it to retain activity against uracil 
as well as cytosine (Pearl, 2000). 
The ability of eCYDG to excise cytosine from DNA led us to suggest that it should be able 
to discriminate between cytosine and 5-methylcytosine in the same way that UDG is able 
to distinguish between uracil and thymine, due to the steric hindrance between Tyr66 and 
the 5-methyl group. 
3.2 Experimental Design 
3.2.1 Mutagenesis of UDG 
To  generate  a  CDG  and  assess  its  properties,  site-directed  mutagenesis  (SDM)  was 
attempted on the wild type eUDG. Even though previous studies had failed to express 
eCDG in E. coli, as a result of its cytotoxicity, we hoped that this might be possible under 
the tight control of expression in the pET vector The N123D mutation generates a third 
cleavage site for restriction enzyme Taq
αI (TCGA; mutated from TCAA in the wild type) 
(Figure  3.2A)  compared  to  two  found  in  pUC19eUDG.  This  difference  was  used  to 
determine  a  potentially  successful  mutation,  which  was  then  confirmed  by  DNA 
sequencing. Mutagenesis for N123D was first performed on pUC19eUDG but this was 
unsuccessful  due  to  cytotoxicity  and  was  therefore  performed  on  pUC18eUDG  that 
produced a positive clone.  
A 
Forward Primer  5′-GCGTCAGGGCGTTCTGCTACTCGATACTGTGTTGACGGTACGCGC-3′ 
Plasmid Template  3′-CGCAGTCCCGCAAGACGATGAGTTATGACACAACTGGCATGCGCG-5′ 
 
Plasmid Template  5′-GCGTCAGGGCGTTCTGCTACTCAATACTGTGTTGACGGTACGCGC-3′ 
Reverse Primer  3′-CGCAGTCCCGCAAGACGATGAGCTATGACACAACTGGCATGCGCG-5′ 
 
B 
Forward Primer  5′-GCACCGCATCCGTCGCCGGCGTCGGCGCATCGTGGATTC-3′ 
Plasmid Template  3′-CGTGGCGTAGGCAGCGGCGAAAGCCGCGTAGCACCTAAG-5′ 
 
Plasmid Template  5′-GCACCGCATCCGTCGCCGCTTTCGGCGCATCGTGGATTC-3′ 
Reverse Primer  3′-CGTGGCGTAGGCAGCGGCCGCAGCCGCGTAGCACCTAAG-5′ 
 
Figure  3.2  Mutation  primers  annealed  to  template  plasmid.  The  N123D  (A)  and  L191A  (B)  base  pair 
mismatches are highlighted in red with the Taq
αI restriction site underlined. 63 
 
The L191A mutation (Figure 3.2) was performed on pUC18eCDG to generate eCYDG (to 
overcome cytotoxicity) that could then be cloned into the pET vector and expressed. The 
L191A mutation was also performed by itself to generate eUYDG. Table 3.1 shows the 
DNA sequences at the mutation sites for these enzymes. Once the gene was created it was 
excised from the pUC18 vector and cloned the pET28a expression vector using appropriate 
restriction enzymes. To confirm the cloning had been successful the plasmid was again 
mapped by Taq
αI digestion and subsequent DNA sequencing. 
Enzyme  Sequence 
UDG  5′-TGCTACTCAATACTGTG--CGTCGCCGCTTTCGGCGCA-3′ 
UYDG  5′-TGCTACTCAATACTGTG--CGTCGCCGGCGTCGGCGCA-3′ 
CYDG  5′-TGCTACTCGATACTGTG--CGTCGCCGGCGTCGGCGCA-3′ 
 
Table 3.1 Theoretical DNA sequences of the different enzymes at the mutagenic sites. Sequence variations 
highlighted in red; -- denotes nucleotide sequence between the two mutation sites. 
3.2.2 Excision Assays 
3.2.2.1 Initial Assays 
To assess the excision properties of eUDG, eUYDG and eCYDG, DNA cleavage assays 
were performed and analysed by denaturing PAGE. The oligonucleotide containing the 
target base was radiolabelled with 
32P at its 5′ end and annealed to a complementary strand 
to form a duplex substrate for the enzyme. The substrates generated contained a target U, T, 
C or 
MC paired opposite a G, A, AP (abasic site). Varying concentrations of enzyme were 
incubated  with  the  DNA  for  up  to  30  minutes  and  the  reaction  quenched  using  a 
formamide  stop  solution  (containing  10  mM  NaOH)  to  cause  cleavage  of  the 
phosphodiester  backbone.  The  resulting  products  were  run  on  denaturing  PAGE, 
phosphorimaged and analysed.  
3.2.2.2 eCYDG Rate of Reaction Determination 
The DNA cleavage assays were performed in the same manner in triplicate, their catalytic 
rate calculated and averaged to determine the rate of reaction of the enzyme against a 
variety of different substrates. The assays were performed over a 24, four or one hour time 
course depending on the activity of the enzyme towards a particular substrate. As well as G, 
A and AP used to generate duplexes with the target base, Z (anthraquinone pyrrolidine), 64 
 
HEG  (hexaethylene  glycol)  and  a  gap  (unpaired)  duplex  substrates  were  generated 
including  the  investigation  of  single  stranded  substrates.  Anthraquinone  pyrrolidine  is 
another bulky synthetic nucleoside analogue that was used to mimic the reported effect of 
pyrene.  After  incubation  with  eCYDG  the  sample  was  placed  on  dry  ice  to  stop  the 
reaction followed by treatment with 10% (v/v) piperidine to cause specific cleavage at the 
3′ carbon-phosphate bond of the DNA to generate a single product band. The resulting 
products were run on denaturing PAGE, phosphorimaged and analysed. 
3.3 Results 
3.3.1 N123D mutagenesis of pETeUDG and pUC19eUDG 
Initial mutagenesis experiments were performed on the pET28a cloning and expression 
vector  containing  the  eUDG  gene  (pETeUDG).  The  aim  was  to  mutate  the  wild  type 
asparagine to aspartate (N123D) altering the hydrogen bonding pattern in the active site, 
allowing  the  enzyme  to  recognise  cytosine  as  well  as  uracil.  Even  though  this  has 
previously been unsuccessful (Kavli et al., 1996, Kwon et al., 2003), it was attempted due 
to the tight control of expression given by the pET vector. This failed to produce any 
colonies upon transformation of products of the Quickchange mutagenesis reaction. It was 
therefore  decided  to  perform  mutagenesis  on  the  sequence  within  the  pUC19  cloning 
vector  (pUC19eUDG)  in  conjunction  with  pETeUDG.  This  too  proved  difficult  but 
eventually  colonies  were  obtained  upon  transformation  for  both  vectors.  These  were 
subjected to restriction mapping with Taq
αI digestion and the agarose gels are shown in 
Figure 3.5A; the presence of a different cleavage pattern to the wild type UDG for both 
vectors suggested that the mutagenesis had been successful. However, upon sequencing 
(MWG), although the clones were found to contain the mutated sequence, they contained 
multiple repeats of the primer sequence (Figure 3.3) or other mutations in addition to the 
desired A to G mutation. Further pUC19eCDG clones were obtained, which also gave the 
correct banding upon restriction mapping, as shown in Figure 3.5B. Theoretical plasmid 
digest maps are shown in Figure 3.4. 
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Figure 3.3 Sequencing chromatogram showing multiple primer sequence repeats. 
 
 
Figure 3.4 Theoretical plasmid digest with Taq
αI of  pUC19eUDG and pUC19eCDG that would produce two 
and three restriction fragments respectively. 
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Figure 3.5 Gel electrophoresis of clones digested with Taq
αI. A) pUC19eCDG and pETeCDG clones post 
mutagenesis.  Arrows  indicate  loss  of  (top)  and  production  (bottom)  of  a  band  of  pETeCDG  clones  in 
comparison to pETeUDG. B) pUC19eCDG clones after first round of mutagenesis. C) pUC19eCDG clones 
after second round of mutagenesis to remove the extra cytosine residue. 0.7% agarose gel ran in 1 x TBE at 
15 Vcm-1 for one hour. 
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However,  sequencing  (MWG)  showed  that  all  three  clones  contained  an  additional 
secondary mutation (Figure 3.6; the addition of an extra cytosine within the region of the 
mutagenic primer) generating a frame shift mutation. Further clones, that also showed the 
correct restriction banding pattern, were all found to have either additions or deletions 
within the primer region. The clone pUC19eCDG1 (Figure 3.5B), containing the extra 
cytosine, was subjected to a second round of mutagenesis using the same primers in an 
attempt to remove the extra base. The colonies from this reaction also showed the correct 
pattern with Taq
αI (Figure 3.5C), but once again sequencing (MWG) revealed that they 
still contained the extra cytosine base. This strongly suggested that eCDG is highly toxic in 
E.  coli,  even  when  present  out  of  frame  in  pUC19;  this  is  further  investigated  and 
discussed in Chapter 6. 
 
Figure 3.6 Sequencing analysis of pUC19eCDG1 highlighting the N123D mutation (A) and extra cytosine 
base (B). Amino acid sequence shown in A with direction of translation indicated by the arrow. 
3.3.2 Determining the Effects of Mutagenesis 
As a control to determine whether the mutagenesis was occurring correctly, pUC19eUDG 
was again subjected to N123D mutagenesis, followed by a second round of PCR using 
pUC18/19 universal primers (Figure 3.7) to amplify the potential eCDG gene. 
Forward:  5′-GTAAAACGACGGCCAGT-3′ 
Reverse:  5′-TCACACAGGAAACAGCTATGAC-3′ 
 
Figure 3.7 Universal primer sequences. 
The  PCR  product  was  sequenced  and  showed  that  the  N123D  mutation  had  been 
successful  and  contained  no  secondary  mutations,  unlike  that  seen  in  Figure  3.6.  It 
therefore appear that the failure to generate a clone of eCDG did not arise from problems 
in the site directed mutagenesis itself, but from the subsequent cloning and transformation, 
which only selected for colonies that contained a mutated (inactive) version of the gene. 
This is consistent with the suggestion that  eCDG is extremely cytotoxic, as shown by 68 
 
Kwon et al., 2003 and Handa et al., 2002. However, it was not expected that positive 
clones could  not  even  be obtained when using  the pUC19  vector, especially since the 
sequence is out of frame with the lacZ gene. 
3.3.3 Cloning of eCDG into pUC18 and pUC19 
The suggestion that eCDG might be very cytotoxic led us to attempt to clone the amplified 
eCDG gene into pUC18, as the multiple cloning site is in the opposite orientation. The 
gene would therefore be cloned in the opposite orientation relative to the lacZ and would 
produce a nonsense protein if transcribed and translated from the lacZ promoter. As a 
control  we  attempted  to  clone  the  amplified  eCDG  gene  into  pUC19.  Colonies  were 
obtained  from  both  reactions  and  were  subjected  to  Taq
αI  digestion  (Figure  3.8).  The 
pUC19eCDG  clone  produced  an  incorrect  banding  pattern,  whereas  the  pUC18eCDG 
clone produced the correct fragment sizes of approximately 1444, 1107 and 785 bp. This 
was subsequently sequenced (MWG) and confirmed that the clone was correct, containing 
the eCDG gene with no secondary mutations. These experiments suggest that the eCDG 
gene is extremely cytotoxic, even when cloned in pUC19. This was especially surprising 
since the eCDG gene is out of frame with the lacZ gene; this effect is explored further in 
Chapter 6. 
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Figure 3.8 Gel electrophoresis of pUC clones digested with TaqαI after eCDG cloning.0.7% agarose gel ran 
in 1x TBE at 15 Vcm-1 for one hour. 
3.3.4 Generating eCYDG 
In order to express an E. coli enzyme with CDG activity it was decided to further mutate 
pUC18eCDG to substitute the “pushing and plugging” leucine to an alanine (L191A). The 
primers used for this are shown in Figure 3.2B. This mutation creates an eCYDG that has 
no  enzymatic  activity  towards  cytosine  unless  rescued  with  a  synthetic  pyrene  base 
opposing  the  cytosine,  as  shown  previously  by  Kwon  et  al.,  2003.  Transformation  of 
pUC18eCDG after SDM to introduce the L191A mutation produced successful clones with 
both the N123D and L191A mutations, thus yielding pUC18eCYDG. 
3.3.5 Cloning eCYDG into pET28a and pUC19 
The eCYDG gene was then subcloned into pUC19 and pET28a, via the restriction enzymes 
HindIII/EcoRI and NdeI/EcoRI respectively. Clones were obtained upon transformation 
and subjected to Taq
αI digestion and sequencing where a positive digestion pattern was 
obtained  for  pETeCYDG3,  shown  in  Figure  3.9A,  which  was  then  confirmed  by 
sequencing, successfully generating pETeCYDG. Positive clones were also obtained for 70 
 
pUC19  as  shown  in  Figure  3.9A  (pUC19eCYDG1  and  3),  and  again  were  confirmed 
through sequencing. 
 
Figure 3.9 Gel electrophoresis of eCYDG clones digested with Taq
αI. Digestion patterns of pETeCYDG (A) 
and  pUC19eCYDG  (B)  clones.  Arrows  indicate  the  different  banding  pattern  seen  for  the  positive 
pETeCYDG3 clone from pET28a and the pETeUDG. 0.7% agarose gel ran in 1x TBE at 15 Vcm-1 for one 
hour. 
3.3.6 Enzyme Expression 
The pET28a vector was used for expression of eUDG proteins as it contains a 6x His-Tag 
that can be used for purifying the protein of interest using a nickel chelating column. The 
purification of this His-tagged eUDG is shown in Figure 3.10. Expression of the protein 
was induced with IPTG, as seen by an increase in band intensity of approximately 27 kDa 
in the post-induction lane (Figure 3.10). A small amount of the enzyme was lost when the 
sample was pelleted. There was further loss when loading the sample onto the column as 
shown in the flow through lane. 20 mM imidazole was used to remove most of any protein 
contaminants remaining whilst UDG was finally eluted in 250 mM imidazole, clearly seen 
in the final lane as indicated by the arrow (Figure 3.10). The imidazole was removed from 
the 250 mM elution by buffer exchange using a PD-10 column, which also further purified 
and concentrated the enzyme giving a yield of 0.75 mg. 71 
 
 
Figure 3.10 SDS-PAGE purification of eUDG. Samples were taken at different purification stages to assess 
enzyme expression and purity. 
For  purification  of  eCYDG  it  was  decided  to  load  the  sample  in  20  mM  imidazole 
followed by enzyme elution in  250 mM  imidazole. This  was  due to  the tight  enzyme 
binding  to  the  column  with  minimal  loss  seen  in  the  20  mM  imidazole  elution  when 
purifying eUDG. eCYDG was further purified and concentrated using a 10000 MW cut off 
Vivaspin centrifugal concentrator and 0.75 mg of eCYDG was obtained; the SDS-PAGE 
gel for this purification is shown in Figure 3.11. The same procedure was used for eUYDG, 
generated by performing the L191A mutation on pETeUDG, and further production of 
eUDG (Figure 3.12) which yielded 1.7 mg and 1.55 mg of enriched enzyme respectively. 
The purification trace for eCYDG is shown in Figure 3.13. The His-Tag was not removed 
during the purification process as it does not affect the activity of the enzymes as shown by 
our results and numerous previous studies (Liu and Liu, 2004). 72 
 
 
Figure 3.11 SDS-PAGE purification of eCYDG. Samples were taken at different purification stages to assess 
enzyme expression and purity. 
 
Figure 3.12 SDS-PAGE purification of eUDG (left) and eUYDG (right). Samples were taken at different 
purification stages to assess enzyme expression and purity. 73 
 
 
Figure 3.13 eCYDG Ni-NTA loading and elution profile. The blue trace is a measure of protein concentration 
absorbance measured at 280 nm. eCYDG is loaded onto the column in 20 mM imidazole allowing unbound 
proteins to pass through and elute. eCYDG was eluted using 250 mM imidazole. Fractions collected are 
shown in red along the x-axis. 
3.3.7 Excision Activity of eUDG 
Before generating a CDG that could be expressed and purified (eCYDG) we first examined 
the properties of eUDG in order to test the viability of our cleavage assay for determination 
of enzyme activity. A cartoon representation of this assay can be seen in  Figure 3.14. 
Figure 3.15A shows the effect of eUDG on fragments in which uracil and thymine are 
paired with guanine, at enzyme concentrations of 300, 30 and 3 nM. The results show that 
eUDG, even at the lowest concentration (3 nM) and shortest reaction time (1 minute), 
produced  assumed  full  cleavage  of  the  uracil  containing  fragment,  as  shown  by  the 
appearance of the lower band(s) and disappearance of the full length substrate fragment 
(top band). This is in agreement with previous studies (Kwon et al., 2003) where full 
cleavage occurred at a concentration of 10 nM. As expected, no cleavage was observed 
with a G.T mismatch, even at the highest enzyme concentration and longest incubation. 
eUDG at 3 nM was therefore used in further experiments. 
Similar experiments were then performed using a wider range of substrates (Figure 3.15B) 
with different bases positioned opposite the target cytosine base including an abasic (AP) 
site. This substrate was also investigated with the addition of two intercalators, ethidium 
bromide and pyrene (in the form of 1-pyrenebutanol). This was to see whether they would 74 
 
intercalate  at  the  AP  site  and  help  to  force  the  target  base  into  the  extrahelical 
conformation required for cleavage, mimicking the effect of the pyrene nucleoside (Kwon 
et  al.,  2003).  Intercalators  were  used  to  see  whether  the  excision  properties  of  eUDG 
would change when the target bases were T, C and 
MC (Figure 3.15). Unsurprisingly, 
activity against these bases was not observed, confirming eUDGs specificity for uracil. As 
expected full cleavage of U was observed with the addition of intercalators, which was as 
full cleavage of U occurred opposite an AP site. 
 
Figure  3.14  Cartoon  representation  of  the  cleavage  assay.  A)  Duplex  substrates  generated  from 
interchangeable oligonucleotides from Table 2.4. B) The oligonucleotide containing the target base (X) to be 
examined for excision is radiolabelled (*) at its 5ʹ end and subsequently base paired with its complementary 
oligonucleotide, generating an X.Y base pair. After incubation with the enzyme, if the base is not cleaved 
(left hand side), the full length oligonucleotide under denaturing conditions appears at the top of the gel. If 
the base is cleaved (right hand side) then the smaller product oligonucleotide appears towards the bottom of 
the gel due to its greater mobility. 
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Figure 3.15 eUDG excision of uracil, thymine, cytosine and5-methylcytosine substrates. A) 31mer duplex 
(~50nM) substrates were incubated with 300, 30 and 3 nM eUDG for up to 30 minutes. B) 31mer substrates 
(~50nM), with the inclusion of 10 μM free ethidium and 10 μM pyrene with AP paired duplexes, were 
incubated with 3 nM eUDG for 30 minutes. All samples were quenched with 3 μl stop solution and heated at 
95°C  for  30  minutes  and  resolved  on  12.5%  denaturing  polyacrylamide  gels  and  analysed  by 
phosphorimaging. The top and bottom bands correspond to the 31mer uncleaved or 15mer cleaved product. 
Control; unreacted G.U duplex, AP; abasic site. 76 
 
3.3.9 Excision Activity of eUYDG 
The activity of eUYDG against the same range of substrates as with eUDG, is shown in 
Figure  3.14.  As  with  eUDG,  eUYDG  also  showed  complete  cleavage  of  all  uracil 
containing duplexes (G.U, A.U and AP.U). This is not surprising, as although the L191A 
mutation should severely reduce the enzymes’ activity, previous studies (Jiang et al., 2001, 
Kwon et al., 2003) have shown that eUYDG still has the ability to excise U in an A.U and 
AP.U context, though at lower rates as the enzyme is deficient in base flipping. This is 
confirmed  in  the  results  shown  in  Figure  3.16  where  eUYDG  is  able  to  excise  all  U 
containing substrates. As expected no activity was seen towards the T, C or 
MC, regardless 
of the addition of intercalators, which were included in an attempt to rescue the effect of 
the L191A mutation. 
 
Figure 3.16 eUYDG excision of uracil, thymine, cytosine and5-methylcytosine substrates. 31mer substrates 
(~50nM), with the inclusion of 10 μM free ethidium and 10 μM pyrene with AP paired duplexes, were 
incubated with 150 nM eUYDG for 30 minutes. All samples were quenched with 3 μl stop solution and 
heated at 95°C for 30 minutes and resolved on a 12.5% denaturing polyacrylamide gel and analysed by 
phosphorimaging. The top and bottom bands correspond to the 31mer uncleaved or 15mer cleaved product. 
AP; abasic site. 
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3.3.10 Excision Activity of eCYDG 
Initial experiments with eCYDG were performed, as for eUDG/eUYDG, to gauge a rough 
estimate  of  eCYDG’s  activity  towards  U,  T,  C  and 
MC  containing  substrates.  We 
hypothesised that since eCYDG has a lower activity the addition of free ethidium and 
pyrene in conjunction with an AP site could have a greater effect. However, this not the 
case, as shown in shown in Figure 3.17 and no C excision activity was observed. These 
results showed that eCYDG retained residual U excision activity but has no activity against 
T,  C  or 
MC.  It  interesting  to  note  that  the  fully  based  paired  duplexes  containing  no 
mismatches (G.C, G.
MC, A.U and A.T) run at a slower mobility (Figure 3.17). 
 
Figure  3.17 eCYDG excision of  uracil, thymine, cytosine and5-methylcytosine substrates. 31mer duplex 
substrates (~50nM), with the inclusion of 10 μM free ethidium and 10 μM pyrene with AP paired duplexes, 
were incubated with 150 nM eCYDG for 30 minutes. All samples were quenched with 3 μl stop solution and 
heated at 95°C for 30 minutes and resolved on a 12.5% denaturing polyacrylamide gel and analysed by 
phosphorimaging. The top and bottom bands correspond to the 31mer uncleaved or 15mer cleaved product. 
AP; abasic site. 
Since  these  initial  experiments  were  performed  at  pH  7.4,  this  could  account  for  the 
absence of C excision activity, as eCYDG has been shown to excise C over a narrow pH 
range (Kwon et al., 2003). We therefore investigated its activity at more acidic pHs (Figure 
3.18A); the results again showed residual U excision activity but no C excision activity.  78 
 
 
Figure 3.18 Effect of pH (A) and temperature (B) on the activity of eCYDG against uracil, thymine, cytosine 
and 5-methylcytosine substrates. 31mer duplex substrates (~50nM) with the inclusion of free ethidium and 
pyrene with AP paired duplexes were incubated with 150 nM eCYDG for 30 minutes. All samples were 
quenched with 3 μl stop solution and heated at 95°C for 30 minutes and resolved on a 12.5% denaturing 
polyacrylamide gel and analysed by phosphorimaging. The top and bottom bands correspond to the 31mer 
uncleaved or 15mer cleaved product. AP; abasic site. B was performed at pH 6.3. 79 
 
Since Kwon et al., 2003 had determined the optimum reaction pH for eCYDG was 6.2, all 
further  experiments  were  performed  at  pH  6.2  rather  than  7.4.  The  apparent  loss  of 
excision  for  A.U  at  pH  5.5  (Figure  3.18B)  is  an  experimental  error  as  no  other  U 
containing substrate is affected. 
Previous experiments with eCYDG (Kwon et al., 2003) were performed at 25°C and we 
wondered whether the enzyme’s activity was temperature dependent, as our experiments 
were conducted at 37°C; a more physiological temperature. We therefore investigated the 
cleavage 25°C and 37°C (Figure 3.18B). Although the rate at G.U appears to be greater at 
37°C, no activity was observed against any of the C-containing duplexes. 
These eCYDG experiments were performed comparatively with eUDG and eUYDG and it 
is unsurprising that it showed no C activity as it is at least 1000-fold less active (Handa et 
al., 2002). Due to this and that eCYDG has been shown to have C excision activity (Kwon 
et al., 2003), it was decided to incubate the enzyme with a range of substrates over a longer 
time course and at a higher enzyme concentration. 
3.3.10.1 Activity Determination 
The  experiments  in  the  previous  section  were  performed  with  only  150  nM  eCYDG, 
allowing 30 minutes for digestion. These experiments were repeated with longer digestion 
times (24 hours) and higher enzyme concentrations (1.25 µM) against a range of DNA 
duplexes  and  the  results  are  shown  in  Figure  3.17.  As  expected  all  the  U-containing 
substrates were fully cleaved by the enzyme (when this is paired with G, A or an abasic 
site), while none of the T-containing substrates were affected. However, most importantly, 
under these conditions eCYDG excised C when it is paired opposite A or an abasic site, 
though  not  when  paired  with  G.  No  activity  is  evident  against 
MC  in  any  of  these 
combinations. We also investigated placing a gap between two oligonucleotides opposite 
the target C, so that it was completely unpaired (gap.C); this again showed activity towards 
C, though interestingly only 50% cleavage was seen (discussed below). Again, no cleavage 
was seen with a similar 
MC-containing substrate. Cleavage was also observed when the C 
(but  not 
MC)  was  placed  opposite  the  non-nucleosidic  linker  hexaethylene  glycol  (see 
below). 
The previous study with CYDG did not study base pair mismatches, but paired the target C 
with  a pyrene nucleoside  (Jiang et  al., 2001, Kwon  et  al., 2003) in  order to  facilitate 80 
 
expulsion of C into an extrahelical conformation. Since oligonucleotides containing this 
nucleotide were not available, we examined the reaction with an alternative commercially 
available nucleoside with a bulky intercalating group, anthraquinone pyrrolidine (Z; Figure 
2.1). We predicted that it might act in the same way as pyrene, and force the opposing base 
out of the DNA duplex into an extrahelical conformation for cleavage by eCYDG. The 
results with this base pair combination (Z.C or Z.
MC) are also included in Figure 3.19 and 
again show cleavage with Z.C, but not Z.
MC. 
 
Figure 3.19 eCYDG excision of uracil, thymine, cytosine and5-methylcytosine substrates.The 
32P labelled 
31mer duplex substrates (~50 nM) were incubated with ~1.25 μM eCYDG for 24 hours followed by heating 
at 95°C in 10% piperidine for 20 minutes. The products were resolved on 12.5% denaturing polyacrylamide 
gels and analysed by phosphorimaging. The top and bottom bands correspond to the uncleaved 31mer or 
15mer cleaved product respectively. Control refers to a G.U substrate unreacted with enzyme. AP; abasic site, 
Z; anthraquinone pyrrolidine, gap; unpaired C. 
CYDG  showed  no  activity  towards  either  C  or 
MC  when  paired  with  G.  We  were 
concerned that because this fragment contains several other G.C base pairs, eCYDG might 
have  weak  cleavage  at  these  sites  that  were  not  detected.  We  therefore  designed  an 
alternative 31mer duplex that was AT rich and contained a single G.C/
MC base pair in the 
centre (sequences G2.C2 in Table 2.4). eCYDG incubation with this new G.C substrate is 
shown in Figure 3.20 and the results confirm that eCYDG does not cleave either substrate. 
The observation that a G.C base pair is not cleaved by CYDG, but that C in any other base 
(mis)pair  combination  is  a  substrate  base  pair,  suggests  that  the  rate  of  cleavage  is 
profoundly affected by the stability of the base pair.  Unstable base combinations, such as 
A.C, allow rotation of the base into the active site, which is now designed to accommodate 81 
 
C. Presumably G.C is too stable to allow this rotation. However, it should be noted that 
CYDG is able to excise U from an A.U base pair.  
 
Figure 3.20 eCYDG excision of G.C/
MC. The 
32P labelled 31mer duplex substrates (~50 nM) were incubated 
with ~1.25 μM eCYDG for 24 hours followed by heating at 95°C in 10% piperidine for 20 minutes. The 
products were resolved on a 12.5% denaturing polyacrylamide gel and analysed by phosphorimaging. The 
top band corresponds to the uncleaved 31mer  product. Control refers to a G.C substrate unreacted  with 
enzyme. The additional bands seen towards the bottom of the gel do not correspond to cleavage of other Cs 
and are degradation products, which most likely arise from treatment with piperidine. 
3.3.11 Rate of Reaction Determination 
In order to determine the best substrate for eCYDG for discriminating between C and 
MC 
we investigated the kinetics of the reaction when C is placed against a variety of opposing 
bases. As the enzyme is in excess of the DNA substrate it is assumed that all substrate is 
bound by enzyme and that the initial velocity represents the rate of reaction as substrate 
turned over per unit time. Representative cleavage profiles are shown for A.C, AP.C and 
Z.C in Figure 3.21A, C and E and the rate of reaction was derived from these and a further 
two repeats. The rates were then averaged and the error (standard deviation) calculated, as 
per Appendix IV, and are summarised in Table 3.2. eCYDG fully excised C from an A.C 
mismatch over a 24 hour period producing a single product at a rate of 0.006 ± 0.001 min
-1.  82 
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Figure 3.21 Kinetics of eCYDG cleavage of the 31mer substrates A.C, AP.C and Z.C. The 
32P labelled 31mer 
duplex substrates (~50 nM) were incubated with ~1.25 μM eCYDG for up to 24 hours followed by heating at 
95°C in 10% piperidine for 20 minutes. The products were resolved on 12.5% denaturing polyacrylamide 
gels and analysed by phosphorimaging (A, C and E). The top and bottom bands correspond to a 31mer 
uncleaved or 15mer cleaved product respectively. The graphs are derived from phosphorimage analysis of 
the gels and show the rate of formation of the cleavage product. These are fitted with single exponential 
curves (B, D and F). AP: abasic site, Z: anthraquinone pyrrolidine. 83 
 
As previously discussed, anthraquinone (Z) was incorporated opposite C to force the base 
into an extrahelical conformation. This Z.C pair produced the fastest cleavage rate of 0.1 ± 
0.02  min
-1;  which  is  approximately  17-fold  faster  than  A.C.  This  is  consistent  with 
previous studies (Kwon et al., 2003), which used pyrene to force C into an extrahelical 
conformation. The rate of C cleavage from AP.C (0.014 ± 0.003 min
-1) is intermediate to 
A.C and Z.C. This is most likely because there is no hydrogen bonding with C, while an 
A.C mismatch has one H-bond, and this is not as destabilising as with Z. This gives an 
overall  substrate  preference  of  Z.C  >  AP.C  >  A.C.
eCYDG 
Rate of 
Reaction (min
-1) 
Relative 
Activity (%) 
G.U  0.36 ± 0.04  100 
HEG.C  0.13 ± 0.01  36 
Z.C  0.1 ± 0.02  29 
A.U  0.02 ± 0.004  5.63 
gap.C  0.017 ± 0.002  4.62 
AP.C  0.014 ± 0.003  4.01 
A.C pH 7.4  0.01 ± 0.002  2.71 
HEG.C(G)
2  0.01 ± 0.001  2.3 
long gap.C  0.007 ± 0.001  2.02 
A.C  0.006 ± 0.001  1.72 
A.C(AG)  0.005 ± 0.001  1.42 
A(T).C(G)
2  0.004 ± 0.001  1.07 
A.U(G)  0.0037  1.03 
A.C(GA)
1  0.0003  0.09 
ssC(polyA)
1  0.0003  0.07 
A.C(G)
1  0.0001  0.02 
ssC(GAT)
3  0.0001  0.02 
G.C(AT)  ND   
I.C  ND   
I.C(G)  ND   
Long HEG.C(G)1  ND   
APHEG.C(G)  ND   
 
Table 3.2 eCYDG reaction rates. Relative activity is in relation to the G.U substrate. The rate of reaction was 
determined as an average of three rates determined from cleavage profiles. Rate values were estimated from a 
single time point at 24 hrs
1, 5 mins
2 and 8 hrs
3 assuming a simple exponential. Z; anthraquinone pyrrolidine, 
AP; abasic site, I; inosine, gap; unpaired C, long gap; unpaired C in a 41mer duplex, HEG; hexaethylene 
glycol, ND; not detectable.   84 
 
3.3.11.1 Excision of uracil 
Uracil excision from G.U (0.36 ± 0.04 min
-1) is approximately 60-fold faster than from 
A.C showing that eCYDG still has a large selectively for U over C. Cleavage at A.U (0.02 
± 0.004 min
-1; again consistent with previous data (Kwon et al., 2003)) is 20-fold lower 
than G.U and 5-fold slower than Z.C, further suggesting that base pair stability plays a 
major role in determining the excision rates. 
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Figure 3.22 Kinetics of eCYDG cleavage of the 31mer substrates G.U and A.U. The 
32P labelled 31mer 
duplex substrates (~50 nM) were incubated with ~1.25 μM  eCYDG for up to 1 or 4 hours respectively 
followed  by  heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5% 
denaturing polyacrylamide gels and analysed by phosphorimaging (A and C). The top and bottom bands 
correspond  to  a  uncleaved  31mer  or  15mer  cleaved  product  respectively.  The  graphs  are  derived  from 
phosphorimage analysis of the gels and show the rate of formation of the cleavage product. These are fitted 
with single exponential curves (B and D). 85 
 
3.3.11.2 Excision of ssC substrates 
Since UDG is known to show good activity against single-stranded DNA substrates we 
investigate the activity of CYDG against single stranded substrates. Since these substrates 
can only contain a single C we designed two different oligos; ssC(polyA) has the central C 
within a polydA tract while ssC(GAT) has the central C flanked by a sequence of G, A and 
T. Cleavage plots for these substrates are shown in Figure 3.23. 
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Figure  3.23  Kinetics  of  eCYDG  cleavage  of  the  31mer  substrates  ssC(polyA)  and  ssC(GAT).  The 
32P 
labelled  31mer  duplex  substrates  (~50  nM)  were  incubated  with  ~1.25  μM  eCYDG  for  up  to  24  hours 
followed  by  heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5% 
denaturing polyacrylamide gels and analysed by phosphorimaging (A and C). The top and bottom bands 
correspond to the uncleaved 31mer or 15mer cleaved product respectively. The graphs are derived from 
phosphorimage analysis of the gels and show the rate of formation of the cleavage product. These are fitted 
with single exponential curves (B and D). 
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Unlike UDG, eCYDG shows very weak activity towards single stranded substrates giving 
rates of 0.0003 min
-1 and 0.0001 min
-1 for ssC(polyA) and ssC(GAT) respectively. These 
rates were calculated from a single time point at 24 and 4 hours respectively assuming a 
simple exponential (Equation 1). 
Rate = -ln(1 - Fraction cleaved) / Time 
Equation 1 Calculation of rate from a single time point. 
These times were chosen as ssC(polyA) only reached a maximum substrate cleavage of 
approximately 31% after a long incubation time. Therefore its rate was calculated based on 
this value after 24 hours. The maximum substrate cleavage efficiency for ssC(GAT) varied 
greatly at the 8 and 24 hour time points, though was still very low, and the reaction rate 
was calculated after 4 hours at which only 4% of the substrate had ben cleaved. 
3.3.12.3 Investigating the Effect of an Unpaired Cytosine 
Since the efficiency of CYDG cleavage at C seems to depend on the stability of the base 
pair we examined the enzyme’s activity against double stranded substrates in which the C 
is unpaired. Figure 3.24A shows the reaction of eCYDG with a substrate containing a 
completely unpaired C (gap.C). This shows a rate of 0.017 ± 0.002 min
-1, which is similar 
to that of AP.C. However, as noted above, only a maximum of approximately 50% of this 
substrate was excised. Since this substrate consists of two shorter duplexes, which will be 
less stable at the reaction temperature, we considered whether the reaction might be limited 
by the stability of the duplex substrate (melting temperatures (Tms) of 39 and 45°C) and 
therefore designed a similar longer duplex containing an extra five base pairs either side of 
the central C (long gap.C), producing a 41mer duplex of greater stability (Tms of 50 and 
54°C) (Figure 3.24C). The reaction rate with this substrate decreased to 0.007 ± 0.001 min
-
1 (Figure 3.24D) and the amount of substrate cleaved increased to approximately 80%. We 
decided to investigate further the reaction at an unpaired C by incorporating hexaethylene 
glycol (HEG) opposite, acting as a “backbone linker” to hold the two oligonucleotides 
(Figure 3.24E). This produced a rate (0.13 ± 0.01 min
-1) similar to Z.C, which is one of the 
best substrates for this enzyme, again highlighting the dependency of the rate of excision 
on base pair stability. 
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Figure 3.24 Kinetics of eCYDG cleavage of the 31mer substrates gap.C, long gap.C and HEG.C. The 
32P 
labelled  31mer  duplex  substrates  (~50  nM)  were  incubated  with  ~1.25  μM  eCYDG  for  up  to  24  hours 
followed  by  heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5% 
denaturing polyacrylamide gels and analysed by phosphorimaging (A, C and E). The top and bottom bands 
correspond to the uncleaved 31mer or 15mer cleaved product respectively. The graphs are derived from 
phosphorimage analysis of the gels and show the rate of formation of the cleavage product. These are fitted 
with single exponential curves. gap: unpaired C, long gap: unpaired C in a 41mer duplex, HEG: hexaethylene 
glycol (B, D and F). 88 
 
3.3.11.4 Investigating the Effect of the Flanking Base Pair on eCYDG Cleavage 
As eCYDG showed no activity towards G.C, but maintained A.U activity, we investigated 
the interaction of C paired with inosine (I); a G.C-like base pair that is less stable as it 
contains only two H-bonds, similar to though more stable than A.U (Sponer et al., 2004). 
We anticipated that this weaker base pairing would allow cleavage of C. The results are 
shown in Figure 3.25 and show that no significant activity can be detected. This suggests 
that other factors than simple base pair stability must have large contributions towards the 
rate of excision. 
 
Figure 3.25 Kinetics of eCYDG cleavage of the 31mer substrate I.C. The 
32P labelled 31mer duplex substrate 
(~50 nM) was incubated with ~1.25 μM eCYDG for up to 24 hours followed by heating at 95°C in 10% 
piperidine  for  20  minutes.  The  products  were  resolved  on  a  12.5%  denaturing  polyacrylamide  gel  and 
analysed  by  phosphorimaging.  The  top  and  bottom  bands  correspond  to  the  uncleaved  31mer  or 15mer 
cleaved product respectively. 
The ability to excise C in any sequence context will be crucial for the development of an 
assay for 
MC detection (Chapter 6). The results above suggest that base pair stability has a 
strong effect on the cleavage efficiency of CYDG at C. Since this will be affected by the 
sequence context we investigated the excision at A.C when surrounded by different base 
pair  combinations.  For  these  experiments  the  duplex  was  mismatched  so  that  the  A.C 
mismatch was flanked by G.C base pairs (A.C(G); using oligos A2 and C3 in Table 2.4 
and  Table  3.3)  instead  of  A.T.  Figure  3.26  shows  that  there  is  little  cleavage  of  this 
substrate and a rate of 0.0001 min
-1 could only be calculated from the small amount of 
cleavage at 24 hours, assuming a simple exponential. This context  reduced the rate of 
cleavage by approximately 100-fold in comparison to A.C in an AT context. The sequence 
was also altered so that the A.C mismatch was flanked by A.T and G.C base pairs on either 
side (A.C(AG) and A.C(GA); Table 3.3) so that the central sequence of the target C strand 89 
 
reads 5′-ACG-3′ or 5′-GCA-3′ respectively. These results are shown in Figure 3.26 and 
reveal rates of A.C(GA) (0.0003 ± 0.0001 min
-1) and A.C(AG) (0.005 ± 0.001 min
-1), both 
of which are lower than A.C flanked by AT (substrate A.C) and had to be calculated from 
a single time point at 24 hours. This is consistent with previous results for UDG in which 
the flanking sequence AG is a better substrate than GA (Eftedal et al., 1993). 
Oligonucleotide  Sequence 
A.C(G)  5′-CCGAATCAGTGCGCGCGGTCGGTATTTAGCC-3′ 
3′-GGCTTAGTCACGCGCACCAGCCATAAATCGG-5′ 
A.C(AG)  5′-CCGAATCAGTGCGCACGGTCGGTATTTAGCC-3′ 
3′-GGCTTAGTCACGCGTACCAGCCATAAATCGG-5′ 
A.C(GA)  5′-CCGAATCAGTGCGCGCAGTCGGTATTTAGCC-3′ 
3′-GGCTTAGTCACGCGCATCAGCCATAAATCGG-5′ 
 
Table 3.3 A.C oligonucleotides used to assess the effect of flanking regions on the rate of excision. Central 
A.C base pair highlighted in bold. 
These  results  suggest  that  the  5′  flanking  base  pairs  have  a  very  important  role  in 
determining the cleavage rate. This could be as a result of changes in the local duplex 
stability  and  base  stacking  on  the  cytosine  or  it  could  be  due  to  interactions  with  the 
enzyme itself and its ability to distort the duplex ready for base flipping (Parikh et al., 
1998).  As  placing  a  HEG  opposite  the  C  provided  the  greatest  rate  of  excision,  we 
investigated how this would be affected by flanking this HEG.C pair with G.C base pairs 
(HEGC.G). The results with this target are shown in Figure 3.27 and show an increase in 
amount  excised  (38%),  but  only  a  small  effect  on  the  rate  of  excision  (0.01  min
-1; 
calculated based on it reaching this level; of cleavage over 24 hours). To further explore 
the effect of flanking GC base pairs we examined the activity of CYDG at an A.U base 
pair with flanking GC base pairs (A.U(G); Figure 3.27). The rate decreased 5.5-fold to 
0.004 ± 0.0001 min
-1 compared to flanking AT base pairs, and only reached a maximum 
cleavage efficiency of 69%. This is also consistent with previous results (Eftedal et al., 
1993) and provides further evidence for the role of base stacking in determining the rate of 
excision. 
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Figure 3.26 Kinetics of eCYDG cleavage of the 31mer substrates A.C(G), A.C(AG) and A.C(GA). The 
32P 
labelled  31mer  duplex  substrates  (~50  nM)  were  incubated  with  ~1.25  μM  eCYDG  for  up  to  24  hours 
followed  by  heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5% 
denaturing polyacrylamide gels and analysed by phosphorimaging (A, B and D). The top and bottom bands 
correspond to the uncleaved 31mer or 15mer cleaved product respectively. The graphs are derived from 
phosphorimage analysis of the gels and show the rate of formation of the cleavage product. These are fitted 
with single exponential curves (C and E). 91 
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Figure 3.27 Kinetics of eCYDG cleavage of the 31mer substrates A.U(G) and HEG.C(G). The 
32P labelled 
31mer duplex substrates (~50 nM) were incubated with ~1.25 μM eCYDG for up to 24 hours followed by 
heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5%  denaturing 
polyacrylamide gels and analysed by phosphorimaging (A and C). The top and bottom bands correspond to 
the uncleaved 31mer or 15mer cleaved product respectively. The graphs are derived from phosphorimage 
analysis of the gels and show the rate of formation of the cleavage product. These are fitted with single 
exponential curves. HEG: hexaethylene glycol (B and D). 
As flanking G.C base pairs seem to have such a large effect on the rate of excision we 
investigated ways to reduce the stability of these flanking regions. Firstly we investigated 
using HEG further to oppose the central C as well as the flanking bases on each side, 
spanning three nucleotides (long HEG.C(G); Table 3.4). The HEG linker has the same 
number of bonds as three nucleotides, and so should be able to bridge this gap. However, 
no cleavage was detected (Figure 3.28C). Further studies examined the use of mismatches 
(G.T) flanking the central A.C mismatch (A(T).C(G); Table 3.4 and Figure 3.28A). This 
increased the amount of substrate cleaved from 12 to 31% over a 24 hour time period, 
though the estimated rate (0.0003 min
-1) is not significantly different to A.C(G) (0.0001 92 
 
min
-1). It is worth noting that the loss of intensity seen for the substrate at 24 hours in 
Figure 3.28A is due to experimental error, i.e. loading error. The substrate is therefore not 
being degraded as a result of time, buffer conditions or contaminants as this is not seen in 
other gels (i.e. Figure 3.28C) and also from substrate unreacted with enzyme for 24 hours 
(controls in Figure 3.19 and Figure 3.20).    
As  G.T  mismatches  failed  to  increase  the  cleavage  rate  we  investigated  the  combined 
effect of using HEG flanked by AP sites so that the flanking Gs of the target C were 
unpaired (APHEG.C(G)). This produced the same result as long HEG.C(G) and no activity 
was detected (Figure 3.28D). I.C(G) (an I.C central base pair flanked on either side by a 
G.C base pair) was also investigated, but as expected no activity was detected (Figure 
3.28E). 
Oligonucleotide  Sequence 
A(T).C(G)  5′-CCGAATCAGTGCGCGCGGTCGGTATTTAGCC-3′ 
3′-GGCTTAGTCACGCGTATCAGCCATAAATCGG-5′ 
long HEG.C  5′-CCGAATCAGTGCGCGCGGTCGGTATTTAGCC-3′ 
3′-GGCTTAGTCACGCG-H-CAGCCATAAATCGG-5′ 
 
Table  3.4  Sequences  of  A(T).C(G)  and  long  HEG.C.  Central  base  pairs  highlighted  in  bold.  -H-: 
hexaethylene glycol. 
In summary eCYDG is able to excise C when paired with any base except guanine but 
showed no activity against 
MC in any sequence context. Although cytosine can be cleaved 
the rate of excision is context dependent and the more stable the base pair, the lower the 
rate of excision activity. 
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Figure 3.28 Kinetics of eCYDG cleavage of the 31mer substrates A(T).C(G), long HEG.C(G), APHEG.C(G), 
and I.C(G). The 
32P labelled 31mer duplex substrates (~50 nM) were incubated with ~1.25 μM eCYDG for 
up to 24 hours followed by heating in at 95°C 10% piperidine for 20 minutes. The products were resolved on 
12.5% denaturing polyacrylamide gels and analysed by phosphorimaging (A, C, D, and E). The top and 
bottom bands correspond to the uncleaved 31mer or 15mer cleaved product respectively. The graphs are 
derived from phosphorimage analysis of the gels and show the rate of formation of the cleavage product. This 
is  fitted  with  a  single  exponential  curve  (B).  long  HEG:  hexaethylene  glycol  linker  spanning  three 
nucleotides, I: inosine. 94 
 
3.3.11.5 The effect of pH on A.C excision 
It has previously been shown that eCYDG is pH sensitive and shows optimum activity at 
pH 6.2, allowing correct protonation of the active site aspartates (Kwon et al., 2003). We 
therefore performed cleavage assays with A.C at pH 7.4 (A.C pH 7.4; Figure 3.29A), a 
more  physiological  pH,  in  contrast  to  all  previous  eCYDG  cleavage  assays  that  were 
performed at pH 6.2. Surprisingly we found that the rate (0.01 ± 0.002 min
-1) increased by 
approximately 50% compared to A.C at pH 6.2. 
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Figure 3.29 Kinetics of eCYDG cleavage the 31mer substrate A.C pH 7.4. The 
32P labelled 31mer duplex 
substrate (~50 nM) was incubated with ~1.25 μM eCYDG for up to 24 hours followed by heating in at 95°C 
10% piperidine for 20 minutes. The products were resolved on a 12.5% denaturing polyacrylamide gel and 
analysed by phosphorimaging (A). The top and bottom bands correspond to the uncleaved 31mer or 15mer 
cleaved product respectively. The graphs are derived from phosphorimage analysis of the gels and show the 
rate of formation of the cleavage product. This is fitted with a single exponential curve (B). 
3.3.12 Mutating F77 and Y66 
Other mutants of eUYDG and eCYDG were also investigated to examine cleavage of U 
and  C.  Phenylalanine  77  was  mutated  to  tyrosine,  tryptophan  or  histidine,  since  these 
residues are involved in base stacking interactions. We were most interested in histidine to 
investigate whether the nitrogens in its ring could interact with other residues or with the 2-
amino of cytosine, and alter the stability and activity. Initial experiments performed with 
eUYDG showed no significant reduction in activity at G.U for F77Y/W but showed lower 
activity for F77H. We therefore investigated the effect of introducing the F77H mutation 
into  eCYDG,  in  anticipation  that  the  reduction  with  uracil  in  eUYDG  might  be 
accompanied by an increase with cytosine. Unfortunately preliminary results showed that 95 
 
eCYDG  F77H  had  lower  excision  activity  towards  C  and  U  than  eCYDG  and 
eCYDG/eUYDG respectively. 
As  mutant  CDGs  may  also  be  developed  for  other  cytosine  modifications,  i.e.  5-
hydroxymethlycytosine (
HMC), we investigated  the effect  of  mutating Tyr66 to  smaller 
residues, so as to open up the active site allowing entry of larger cytosine analogues. This 
has already been shown for UDG in which the Y66A mutation allows the accommodation 
of thymine and thus its excision. We investigated the Y66A mutation within the context of 
eUDG, eUYDG and eCYDG generating eTDG, eTYDG and eCTYDG respectively. We 
were unable to express eTDG suggesting that like eCDG it was cytotoxic. Cleavage assays 
to  determine  eTYDG  and  eCTYDGs  activity  were  performed  over  24  hours  and  both 
showed residual U excision activity, with only slight T excision activity observed with 
eTYDG  when  opposite  the  anthraquinone  pyrrolidine;  consistent  with  previous  studies 
(Kwon et al., 2003). Neither thymine, cytosine or 5-methylcytosine release was detected 
with eCTYDG suggesting that a triple mutation severely reduces the enzyme’s activity. 
We also mutated Y66 to threonine, leucine and serine to see whether their side groups 
would  be  able  to  form  any  favourable  interactions  that  would  increase  activity,  while 
causing discrimination between 
MC and 
HMC. Preliminary results showed that all three 
mutations  caused  a  loss  of  C  excision  activity  while  decreasing  U  excision  activity 
compared to standard eCYDG. 
3.4 Discussion 
The main role of eUDG is to excise uracil in the context of a G.U base pair to prevent 
transition mutations that result from cytosine deamination. This base pair combination has 
not  previously been investigated for  eUYDG and  eCYDG. The results show that both 
eUDG and eUYDG are able to excise uracil in any sequence context and show no activity 
towards any other base. It was surprising that eUYDG was able to excise uracil from A.U 
with such efficiency, as the L191A mutation has been reported to severely reduce the 
activity of the enzyme (Jiang et al., 2001, Jiang et al., 2002b), and L191A mutants can 
only cause base excision if the base is flipped into an extrahelical conformation by other 
means (such as pyrene). It is therefore not surprising that eUYDG is able to excise uracil 
from a G.U or AP.U base pair. This is because these base pairs are less stable than A.U, 
being  a  “wobble”  base  pair  (G.U)  and  an  unpaired  (AP.U)  respectively.  The  uracil  is 
therefore more likely to become extrahelical through DNA breathing or by DNA distortion 96 
 
caused by  enzyme binding  (Werner  et  al., 2000). The ability of  eCYDG to  excise all 
uracil-containing substrates was also not expected, especially since previous studies have 
shown a large decrease in activity towards A.U (Kwon et al., 2003). The difference may be 
due to different reaction conditions; 25°C in the previous study compared to 37°C in this 
work. 
These results show that as expected eCYDG is able to discriminate between cytosine and 
5-methylcytosine, since Y66 is positioned so as to cause a steric clash with the 5-methyl 
group  of  a  pyrimidine  base.  The  N123D  mutation  changes  the  specificity  of  eUDG 
enabling recognition of cytosine. This mutation does not affect its ability to discriminate 
between a pyrimidine and a 5-methylpyrimidine. The mutant enzyme is able to excise 
cytosine when paired with anything other than guanine, while retaining its ability to excise 
uracil (Kwon et al., 2003), and no 5-methylcytosine activity was observed in any context. 
It is clear from these results that base pair stability is crucial for determination of the rate 
of excision (Krosky et al., 2004, Krosky et al., 2005). This is highlighted by eCYDG 
excising cytosine from Z.C faster than uracil from A.U. It is likely that the anthraquinone 
forces the cytosine out of the duplex into an extrahelical conformation more readily than 
uracil, which is held in a normal Watson-Crick A.U base pair. The faster rates observed 
with AP.C, gap.C and HEG.C (with the latter being equal to or greater than Z.C) than A.C, 
are probably because there is no opposing base to the cytosine. 
The rate of cleavage of A.C was not significantly affected by a changing the pH to 7.4, in 
contrast to previous reports (Kwon et al., 2003), though our experiments also showed that 
pH had no significant effect on excision of uracil. This difference could be due to the 
higher temperature used in the present work. It is interesting that only 50% of the substrate 
is cleaved with gap.C where the cytosine was completely unpaired. eUDG is known to 
bind strongly to AP sites (Parikh et al., 1998) and it is conceivable that eCYDG may bind 
even more strongly to an unpaired site. The 50% maximal cleavage of gap.C could arise if 
eCYDG binds to the target cytosine and unpaired site with equal affinity. However, this 
would not explain why the same effect is not seen for AP.C. An alternative explanation is 
that the Tm of one half of the duplex (39°C) is very close to the reaction temperature (37°C) 
and may therefore have melted leaving a single stranded region that prevented binding. 
This explanation seems more plausible, and is consistent with the weak activity seen with 
ssC substrates. This could account for the increase in maximal cleavage from 50% (gap.C) 
to 80% (long gap.C) by working with a longer, more stable, gapped duplex. Similarly the 97 
 
gap could generate a hinge region within the duplex, with the C acting as if single stranded, 
limiting enzyme binding and the maximal excision rate. We suggest that the fast rate seen 
with HEG.C is because the cytosine is unpaired; with a greater helical distortion than with 
AP.C.  Furthermore,  the  HEG  linker  may  generate  a  flexible  region  opposite  cytosine 
allowing it to become extrahelical more easily upon enzyme binding (serine pinching; see 
Section 1.3.1.3.1) (Werner et al., 2000). 
We assumed that ssC would produce the fastest rate for eCYDG, based on the substrate 
preference of eUDG (ssU > G.U > A.U) (Panayotou et al., 1998); however, this was not 
observed and very low single stranded activity was detected. This may be because the 
ssDNA  can  enter  and  quickly  leave  the  active  site  as  there  is  no  leucine  (L191A)  to 
maintain the target base in the active site. Furthermore, since eCYDG prefers uracil over 
cytosine, it is possible that aspartate (N123D) adopts the optimal conformation for uracil 
recognition and it is not until cytosine enters the active site that it rotates to form the 
favourable interactions to allow excision of this base (Pearl, 2000). In this case the base is 
not retained within the active site for long enough for recognition and subsequent excision. 
The ability of eCYDG to excise uracil from A.U but not cytosine from G.C suggests that 
the activity of the enzyme is dependent on the stability of the base pair; G.C is more stable 
as there is one more hydrogen bond compared to an A.U base pair. In addition, the enzyme 
may have a higher affinity for uracil and more readily forms favourable bonds with this as 
a result of D123′s conformation (as discussed above). These results also suggest that the 
major role of L191 is to plug the space left behind after base flipping (thereby increasing 
the time the base resides in the active site), rather than base flipping itself as suggested by 
previous studies (Jiang and Stivers, 2002). It therefore appears that base flipping may be 
initiated by duplex destabilisation as a result of enzyme binding, which is sufficient to 
destabilise A.U but not G.C (Parikh et al., 1998, Werner et al., 2000, Jiang and Stivers, 
2002). The lack of activity of eCYDG towards I.C (even though this has two hydrogen 
bonds as with A.U) suggests that this base pair increases local stability more than A.U due 
to base stacking interactions (SantaLucia et al., 1996, Watkins and SantaLucia, 2005). This 
limits the amount of time cytosine is extrahelical, reducing the opportunity for which the 
enzyme can bind and base excision to occur. 
The rate of A.C cleavage is severely reduced if it is flanked by G.C base pairs (A.C(G)) 
that is most likely explained by an increase in local DNA stability (Seibert et al., 2002) and 98 
 
the enzyme’s inability to base flip (Jiang et al., 2001, Jiang and Stivers, 2002, Jiang et al., 
2002b).  The increase in local  stability is  most  likely due to  base stacking interactions 
(SantaLucia et al., 1996) in which the 5′ base seems to have the greatest impact as seen by 
A.C(GA), for which the cleavage activity is only slightly greater than A.C(G). This is 
supported by the increased activity with A.C(AG), though this is still slower than A.C and 
only reaches a maximum cleavage efficiency of 53%. These variations in the efficiency of 
cleavage are important when considering cytosine in a CpG context. This is consistent with 
the decreased cleavage of A.U activity when this is flanked by G.Cs (A.U(G)), as noted in 
Table 3 in Eftedal et al., 1993, in which greater local duplex stability produces a slower 
rate of excision. Placing HEG opposite a cytosine which is flanked by G.C base pairs only 
increased the cleavage rate by approximately 3-fold. In contrast no activity was detected 
with long HEG.C(G), which is consistent with the result for APHEG.C(G). As the HEG 
linker spans three bases in long HEG.C, this small region may act like single-stranded 
DNA and thereby reduce the rate of excision.  It is possible that the DNA is now too 
flexible at the target region, preventing the enzyme from binding and further compounding 
its loss of activity. The use of a G.T mismatch to cause a destabilisation of the flanking 
base pairs again increased the amount cleaved and enhanced the rate by approximately 3-
fold compared to A.C(G). These results suggest that π–π base stacking provides significant 
stability to prevent the cytosine from becoming extrahelical. 
It was not surprising that the F77Y mutation caused no discernible change in activity, as 
tyrosine is similar to phenylalanine and is unlikely to alter the structure of the active site. 
Tryptophan would be expected to have a similar effect, though it has a large aromatic 
surface area that might be able to provide improved base stacking interactions with the 
target base, which could stabilise interactions in the active site. Crystal structures (i.e. PDB 
1SSP (Parikh et al., 1998)) show that the base of the active site is fairly open and suggest 
that it can comfortably accommodate a tryptophan without any structural distortion to the 
enzyme(s).  The  reduction  in  activity  with  F77H  is  most  likely  due  to  unfavourable 
electrostatic interactions caused by the additional nitrogens in ring. The reduced activity of 
Y66A has previously been reported as to have the observation that eTDG is cytotoxic and 
cannot  be  expressed  (Kavli  et  al.,  1996,  Handa  et  al.,  2002,  Kwon  et  al.,  2003). 
Furthermore, eTYDG has been shown to be 100-fold less active than eCYDG, and its 
slight activity towards thymine in a Z.T context is in agreement with this previous study 
(Kwon et al., 2003). As the activity of eCYDG is approximately three orders of magnitude 99 
 
lower than eUDG (Handa et al., 2002, Kwon et al., 2003), the addition of a third mutation 
(eCYTDG),  has  clearly  impacted  the  activity  of  the  enzyme,  resulting  in  the  loss  of 
cytosine activity. As this mutation has such a major effect on the activity of the enzyme 
another approach may be needed to gain specificity towards other cytosine modifications. 
The other Y66 mutations (Y66T/S/L) showed no activity towards thymine and a decrease 
in activity towards uracil. The exception to this is Y66F for which the activity is similar to 
that of the wild type (Handa et al., 2002), though based on our F77 results, we would 
suggest that this would also be the same for a tryptophan substitution. Further experiments 
will be required to determine the catalytic rates of these various mutants and to assess the 
difference in their lower activity. 
In summary we have shown that eCYDG is able to discriminate between cytosine and 5-
methylcytosine  in  any  active  substrate  context.  These  results  showed  that  the  rate  of 
excision is determined by the stability of the target base pair, the flanking base pairs and 
base stacking. This is consistent with the properties of UDG, which has a preference for 
G.U over A.U (Panayotou et al., 1998). The inability of eCYDG to excise cytosine from 
G.C base pairs, and its lack of ssC activity, provides the possibility of using the enzyme to 
probe the methylation status of any cytosine by generating a mismatch at a target cytosine 
to allow for excision if unmethylated. The proposed assay is discussed in Chapter 6. One 
way to overcome the low activity with the more stable substrates could be to exploit the 
more active hCDG, and this is discussed in Chapter 4.   100 
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Chapter 4: Exploring the inability to clone eCDG 
4.1 Introduction     
The results presented in Chapter 3 (section 3.3.1) showed that plasmids containing eCDG 
could not be generated in E. coli and suggested that this protein is exceptionally cytotoxic 
and  may  also  be  translated  by  an  unusual  mechanism.  This  sequence  could  not  be 
generated within pUC19, even though it was out of frame with the LacZ gene, suggesting 
some form of leakage or alternative initiation. In contrast the mutation could be made 
using the same sequence in pUC18, placing it in the opposite orientation, which would lead 
to transcription of the non-coding strand. We therefore decided to investigate this further in 
order to understand the basis of this toxicity and to see whether this could be overcome. 
It is known that the basal expression of proteins can be repressed when cells are grown in 
glucose-containing media (Grossman et al., 1998, Pan and Malcolm, 2000). The presence 
of glucose keeps the levels of cyclic AMP (cAMP) low and so reduces transcription, as the 
cAMP receptor protein (CAP) requires cAMP in order to bind DNA at the lac promoter. 
This complex then promotes transcription by recruiting E. coli RNA polymerase. Another 
possible  mechanism  by  which  this  toxic  gene  might  be  produced  is  via  a  form  of 
prokaryotic internal ribosomal entry (IRES) or ribosome “slippage” to initiate translation at 
the eUDG start codon (which is out of frame with the LacZ gene). In this process the first 
AUG  start  codon  is  missed  or  skipped  and  translation  occurs  at  the  next  (or  further 
downstream) AUG; in this instance at the start of the eUDG/CDG gene. To determine how 
active eCDG might be produced, even though it is out of frame with LacZ, we therefore 
prepared constructs with different regions between the LacZ and eUDG start codons. 
Another approach for reducing the cytotoxic effects of eCDG would be to co-express it 
with  the  uracil  DNA  glycosylase  inhibitor  (Ugi).  This  binds  very  tightly  (effectively 
irreversibly) to UDG under physiological conditions and inhibits its action (Bennett and 
Mosbaugh, 1992). Examination of the structure of the complex suggests that CDG should 
also be inhibited by Ugi (Kavli et al., 1996). We predict that although the affinity of hCDG 
for DNA (Kd) is reduced compared to that of hUDG (Kavli et al., 1996), Ugi should still be 
able to bind tightly and to cause inhibition. It has also been shown that UDG and Ugi can 
be expressed from the same plasmid (Roy et al., 1998, Acharya et al., 2002). However, this 
will require the two proteins  to  be generated at equal  rates. We therefore  investigated 
whether a fusion between eUDG and Ugi might overcome these problems as the proteins 102 
 
will be generated in 1:1 stoichiometry and the covalent attachment will allow rapid and 
direct inhibition of eUDG/CDG. Generation of a fusion protein may therefore provide a 
method for eCDG expression by direct inhibition of its cytotoxic properties. 
We  therefore  attempted  to  address  the  problem  of  cytotoxicity  through  (i)  reverse 
mutagenesis, (ii) reducing basal expression, (iii) examining the mechanisms of IRES and 
(iv) co-expression with an inhibitor. Unfortunately all of these attempts were unsuccessful. 
4.2 Experimental Design 
4.2.1 Reverse Mutagenesis 
To  determine  whether  the  cytotoxicity  of  eCDG  was  directly  related  to  the  N123D 
mutation we attempted to reverse the L191A mutation in eCYDG and convert it back to 
eCDG. We used both pUC19eCYDG and pUC18eCYDG as a control as we have already 
shown that pUC18eCDG is a stable clone. The A191L mutation was introduced via site 
directed mutagenesis (section 2.3.1). 
4.2.2 Using different Cell Types to Generate a Stable eCDG Clone 
4.2.2.1 Recombination Deficient Cells 
Sure cells (Agilent Technologies) are used in the cloning of unstable clones as they are 
deficient  in  specific  repair  genes  and  may  be  able  to  accommodate  a  cytotoxic  repair 
protein. Therefore the pUC19eCDG mutagenesis product was transformed into these cells. 
4.2.2.2 Glucose Supplementation 
To establish whether glucose could repress any basal expression of eCDG, agar plates were 
prepared containing 1% glucose. The pETeCDG mutagenesis  product  was  transformed 
directly into BL21(DE3)pLysS expression cells that are sensitive to glucose, whilst also 
having the protein expression regulatory secondary plasmid of pLysS. 
4.2.3 Altering the Region Upstream of the eUDG Start Codon 
We designed a pair of 50mer oligonucleotides to increase the distance between the start 
codons of the LacZ and eUDG within pUC19, while maintaining the original reading frame. 
The insert (Figure 4.1A) contained pairs of restriction sites (coloured) that could be used to 
shorten the linker if necessary, as shown in Figure 4.1B and C. 103 
 
A 
5′-AGCTACGTAAGATCTTATACTCGAGCAAGGATATCGACTGCTCGAGCCAGATCTTCC-3′ 
    3′-TGCATTCTAGAATATGAGCTCGTTCCTATAGCTGACGAGCTCGGTCTAGAAGGTCGA-5′ 
 
B 
5′-AGCTACGTAAGATCTTATACTCGAGCCAGATCTTCC-3′ 
    3′-TGCATTCTAGAATATGAGCTCGGTCTAGAAGGTCGA-5′ 
 
C 
5′-AGCTACGTAAGATCTTCC-3′ 
    3′-TGCATTCTAGAAGGTCGA-5′ 
 
Figure 4.1 Sequences produced to vary the distance between the LacZ and eUDG start codons. A) The full 
length sequence designed with overhangs complementary to the HindIII restriction site (green) for original 
cloning, BglII (purple) and XhoI (red) for production of sequences B and C. The full length sequence was 
designed to maintain the reading frame, whilst an EcoRV (blue) site was included to act as a diagnostic for 
successful cloning prior to sequencing. 
We also inserted a stop codon, both in frame and out of frame of the eUDG start codon 
(Figure 4.2), between the LacZ start and eUDG in pUC19eUDG. It was hoped that this 
would stop any premature translation of eCDG that had initiated from the LacZ start codon. 
A  
5′-ATGACCATGATTACGCCAAGCTTCATATGGCT-3′ 
 
B  
5′-ATGACCATGATTACGCCAAGTAACATATGGCT-3′ 
 
C 
5′-ATGACCATGATTACGCCATAATTCATATGGCT-3′ 
 
Figure 4.2 The DNA sequences of the region between the start codons of LacZ (5′ blue) and eUDG (3′ blue). 
A) Unmutated sequence. B) Incorporation of a stop codon (red) in frame with UDG. C) Incorporation of a 
stop codon (red) in frame with LacZ. 
4.2.4 Co-transformation of Ugi 
The products of pETeUDG N123D mutagenesis reactions were co-transformed with Ugi 
(contained  within  the  vector  pRSETB  that  has  ampicillin  resistance)  or  with  Ugi-
containing  competent  cells.  The  transformations  were  then  spread  onto  agar  plates 
containing carbenicillin (100 μg/ml) and kanamycin (30 μg/ml) to give selectivity towards 
cells that contained both plasmids. 
4.2.5 Generating an eUDGUgi Fusion Protein 
Oligonucleotides were designed to amplify Ugi, including restriction sites for cloning into 
pETeUDG.  eUDG  and  Ugi  have  4  and  14  residues  at  the  C-terminus  and  N-terminus 
respectively, which appear to be unstructured, as they are not seen in crystal structures. It 104 
 
should therefore be possible to directly link the two proteins together. We also engineered 
a thrombin cleavage site into the 5′ oligonucleotide primer so as to allow for separation of 
the proteins during purification. The thrombin site also acts to extend the linker between 
the two proteins and should allow Ugi to fold  easily around the DNA binding site of 
eUDG/CDG. 
4.2.6 Further Mutagenesis of eUDGUgi 
After cloning the Ugi sequence into pETeUDG, the eUDG stop codons and the upstream 
thrombin cleavage site had to be removed.  The thrombin cleavage site is 18 bp long which 
provides enough base pairing between the primer and template to generate a stable duplex. 
Gaining specificity for mutating one thrombin site (upstream of eUDG) over the other 
(between eUDG and Ugi) may be difficult to achieve. To increase the specificity, and the 
chances of success, we designed 31mer oligonucleotides that included the flanking regions 
specific to the upstream thrombin site (Figure 4.3). 
Finally  the  N123D  mutation  could  be  performed  to  see  if  pETeCDGUgi  could  be 
generated. All mutations were introduced via site directed mutagenesis and were confirmed 
by sequencing. The oligonucleotides used are shown in Table 2.2. 
5′-AGCGGCCTGGTGCCGGGCGGCAGCCATATGG-3′ 
3′-TCGCCGGACCACGGCCCGCCGTCGGTATACC-5′ 
Figure  4.3  Oligonucleotide  primers  designed  for  mutation  of  the  upstream  thrombin  cleavage  site.  The 
thrombin site and the single base mutation highlighted in blue and red respectively. 
4.3 Results 
4.3.1 Restoration of eCDG Activity 
Both pUC18eCYDG and pUC19eCYDG were subjected to further SDM to generate eCDG 
by  reversing  the  L191A  mutation.  Both  reactions  produced  successful  colonies,  which 
were subjected to Taq
αI digestion in order to confirm that they still contained the N123D 
mutation. All clones showed the correct three band pattern. These were then sequenced 
using  the  CEQ8000  genetic  analysis  system.  The  results  were  positive  for  pUC18, 
producing  pUC18eCDG,  but  negative  for  pUC19  in  which  all  the  clones  contained  a 
secondary mutation. 
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4.3.2 Effects of Different Cell Types 
4.3.2.1 Using Sure Cells 
The use of Sure cells did not produce any positive pUC19eCDG clones, suggesting that 
cytotoxicity is directly related to eCDG and/or the BER pathway and not general cellular 
repair. 
4.3.2.2 Effects of Glucose 
No  positive  pETeCDG  clones  were  obtained  when  using  glucose  to  repress  basal 
expression of eCDG. This suggests that either glucose is not able to completely repress 
basal expression, or supress it to a level at which eCDG expression is low enough not to 
cause cytotoxicity. 
4.3.3 Alternative Initiation 
The  linker  oligonucleotide  (Figure  4.1A)  was  cloned  into  the  upstream  region  of 
pUC19eUDG by ligating it into the plasmids via a single HindIII site. Once the full length 
insert  had been  successfully  cloned, this  was  truncated by selective cutting with  BglII 
(Figure  4.1B)  or  XhoI  (Figure  4.1C)  and  re-ligated  to  generate  the  shorter  linkers. 
Restriction digests were performed with XhoI/EcoRV or EcoRV respectively to determine 
successful cloning, as correct constructs would not contain the respective restriction sites 
resulting  in  an  undigested  plasmid.  Positive  clones  were  then  sent  for  sequencing  for 
confirmation. These were then used for site directed mutagenesis to introduce the N123D 
mutation. As with previous experiments, the N123D mutation yielded no clones of the 
correct mutated sequence with any of the three constructs. 
4.3.4 Addition of Stop Codons 
After successful mutagenesis to incorporate stop codons into the upstream region of eUDG, 
mutagenesis was performed to attempt to generate an eCDG clone. This still produced no 
viable clones, suggesting that translation initiation was occurring from the start codon of 
eUDG and not from that of LacZ. 
4.3.5 Introduction of Ugi 
Co-transformation of Ugi with the mutagenesis reaction mixture for converting pETeUDG 
to pETeCDG yielded very few colonies. These colonies were subjected to Taq
αI digestion 106 
 
and were determined to be wild type pETeUDG. As a control, pETeUDG was also co-
transformed with Ugi to determine dual transformation efficiency. The number of colonies 
yielded was not significantly greater than with pETeCDG transformation. This then led us 
to make competent cells containing Ugi that could then be transformed with pETeCDG. 
Ugi was successfully transformed into XL-1 Blue cells and viable competent cells made 
from  these.  The  number  of  colonies  significantly  increased  (approximately  10  fold 
compared to co-transformation) upon transformation with pETeUDG, but there were still 
very  few  (≤  5  colonies)  after  pETeCDG  transformation.  These  again  proved  to  be 
pETeUDG and no positive pETeCDG clones were obtained. 
Rather than relying on basal expression of Ugi to inhibit any eCDG protein produced we 
attempted to induce production of Ugi using agar plates containing 0.2 mM IPTG. It was 
hoped  that  Ugi  would  be  produced  at  a  stoichiometry  of  at  least  1:1  with  eCDG. 
Expression from pET28a is also under IPTG control and therefore eCDG and Ugi would 
be induced together. This too failed to yield any positive colonies. As pRSETB is also 
induced by IPTG we decided to clone Ugi into a vector that was under a different inducer. 
We therefore amplified Ugi using primers containing SacI and EcoRI restriction sites for 
cloning  into  the  pBADA  vector  that  is  induced  by  arabinose  (see  Appendix  I  for 
oligonucleotide sequences: Ugi For and Ugi Rev). Ugi was cloned into pBADA and colony 
PCR was performed and positive clones sent for sequencing for confirmation; generating 
pBADAUgi. pBADAUgi was co-transformed with pETeCDG onto agar plates containing 
0.02 to 20% (w/v) arabinose (and kanamycin) so that only Ugi would be induced to inhibit 
any basal expression of eCDG. Again no positive clones were obtained. 
4.3.6 Cloning and Mutagenesis of UDG-Ugi Constructs 
4.3.6.1 Generating a pETeUDGUgi Fusion Construct 
The bacteriophage PBS1 Ugi was amplified by PCR to generate a product that contained 
an EcoRI restriction site and a thrombin cleavage site at its N-terminus, and a HindIII site 
at  its  C-terminus  (see  Appendix  I  for  oligonucleotide  sequences:  UDGUgi  For  and 
UDGUgi Rev). The product (approximately 300 bp) generated was confirmed by agarose 
gel electrophoresis and cloned into pETeUDG via the restrictions sites EcoRI and HindIII 
(Figure 4.4). 107 
 
 
Figure 4.4 Cartoon of the pETeUDGUgi construct.  
The cloning of Ugi into pETeUDG should generate an eUDGUgi construct of 972 bp. 
Upon transformation, colonies were subjected to colony PCR using primers designed to 
flank the construct and thus generate a product of 1102 bp. This can clearly be seen in 
Figure 4.5 (Lanes 2 – 5 and 10 – 12) where positive clones of pETeUDGUgi are seen at 
approximately the 1000 bp marker. The identity of the clones in lanes 2 – 4 was then 
confirmed by sequencing. 
pETeUDGUgi was then subjected to two rounds of mutagenesis to remove the upstream 
thrombin cleavage site and the stop codons of eUDG. The stop codons were mutated to 
two glycine residues, to allow for continual translation into the Ugi gene. This construct 
was denoted pETeUDGUgiS. Secondly the upstream thrombin site was mutated so that 
Ugi  could  be  released  from  the  hybrid  protein  after  thrombin  cleavage,  leaving  the 
eUDG/CDG  bound  to  the  nickel  column.  The  sequencing  results  show  a  cytosine  to 
guanine  mutation,  which  is  sufficient  to  prevent  thrombin  cleavage,  in  the  upstream 
thrombin site but not in the thrombin site between eUDG and Ugi, as indicated by the 
arrows. This final construct was denoted pETeUDGUgiST and its identity was confirmed 
by sequencing (Figure 4.6).  108 
 
 
Figure 4.5 Colony PCR to determine positive pETeUDGUgi clones. Positive clones are shown in lanes 2 – 5 
and 10 – 12; clones 2 – 4 sent for sequencing. 0.7% agarose gel ran in 1x TBE at 15 Vcm
-1 for one hour. 109 
 
 
Figure 4.6 Sequencing analysis of pETeUDGUgiST. A) The upstream thrombin cleavage site (red box) with 
the C to G single base mutation indicated by an arrow. B) The base required for the N123D mutation. C) The 
mutation  of  the  stop  codons  to  glycine  residues  (GGA;  blue  box)  and  the  internal  unmutated  thrombin 
cleavage  site (red box). The equivalent base  mutated in  the upstream  site is indicated by an arrow and 
remains as a cytosine. D) The start codon (ATG; black box) of Ugi. 110 
 
4.3.6.2 Generation of pEThUDGUgi via complete gene synthesis 
The bacteriophage  ugi  gene is  very  AT-rich and we  were therefore concerned that its 
unusual codon usage might not facilitate expression in E. coli. We therefore prepared a 
synthetic version of this gene (eUgi) which, though still very AT-rich, was optimised for 
expression  in  E.  coli  (Figure  4.7).  We  combined  this  with  the  synthetic  version  of 
hUDGΔ81 (which is described in Chapter 5) to generate the construct hUDGΔ81Ugi.  This 
was  prepared  from  two  rounds  of  PCR  (Figure  4.8A),  as  described  for  hUDGΔ81  in 
chapter 5. 
PBS1Ugi ATGACCAATTTATCTGACATCATTGAAAAAGAAACAGGAAAACAACTAGTGATTCAAG  
         M  T  N  L  S  D  I  I  E  K  E  T  G  K  Q  L  V  I  Q 
eUgi    ATGACCAACTTGTCCGACATCATCGAAAAAGAGACCGGCAAGCAACTGGTTATTCAAG    
         M  T  N  L  S  D  I  I  E  K  E  T  G  K  Q  L  V  I  Q 
 
AATCAATTCTAATGTTACCAGAAGAAGTAGAGGAAGTAATTGGGAATAAACCAGAAAGTGATATTT 
E  S  I  L  M  L  P  E  E  V  E  E  V  I  G  N  K  P  E  S  D  I 
AATCTATCTTGATGCTCCCTGAAGAAGTAGAAGAGGTTATCGGTAATAAGCCGGAGTCCGACATTC 
E  S  I  L  M  L  P  E  E  V  E  E  V  I  G  N  K  P  E  S  D  I 
 
TAGTTCATACTGCTTATGATGAAAGTACAGATGAAAATGTAATGCTATTAACTTCAGATGCTCCAG 
L  V  H  T  A  Y  D  E  S  T  D  E  N  V  M  L  L  T  S  D  A  P 
TGGTGCACACTGCTTATGACGAATCTACTGATGAGAACGTAATGCTGCTGACTAGCGACGCTCCGG 
L  V  H  T  A  Y  D  E  S  T  D  E  N  V  M  L  L  T  S  D  A  P 
 
AATATAAACCTTGGGCTTTAGTAATTCAAGACAGTAATGGAGAAAATAAAATTAAAATGTTATAA 
E  Y  K  P  W  A  L  V  I  Q  D  S  N  G  E  N  K  I  K  M  L 
AATACAAACCGTGGGCTCTGGTAATTCAAGACTCTAACGGCGAAAACAAAATCAAGATGCTGTAA 
E  Y  K  P  W  A  L  V  I  Q  D  S  N  G  E  N  K  I  K  M  L 
 
Figure 4.7 DNA and protein sequence alignments of bacteriophage PBS1 and E. coli to show optimisation 
for expression in E. coli. Base, but not amino acid, changes highlighted in red. 
As with hUDGΔ81 the first round of PCR generated a mixture of species (shown as a 
smear in lane 2) containing the full length product, which was selectively amplified by a 
second  round  of  PCR  using  excess  of  the  terminal  primers,  to  produce  an  amplified 
product of 973 bp (lane 3). As hCDG can be produced in E. coli we had no need to use the 
clone for the potential production of hCDG. 111 
 
 
Figure 4.8 Complete gene synthesis of hUDGΔ81Ugi. A) Products after first round (lane 2) and second 
rounds (lane 3) of PCR amplification. B) PCR purification of lane 3 of A. 0.7% agarose gel run in 1x TBE at 
15 Vcm
-1 for one hour. 
4.3.7 Expression of pETeUDGUgiST 
As positive pETeCDGUgiST clones could not be generated, it suggested that the fusion 
protein was still cytotoxic or that the Ugi was not able to inhibit the eCDG protein. To 
investigate this we attempted to express eUDGUgi, with the aim of testing its activity 
against a G.U substrate. If the fusion protein still has UDG activity it would suggest that 
the Ugi is not inhibiting eUDG and therefore explain why a positive eCDGUgi construct 
cannot be made. Alternatively if the fusion protein is inactive it would suggest that the Ugi 
was causing inhibition and that it should be possible to generate an eCDGUgi construct. 
Surprisingly we were unable to express and purify eUDGUgiST as shown by Figure 4.9A 
and B. Figure 4.9A a potential band of eUDGUgiST (~ 37 kDa) in fraction 1, though no 
induction band, or a corresponding band in the sonication sample can be seen, suggesting 
this is an artefact at the expected MW. The purification was repeated to investigate this 112 
 
further (Figure 4.9B) and again no clear induction can be seen and this time a darker band 
can be seen in fraction 1 and 2 at approximately 27 kDa. This is indicative of  eUDG 
expression and not the eUDGUgiST construct. This was not pursued further. 
 
Figure 4.9 SDS-PAGE purification of eUDGUgiST.Samples were taken at different purification stages to 
determine enzyme expression and purity. 
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4.4 Discussion 
We assume that eCDG is very cytotoxic, as expression of the enzyme will lead to excision 
of cytosine from plasmid and genomic DNA and result in fragmentation of the genome. If 
this excision occurs at a faster rate than the ability of the E. coli cells to repair the damage, 
then cell death will be inevitable. This appeared to be the case as clones for eCDG could 
not be obtained in either pUC19 or pET28a. We assumed that this occurs through “leaky” 
expression  in  the  pET  vector,  but  is  more  puzzling  for  the  pUC  clone.  The  mRNA 
produced by reading from the LacZ promoter, would contain the eCDG sequence, but this 
will be out of frame with the LacZ sequence and therefore produce a nonsense protein. 
Therefore any eCDG produced must have occurred through translation from its own start 
codon arising from ribosomal scanning and/or slippage missing the initial LacZ start codon 
via a form of alternative initiation. 
This  alternative  initiation  is  most  likely  to  occur  through  ribosomal  binding  at  Shine-
Dalgarno sequences (AGGAGG) within the LacZ and eCDG start codons. Upon review of 
this  region,  though  there  is  no  exact  consensus  match,  there  are  two  positions  that 
correspond to the sequence AXXAXG. It has been reported that GAGG is only required 
for translation of early genes in phages (Malys, 2012). It is therefore conceivable that other 
partial sequences can be tolerated, allowing ribosomal binding, and in our case translation 
from the eCDG start codon. Any expression of eCDG in this way is likely to be very low 
but these results suggest that only a small amount of eCDG is enough for it to be cytotoxic 
to the cell. This is consistent with the observation that this sequence could be stably cloned 
in pUC18, in which it is inserted in the opposite orientation, so that transcription from the 
LacZ promoter would lead to production of a completely different nonsense protein. It is of 
note  that  even  using  different  cell  types  that  are  under  tighter  control  of  expression 
(BL21DE3pLysS cells) or are repair deficient (Sure cells), we were still unable to produce 
an eCDG clone. 
All the clones that were obtained when attempting  to produce the N123D mutation of 
eUDG, in pUC19 or pET28a, were found to be incorrect upon sequencing. These had each 
undergone a secondary mutation generating either a deletion or insertion of a nucleotide 
(or nucleotides). As a result the rest  of the protein would be out  of frame and would 
produce  a  nonsense  protein.  These  secondary  mutations  therefore  produced  a  protein 
without CDG activity and so enabled the host and the plasmid to survive. This was also 114 
 
shown by the reverse mutagenesis of eCYDG to eCDG, in which the A191L mutation was 
successful for pUC18eCYDG (generating pUC18eCDG) but not for pUC19eCYDG, for 
which the N123D was only obtained in conjunction with a secondary mutation(s). 
The failure of Ugi to allow stable eCDG expression was not completely unexpected. As the 
two proteins are made from separate plasmids it is highly likely that they are produced in 
different amounts and at different rates. If eCDG is produced at a greater rate than Ugi then 
the Ugi concentration will not be sufficient to prevent the cytotoxicity. Secondly, as the 
proteins  are  made  separately,  Ugi  may  not  inhibit  eCDG  fast  enough.  There  may  be 
sufficient time for eCDG to locate and start excising cytosine from plasmid and genomic 
bacterial DNA, leading to DNA damage and cell death. Therefore, for Ugi to be effective, 
even if it was being produced at a greater rate, it would still have to locate and bind to the 
eCDG. Finally, Ugi is a phage protein and the gene for this is extremely AT rich, meaning 
the codon usage is different to E. coli and could reduce the rate of Ugi translation. To 
overcome these problems we attempted to generate a fusion protein between eUDG and 
Ugi, whereby this would guarantee a 1:1 stoichiometry while keeping the proteins in close 
proximity to allow for rapid inhibition upon expression. Though we successfully generated 
a full fusion construct of eUDG and Ugi (pETeUDGUgiST), we were still unable to obtain 
any clones with the N123D mutation without a secondary mutation. Furthermore, we were 
unable  to  express  eUDGUgiST  and  our  results  showed  inconsistent  purification  in  the 
various  fractions.  Further  investigation  is  therefore  required  to  understand  this  and  to 
ascertain whether a fusion protein can allow the expression and purification of an eCDG. 
The investigation of cytotoxicity from a variety of different methods strongly suggest that 
eCDG is extremely cytotoxic to E. coli cells as the enzyme is unable to be produced except 
when ‘inactivated’, i.e. through secondary mutations. Therefore its production may only be 
possible by in vitro transcription translation systems. We suggest that apart from eCDG 
being  more  active  (as  our  results  in  Chapter  3  would  suggest),  eCDG  is  cytotoxic 
compared to hCDG in E. coli as hCDG is unable to recruit the other E. coli proteins in the 
BER pathway for DNA repair. Based on this assumption it would be interesting to attempt 
to express both CDGs in other cell lines (e.g. HeLa cells, yeast or insect cells) to see if the 
effect is reversed and cell type dependent. 
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Chapter 5: Excision Properties of hCDGs 
5.1 Introduction 
As previously reported (Kavli et al., 1996, Handa et al., 2002), eCDG is toxic and cannot 
be expressed in E. coli. This was confirmed in Chapter 3 of this thesis, which therefore 
examined the properties of the double mutant N123D, L191A (eCYDG). It would have 
been  preferable  to  study  eCDG  itself,  though  this  enzyme  has  previously  only  been 
prepared using an in vitro transcription-translation system (Handa et al., 2002). The yield 
of enzyme from this system was much lower than that of direct expression of UDG in E. 
coli. Another disadvantage with this system for generating eCDG is that the transcription 
and translation steps have to be performed separately rather in a one-pot dual assay. As 
soon as eCDG is produced it will begin to degrade the template DNA preventing  any 
further transcription. Therefore the amount of eCDG mRNA is limited and decreases over 
time through degradation of the DNA template. Therefore finding a way to produce a CDG 
in vivo would be highly advantageous. This has previously been achieved for the human 
enzyme hCDG  using  recA
- strains  of  E. coli as  it this  enzyme  appears  to  have lower 
cytotoxicity than the equivalent E. coli enzyme (Kavli et al., 1996). The difference in 
toxicity might be because the human and E. coli enzymes have different amino acid codon 
usage, resulting in a lower rate of hCDG expression in E. coli, allowing repair of any 
lesions to keep pace with the damage. Alternatively it is possible that the toxic effects of 
eCDG result from other E. coli proteins that are recruited to the sites, which are not able to 
interact with hUDG. We therefore looked to exploit this as a means for expressing hCDG 
in E. coli and assessing its activity towards a variety of cytosine-containing substrates. This 
chapter describes the preparation and properties of hCDG, as well as hCYDG, to allow 
direct comparison with eCYDG. 
5.2 Experimental Design 
5.2.1 Complete Gene Synthesis of hUDG  
The sequence of human placental UDG cDNA (Olsen et al., 1989) was used to generate 
the hUDG gene by total gene synthesis. Slupphaug et al. (1995) have shown that hUDG is 
fully  active  with  a  truncated  N-terminus,  as  this  signal  sequence  is  only  required  for 
translocation  to  the  nucleus/mitochondria.  This  truncated  sequence  was  divided  into 
~60mers  that  allowed  for  approximately  20  base  overlap  between  each  of  the 116 
 
complementary strands. The central unpaired regions were then filled in and the whole 
gene amplified using a high fidelity polymerase. An additional benefit of this method is 
that  mutations  can  be  introduced  made  by  simply  changing  one  of  the  cassette 
oligonucleotides. The sequences of the oligonucleotides that were used to generate this 
clone are shown in Appendix II.  As described below, this generated the sequence coding 
for hUDGΔ81 (hUDG with residues 3 - 84 removed). 
5.2.2 Mutagenesis of hUDG 
The  N204D  and  L191A  mutations  were  introduced  into  hUDGΔ81  via  site  directed 
mutagenesis as in described in Section 2.3.1. The oligonucleotides used for this are shown 
in the Materials and Methods; Table 2.2. 
5.2.3 Excision Properties  
As with eCYDG, DNA cleavage assays were used to assess the excision properties of the 
hCDGs. These assays were performed in triplicate; the rate constants were calculated and 
averaged to determine the rate of reaction of the enzyme against a variety of different 
substrates. The assays were performed over 24, 4 or 1 hour time courses, depending on the 
activity of the enzyme towards each particular substrate. The oligonucleotides containing 
the target base were radiolabelled with 
32P at the 5′ end and annealed to a complementary 
strand to form duplex substrates for the enzyme. The substrates generated contained target 
U, T, C or 
MC paired opposite a G, A, AP (abasic site), Z (anthraquinone pyrrolidine) and 
HEG (hexaethylene glycol). As in the previous chapter anthraquinone pyrrolidine was used 
as  a  bulky  synthetic  nucleoside  instead  of  pyrene,  as  the  pyrene  nucleoside  is  not 
commercially available. After incubation with hCDG the DNA was treated with 10% (v/v) 
piperidine to cause specific cleavage at the abasic site, generating a single product band. 
The resulting products were run on denaturing PAGE, phosphorimaged and analysed. 
5.3 Results 
5.3.1 Complete Gene Synthesis of hUDGΔ81 
hUDGΔ81  was  generated  through  complete  gene  synthesis  from  two  rounds  of  PCR 
(Figure 5.1). The first round generated the full length construct from a series of partially 
overlapping oligonucleotides, optimising the PCR reaction  as detailed in Materials and 
Methods  2.3.7.  The  resulting  product  seen  as  a  smear  in  Figure  5.1A  (lane  2),  which 117 
 
contained the full length product as well as many other partial sequences. This was further 
amplified using the terminal primers to generate a band of 697 bp (lane 3). This can be 
seen more clearly after purification of the PCR reaction using a PCR product purification 
kit (QIAGEN) (Figure 5.1B). 
 
Figure 5.1 Complete gene synthesis of hUDG. A) Products after the first (lane 2) and second (lane 3) rounds 
of PCR amplification. B) PCR purification of lane 3 of A. These 0.7% agarose gels were run in 1x TBE at 15 
Vcm
-1 for one hour. 
5.3.2 hCDG Mutagenesis 
The PCR mixture from  Figure 5.1B underwent a PCR clean-up and the construct was 
cloned into the vector pET28a. Colonies were screened by colony PCR (Materials and 
Methods 2.3.9) and a positive clone was obtained (Figure 5.2A, hUDGΔ81 2). Plasmid 
DNA  from  the  positive  colony  (pEThUDGΔ81  2)  was  prepared  and  the  sequence 
confirmed  by  sequencing.  This  clone  was  then  subjected  to  further  site  directed 
mutagenesis, to introduce the N204D mutation, generating human CDG (pEThCDGΔ81). 118 
 
After transformation plasmids were prepared from two of the successful colonies and were 
subjected to digestion by Taq
αI. The N204D mutation creates an extra restriction site for 
Taq
αI, which then generates a different digestion pattern. Though there is a difference in 
the cleavage patterns produced with hUDGΔ81 and hCDGΔ81 (Figure 5.2B) the pattern is 
not as predicted from a theoretical digest. The largest fragment should be 1420 bp, while 
the additional restriction site should remove a 627 bp fragment, which should be cleaved 
into two fragments of 526 and 101 bp. This may be due to secondary structure forming 
preventing  restriction  enzyme  binding.  Despite  this,  the  two  clones  were  sent  for 
sequencing and confirmed the N204D mutation had been successful. The ability to obtain a 
pEThCDG  clone  suggests  that  hCDG  does  not  have  the  same  downstream  cytotoxic 
properties as eCDG or it may be less active. 
 
Figure 5.2 Generation of hCDGΔ81. A) Colony PCR of the hUDG gene of two potential clones. Control 
relates to the amplification of pUC19eUDG for size reference. B) Taq
αI digestion of pEThCDGΔ81 clones. 
A different digest pattern can be seen in the region of 1200 to 1500 bp. 0.7% agarose gel ran in 1x TBE at 15 
Vcm
-1 for one hour. 
5.3.3 Expression of hCDGΔ81 
hCDGΔ81 was expressed and purified (Figure 5.3) in the same manner as for all other 
UDG variants (Chapter 3). The yield obtained was 0.45 mg from 0.5 L of culture, which is 
significantly less than the for the other mutant E. coli proteins that varied between 0.75 and 119 
 
1.5  mg.  Despite  the  low  yield,  Figure  5.3  shows  an  enriched  protein  of  the  correct 
molecular weight (approximately 28 kDa) in the final two lanes.  
 
Figure 5.3 SDS-PAGE showing the purification of hCDG. Samples were taken at different purification stages 
to assess enzyme expression and purity. 
5.3.4 Excision Activity Determination 
To determine the substrate preference of hCDG, initial cleavage assays were performed by 
incubating  hCDG  with  a  variety  of  substrates  for  24  hours  and  analysing  these  by 
denaturing PAGE. The  results  are presented in  Figure  5.4. As observed  with  eCYDG, 
hCDG retains activity towards the U-containing substrates (G.U, A.U and AP.U), which 
show the expected single cleavage product. As expected, no activity is seen against T (G.T 
and Z.T). The enzyme also cleaves the C-containing substrates A.C, AP.C and Z.C, but 
shows no activity against G.C. As anticipated, the enzyme shows no activity against any of 
the  substrates  containing 
MC.  There  is  also  some  activity  against  the  single  stranded 
substrate (ssC: see below for ssC(GAT)), though only about 50% of this DNA is cleaved 
within the 24 hour incubation. Once again,  no  cleavage is  seen  with  the single-strand 
substrate containing 
MC. 120 
 
 
Figure  5.4  hCDG  excision  of  uracil,  thymine,  cytosine  and5-methylcytosine  substrates.The 
32P  labelled 
31mer duplex substrates (~50 nM) were incubated with ~1.25 μM hCDG for 24 hours followed by heating at 
95°C in 10% piperidine for 20 minutes. The products were resolved on a 12.5% denaturing polyacrylamide 
gel and analysed by phosphorimaging. The top and bottom bands correspond to the uncleaved 31mer or 
15mer cleaved product respectively. AP; abasic site, Z; anthraquinone pyrrolidine. 
Although hCDG showed no activity against the substrate with a central G.C base pair, we 
also examined its activity against a substrate containing a central G.C base pair that is 
flanked by blocks of A and T (sequence G.C(AT); Table 5.1) and the results are shown in 
Figure 5.5, and can be compared with equivalent experiments with eCYDG (Figure 3.20). 
Surprisingly it can be seen that hCDG is able to cleave the central G.C base pair in this 
sequence, albeit with low efficiency, though again no activity was observed with 
MC.G. 
Oligonucleotide  Sequence 
G.C  5′-CCGAATCAGTGCGCACAGTCGGTATTTAGCC-3′ 
3′-GGCTTAGTCACGCGTGTCAGCCATAAATCGG-5′ 
G.C(AT)  5′-CGAATAATTATATAACATATATATATTTAGC-3′ 
3′-GCTTATTAATATATTGTATATATATAAATCG-5′ 
 
Table 5.1 G.C oligonucleotides used in excision assays. Central G.C base pair highlighted in bold. 
 121 
 
 
Figure 5.5 hCDG excision of G.C/
MC. The 
32P labelled 31mer duplex substrates (~50 nM) were incubated 
with ~1.25 μM hCDG for 24 hours followed by heating at 95°C in 10% piperidine for 20 minutes. The 
products were resolved on a 12.5% denaturing polyacrylamide gel and analysed by phosphorimaging. Top 
and bottom bands correspond to a 31mer uncleaved or 15mer cleaved product respectively. 
5.3.5 Rate of Reaction values for hCDG with different DNA substrates 
To assess the best substrate for hCDG for discriminating between C and 
MC, we performed 
a series of cleavage assays to determine the rate of reaction against a range of different 
substrates (similar to the experiments with eCYDG that are described in Chapter 3). Again, 
the rate refers to the initial velocity of the reaction by assumption that all substrate is bound 
by  enzyme.  The  results  are  summarised  in  Table  5.2.  Figure  5.6  shows  the  cleavage 
profiles of substrates containing central A.C, AP.C and Z.C pairs. The rates with A.C 
(0.165  ±  0.015  min
-1)  and  AP.C  (0.038  ±  0.004  min
-1)  were  faster  than  eCYDG  by 
approximately 28 and 3-fold respectively, demonstrating that hCDG has greater activity. 
However, the rate at Z.C was 0.0051 ± 0.0008 min
-1, which is approximately 20-fold lower 
than eCYDG. This was surprising since this substrate produced one of the fastest rates with 
eCYDG. The rate for Z.C was calculated from a single time point at 2 hours, assuming a 
simple exponential. 122 
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Figure 5.6 Kinetics of hCDG cleavage of the 31mer substrates A.C, AP.C and Z.C. The 
32P labelled 31mer 
duplex substrates (~50 nM) were incubated with ~1.25 μM hCDG for up to 24 hours and followed by heating 
at 95°C in 10% piperidine for 20 minutes. The products were resolved on 12.5% denaturing polyacrylamide 
gels  and  analysed  by  phosphorimaging  (A,  C  and  E).  Top  and  bottom  bands  correspond  to  a  31mer 
uncleaved or 15mer cleaved product respectively. The graphs are derived from phosphorimage analysis of 
the gels and show the rate of formation of the cleavage product. These are fitted with single exponential 
curves (B and D). AP: abasic site, Z: anthraquinone pyrrolidine. 123 
 
hCDG 
Rate of 
Reaction (min
-1) 
Relative 
Activity (%) 
G.U  3.8 ± 0.7  100 
A.U  1.27 ± 0.08  33 
HEG.C  0.26 ± 0.02  6.8 
A.C  0.17 ± 0.02  4.3 
AP.C  0.04 ± 0.004  0.99 
long gap.C  0.03 ± 0.007  0.67 
ssC(polyA)  0.03 ± 0.005  0.78 
gap.C  0.02 ± 0.003  0.58 
ssC(GAT)  0.02 ± 0.002  0.46 
A.C pH 7.4  0.02 ± 0.002  0.43 
A(T).C(G)  0.006 ± 0.001  0.15 
Z.C
2  0.005 ± 0.001  0.13 
A.C(G)
1  0.0012  0.03 
G.C(AT)
2  0.0006  0.09 
I.C
3  0.0004  0.01 
 
Table 5.2 hCDG reaction rates. Relative activity is compared to the G.U substrate. The rate of reaction was 
determined as an average of three experiments. Rate values were estimated from a single time point at 8 hrs
1, 
2 hrs
2 and 4 hrs
3 assuming a simple exponential. Z, anthraquinone pyrrolidine; AP, abasic site; I, inosine; gap, 
unpaired C; long gap, unpaired C in a 41mer duplex; HEG, hexaethylene glycol; ND, not detectable. 
Figure 5.7 shows the activity of hCDG against G.U and A.U which are cut with rates of 3.8 
± 0.7 min
-1 and 1.27 ± 0.08 min
-1 respectively, which are approximately 10- and 6-fold 
faster than with eCYDG. This Figure also shows the results for hCDG cleavage of HEG.C, 
which is cut with a rate of 0.26 ± 0.02 min
-1. HEG.C is the best C-containing substrate for 
hCDG, as with eCYDG. However eCYDG cut Z.C and HEG.C at similar rates, while 
hCDG has only very weak activity against Z.C. This suggests that the low rate with Z.C is 
a combination of the properties of both the mutant enzyme and the substrate. It is also 
worth noting that eCYDG cut Z.C and HEG.C faster than A.U, while the activity of hCDG 
at HEG.C is only about one fifth of that at A.U. 
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Figure 5.7 Kinetics of hCDG cleavage of the 31mer substrates G.U, A.U and HEG.C. The 
32P labelled 31mer 
duplex substrates (~50 nM) were incubated with ~1.25 μM hCDG for up to 1 hour, followed by heating at 
95°C in 10% piperidine for 20 minutes. The products were resolved on 12.5% denaturing polyacrylamide 
gels  and  analysed  by  phosphorimaging  (A,  C  and  E).  Top  and  bottom  bands  correspond  to  a  31mer 
uncleaved or 15mer cleaved product respectively. The graphs are derived from phosphorimage analysis of 
the gels and show the rate of formation of the cleavage product. These are fitted with single exponential 
curves (B, D and F). HEG: hexaethylene glycol. 
5.3.5.1 Excision of ssC substrates with hCDG 125 
 
The activity of hCDG against single-stranded substrates was also investigated (Figure 5.8); 
eCYDG had weak activity towards ssC substrates. These were both excised to completion; 
the rate with ssC(polyA) (0.03 ± 0.005 min
-1) was nearly twice as fast as ssC(GAT) (0.02 ± 
0.002 min
-1); showing how local sequence context can affect the rate of excision, even for 
these single stranded substrates. Additional bands can be seen at the longer time points for 
both substrates.  
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Figure 5.8 Kinetics of hCDG cleavage of the 31mer substrates ssC(polyA) and ssC(GAT). The 
32P labelled 
31mer duplex substrates (~50 nM) were incubated with ~1.25 μM  hCDG for up to 1 hour, followed by 
heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5%  denaturing 
polyacrylamide gels and analysed by phosphorimaging (A and C). Top and bottom bands correspond to a 
31mer  uncleaved  or  15mer  cleaved  product  respectively.  The  graphs  are  derived  from  phosphorimage 
analysis of the gels and show the rate of formation of the cleavage product. These are fitted with single 
exponential curves (B and D).  126 
 
These are clearly not specific cleavage products and are most likely generated by some 
contaminating 3′-exonuclease activity (Hodskinson et al., 2007), which is able to act on 
ssDNA rather than dsDNA substrates. 
5.3.5.2 Examining the Effect of Flanking Regions on Excision 
As previously noted (Figure 5.5) hCDG is able to excise C from a G.C base pair when 
surrounded by long blocks of A.T base pairs (sequence G.C(AT)). We therefore further 
examined  the  activity  of  hCDG  against  this  substrate  and  a  number  of  other  related 
substrates, assessing the effect of flanking base pairs. G.C(AT) produced a rate of 0.0006 ± 
0.0001 min
-1 (Figure 5.9 and Table 5.2), though a maximal cleavage of only 35% was 
obtained.  The rate against A.C(G) (a central A.C mismatch flanked by G.C base pairs) 
was 0.0012 ± 0.003 min
-1. While this is slow (and only about 40% of the substrate is 
cleaved) it is twice as fast as against G.C(AT) and is very different to the result with 
eCYDG, which showed no activity against this substrate.  The ability of hCDG to cleave at 
I.C was also tested, as this base pair only contains two hydrogens bonds, like A.U. A 
similar slow rate, compared to G.C(AT), of 0.0006 ± 0.0001 min
-1 was observed and the 
cleavage  only  reached  approximately  20%.  These  results  suggest  that  the  loss  of  a 
hydrogen bond between a G.C and I.C base pair does not affect the rate of excision. 
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Figure 5.9 Kinetics of hCDG cleavage of the 31mer substrates G.C(AT), A.C(G) and I.C. The 
32P labelled 
31mer duplex substrates (~50 nM) were incubated with ~1.25 μM  hCDG for up to 1 hour, followed by 
heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5%  denaturing 
polyacrylamide gels and analysed by phosphorimaging (A, C and E). Top and bottom bands correspond to a 
31mer  uncleaved  or  15mer  cleaved  product  respectively.  The  graphs  are  derived  from  phosphorimage 
analysis of the gels and show the rate of formation of the cleavage product. These are fitted with single 
exponential curves (B and D). I: inosine. 128 
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Figure 5.10 Kinetics of hCDG cleavage of the 31mer substrate A(T).C(G). The 
32P labelled 31mer duplex 
substrate (~50 nM) was incubated with ~1.25 μM hCDG for up to 1 hour followed by heating at 95°C in 10% 
piperidine  for  20  minutes.  The  products  were  resolved  on  a  12.5%  denaturing  polyacrylamide  gel  and 
analysed by phosphorimaging (A). Top and bottom bands correspond to a 31mer uncleaved or 15mer cleaved 
product respectively. The graph is derived from phosphorimage analysis of the gel and show the rate of 
formation of the cleavage product. This is fitted with a single exponential curve (B).  
hCDG’s greater activity led us to investigate whether it would be able to excise C more 
efficiently in  a  context  in  which the surrounding base pairs  are GT mismatches  using 
sequence A(T).C(G) (see Table 3.4) and the results are shown in Figure 5.10. With this 
sequence the rate of cleavage increased to 0.006 ± 0.001 min
-1 and the maximum cleavage 
observed  improved  to  70%,  suggesting  that  the  destabilising  properties  of  the  G.T 
mismatches increased the excision efficiency (also seen with eCYDG). The targets with an 
unpaired  central  C  (gap.C  and  long  gap.C)  produced  similar  results  to  eCYDG  with 
maximal cleavage of 60 and 75%, though their rates were significantly faster (0.022 ± 
0.003 min
-1 and 0.026 ± 0.007 min
-1 respectively (Figure 5.11)). Interestingly a second 
longer  but  weaker  cleavage  product  can  be  seen  with  gap.C  (indicated  by  ▲  in  the 
cleavage plot (Figure 5.11B)). This probably corresponds to the region with four Cs on the 
3′-side of the expected target C.  Since these oligonucleotides have Tms that are close to the 
reaction temperature it is possible that these regions temporarily melt and the additional 
hCDG cleavage products correspond to cleavage of Cs in this transient single stranded 
region. The rate calculated for the primary cleavage product with gap.C was 0.023 ± 0.003 
min
-1; ● as this was equivalent to the rate of the total product (0.022 ± 0.003 min
-1; ■). 129 
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Figure 5.11 Kinetics of hCDG cleavage of the 31mer substrates gap.C and long gap.C. The 
32P labelled 
31mer duplex substrates (~50 nM) were incubated with ~1.25 μM  hCDG for up to 1 hour, followed by 
heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5%  denaturing 
polyacrylamide gels and analysed by phosphorimaging (A and C). Top and bottom bands correspond to a 
31mer  uncleaved  or  15mer  cleaved  product  respectively.  The  graphs  are  derived  from  phosphorimage 
analysis of the gels and show the rate of formation of the cleavage product. These are fitted with single 
exponential curves (B and D). For the gap.C graph; ● bottom/primary band, ■ middle band, ▲ top/total band. 
gap: unpaired C, long gap: unpaired C in a 41mer duplex. 
5.3.5.3 The Effect of pH on A.C excision 
Since eCYDG showed an unexpected increase in the rate of excision at higher pH we also 
investigate the effect of pH on the activity of hCDG. Unlike eCYDG, hCDG showed a 
decrease in the rate of excision at A.C (0.016 ± 0.002 min
-1) at pH 7.4 (Figure 5.12A), as 
would be expected, compared to A.C performed at pH 6.3 (the standard pH used for all 
other cleavage assays). This is different to the results with eCYDG (Section 3.3.12), but is 
consistent with (Kwon et al., 2003), and is as would be expected from the protonation of 
both the aspartates in the active site. 130 
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Figure 5.12 Kinetics of hCDG cleavage of the 31mer substrate A.C pH 7.4. The 
32P labelled 31mer duplex 
substrate (~50 nM) was incubated with ~1.25 μM hCDG for up to 1 hour, followed by heating at 95°C in 10% 
piperidine  for  20  minutes.  The  products  were  resolved  on  a  12.5%  denaturing  polyacrylamide  gel  and 
analysed by phosphorimaging (A). Top and bottom bands correspond to a 31mer uncleaved or 15mer cleaved 
product respectively. The graph is derived from phosphorimage analysis of the gel and show the rate of 
formation of the cleavage product. This is fitted with a single exponential curve (B).  
5.3.6 Rate of Reaction Determination of hCYDG 
Since  Chapter  3  examined  the  properties  of  the  double  mutant  of  the  E.  coli  enzyme 
(eCYDG) we also examined the properties of the equivalent human enzyme (hCYDG) 
against a range of different substrates. The results are summarised in Table 5.3. 
 
hCYDG 
Rate of 
Reaction (min
-1) 
Relative 
Activity (%) 
G.U  0.51 ± 0.01  100.00 
Z.C  0.02 ± 0.005  3.6 
HEG.C  0.013 ± 0.002  26 
AC  0.013 ± 0.001  2.6 
AP.C
1  0.0001  0.7 
A.C(G)  ND  0 
ssC(GAT)  ND 
  G.C(AT)  ND 
   
Table 5.3 hCYDG reaction rates. Relative activity is in relation to the G.U substrate. The rate of reaction was 
determined as an average of three rates. 
1The rate value was estimated from a single time point at 24 hrs 
assuming a simple exponential. Z; anthraquinone pyrrolidine, AP; abasic site, HEG; hexaethylene glycol, ND; 
not detectable. 
Figure 5.13 shows the cleavage of A.C by hCYDG from which a rate constant of 0.013 ± 
0.001 min
-1 was determined. This is about 10-fold lower than hCDG with the substrate 131 
 
confirming that, as expected, the double mutant hCYDG has a much lower activity than 
hCDG. This is also about 3-fold slower than the rate of eCYDG cleavage of this substrate; 
though it should be noted that only 30% of the substrate was cleaved. 
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Figure  5.13  Kinetics  of  hCYDG  cleavage  of  the  31mer  substrate  A.C.  The 
32P  labelled  31mer  duplex 
substrate (~50 nM) was incubated with ~1.25 μM hCDG for up to 24 hours, followed by heating at 95°C in 
10% piperidine for 20 minutes. The products were resolved on a 12.5% denaturing polyacrylamide gel and 
analysed by phosphorimaging (A). Top and bottom bands correspond to a 31mer uncleaved or 15mer cleaved 
product respectively. The graph is derived from phosphorimage analysis of the gel and show the rate of 
formation of the cleavage product. This is fitted with a single exponential curve (B). 
Figure 5.14 shows the cleavage of Z.C, HEG.C and AP.C by hCYDG. Z.C (0.02 ± 0.005 
min
-1) and HEG.C (0.013 ± 0.002 min
-1) are cut at comparable rates, though this is much 
slower than with eCYDG, while cleavage of AP.C was barely detectable and a rate (0.0001 
min
-1) could only be estimated from a single time point at 24 hours. No detectable activity 
was observed with ssC(GAT) or the more stable duplex substrates G.C(AT) or A.C(G) 
(Figure 5.15). Though hCYDG has the weakest activity against C out of the three enzymes 
investigated, it showed greater activity against U than eCYDG with a rate of 0.5 ± 0.01 
min
-1 (Figure 5.16). 132 
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Figure 5.14 Kinetics of hCYDG cleavage of the 31mer substrates AP.C, Z.C and HEG.C. The 
32P labelled 
31mer duplex substrates (~50 nM) were incubated with ~1.25 μM hCDG for up to 24 hours, followed by 
heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5%  denaturing 
polyacrylamide gels and analysed by phosphorimaging (A, C and E). Top and bottom bands correspond to a 
31mer  uncleaved  or  15mer  cleaved  product  respectively.  The  graphs  are  derived  from  phosphorimage 
analysis of the gels and show the rate of formation of the cleavage product. These are fitted with single 
exponential curves (B, D and F). AP: abasic site, Z: anthraquinone pyrrolidine, HEG: hexaethylene glycol. 133 
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Figure 5.15 Kinetics of hCYDG cleavage of the 31mer substrates ssC(GAT), G.C and  A.C(G). The 
32P 
labelled  31mer  duplex  substrates  (~50  nM)  were  incubated  with  ~1.25  μM  hCDG  for  up  to  24  hours, 
followed  by  heating  at  95°C  in  10%  piperidine  for  20  minutes.  The  products  were  resolved  on  12.5% 
denaturing polyacrylamide gels and analysed by phosphorimaging (A, B and C). Top and bottom bands 
correspond to a 31mer uncleaved or 15mer cleaved product respectively. 
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Figure  5.16  Kinetics  of  hCYDG  cleavage  of  the  31mer  substrate  G.U.  The 
32P  labelled  31mer  duplex 
substrate (~50 nM) was incubated with ~1.25 μM hCDG for up to 24 hours, followed  by heating at 95°C in 
10% piperidine for 20 minutes. The products were resolved on a 12.5% denaturing polyacrylamide gel and 
analysed by phosphorimaging (A). Top and bottom bands correspond to a 31mer uncleaved or 15mer cleaved 
product respectively. The graph is derived from phosphorimage analysis of the gel and show the rate of 
formation of the cleavage product. This is fitted with a single exponential curve (B). 
5.4 Discussion 
By using complete gene synthesis we have generated two functional human glycosylases 
(hCDG and hCYDG) that are able to excise cytosine and show no activity towards 5-
methylcytosine.  As  with  eCYDG,  they  are  most  efficient  when  the  cytosine  is  in  an 
unstable base pair (i.e. not paired with guanine). The ability to express hCDG in E. coli 
suggests  that  it  is  not  cytotoxic  and  therefore  only  has  weak  activity.  This  could  be 
explained  on  account  of  the  asparagine  to  aspartate  mutation,  which  compromises  the 
activity of the human variant more than that in the E. coli enzyme. Despite this expectation, 
hCDG still showed significant activity with a 25-fold and 10-fold greater activity for A.C 
and  G.U  compared  to  eCYDG.  A  possible  explanation  for  the  lack  of  cytotoxicity  of 
hCDG could be that it is unable to recruit other E. coli proteins in the BER pathway, while 
the equivalent E. coli protein will be able to do so as it is expressed in its normal host 
organism. It is not surprising that hCYDG has weaker activity than hCDG as it is a double 
mutant. hCYDG has the weakest activity of the three enzymes investigated and suggest 
that the human variants have weaker intrinsic activity than their E. coli counterparts. These 
results, along with the cytotoxicity of eCDG, strongly suggests that if an eCDG could be 
expressed it would be the most active enzyme:  eCDG > hCDG > eCYDG > hCYDG. This 
is  supported  by  the  observation  that  hCDG  has  greater  activity  against  cytosine  than 
eCYDG (i.e. at A.C and AP.C). This suggests that an eCDG might have greater activity 135 
 
than hCDG, and could be cytotoxic through excision of G.C base pairs within the E. coli 
DNA, for which hCDG has very low activity (and eCYDG has none). 
As G.C activity was not seen initially, but was seen when put into the context of flanking 
A and T bases (G.C(AT)), strongly suggests that the G.C duplex was being cleaved into 
smaller  fragments  due  to  excision  at  other  G.C  sites  within  the  duplex.  Alternatively, 
binding of the enzyme to other G.C sites could prevent binding and therefore cleavage at 
the  central  G.C,  reducing  observed  activity.  Therefore  the  ability  of  hCDG  to  excise 
cytosine from a G.C base pair, albeit at a low efficiency, supports the suggestion that the 
role of leucine 191 is to “plug” rather than to “push”. This is because the leucine, which is 
still present in hCDG, is unable to force the cytosine into an extrahelical conformation. 
This is energetically less likely at a G.C pair, as a result of its greater stability compared to 
A.U.  However,  hCDG has  weak activity towards  I.C, even though this  base pair  only 
contains two hydrogen bonds, as with A.U, compared to three with G.C. This suggests 
firstly that hCDG has greater affinity towards uracil than  cytosine, due to the greater 
activity at A.U than I.C. Secondly this suggests that base stacking plays an important role 
in base flipping, and it is not merely dependent on the stability of the base pair itself 
(SantaLucia  et  al.,  1996,  Watkins  and  SantaLucia,  2005).  This  is  consistent  with  the 
observation that the rate at I.C is similar to that of A.C(G) and G.C(AT). This is further 
supported by the increased rate of cleavage at A(T).C(G), in which the flanking guanines 
are mismatched with thymine. This suggests that the G.T mismatches not only destabilise 
the flanking base pairs but also affect the base stacking due to their “wobble” base pairs. 
The role of leucine as a “plugger” is also supported by the greater ssC activity of hCDG 
compared  to  eCYDG,  suggesting  that  the  leucine  is  able  to  hold  the  ssDNA  in  the 
enzyme’s active site for longer. This allows for the rotation of the aspartate so that the 
correct  hydrogen  bonds  are  formed  with  the  base  that  is  to  be  excised  (as  previously 
explained in the discussion of Chapter 3). The increase in ssC activity is also evident with 
gap.C,  for which a second product  band is  observed, and which may  arise from  local 
duplex melting around the gap, exposing a 3′ ssC region that exposes a cytosine four bases 
3′ of the target cytosine, allowing its excision. 
As with eCYDG, excision of cytosine by hCDG is most efficient when it is placed opposite 
the  hexaethylene  glycol  linker,  presumably  because  this  easily  allows  the  cytosine  to 
become extrahelical. Although eCYDG cuts Z.C and HEG.C at comparable rates Z.C is a 
very poor substrate for hCDG. This may be due to steric clash between leucine and the 136 
 
anthraquinone when leucine intercalates into the duplex DNA, occupying the space left by 
the extrahelical base. This cannot happen when an anthraquinone is present as it occupies 
the space of both base pairs, as with pyrene (Jiang et al., 2001), causing steric hindrance 
and preventing enzyme binding and therefore hindering base docking and excision. This is 
supported by the much greater activity of hCYDG at Z.C, compared to hCDG, though this 
still occurs  at  a slow  rate and  does  not  go  to  completion within a 24 hour period.  In 
contrast to the other enzymes hCYDG appears to have very little activity at AP.C. It is not 
clear why this occurs as both eCYDG and hCDG show AP.C activity. Although HEG and 
AP are similar, in that they do not form a base pair with the target cytosine, AP is shorter 
by  ~18  Å  and still  contains a ribose sugar that  makes  it more rigid  and would likely 
produce  greater  local  stability  that  is  only  noticeable  with  the  weak  hCYDG  enzyme. 
Though the A.C pair has one hydrogen bond and would be expected to be more stable than 
AP.C, it seems to have a greater effect on the cytosine base stacking interactions, allowing 
it to become extrahelical and thus providing A.C activity. This also  suggests that base 
stacking is important in determining the rate of excision. 
In contrast to eCYDG, hCDG shows the expected decrease in rate at pH 7.4 compared to 
when the assay was performed at pH 6.3. This suggests that the human enzyme may be 
more susceptible to changes in pH. This is consistent with the notion that CDGs are pH 
dependent as a result of the protonation state of the critical aspartate residue, and that 
activity should decrease at pH 7.4 (Kwon et al., 2003). 
In summary  hCDG is  able to  discriminate between cytosine and 5-methylcytosine and 
shows cytosine excision in any base pair combination, though the rate is greatly reduced in 
more stable duplex contexts, while showing no 5-methylcytosine in any context. The data 
for both hCDG and hCYDG provide further evidence that base stacking is a major player 
in determining variations in cleavage efficiency. In view of its greater activity hCDG might 
be a better enzyme than eCYDG for use in developing of an assay for detection of 5-
methylcytosine (Chapter 6).   137 
 
Chapter 6: Developing an Assay for the Detection of 5-methylcytosine 
6.1 Introduction 
The detection and quantification of 5-methylcytosine is important in epigenetics and for 
understanding its effects on gene regulation. Many different methods are now available for 
detecting  the  location  of  5-methylcytosines  (Shapiro  et  al.,  1973,  Cedar  et  al.,  1979, 
McClelland et al., 1994, Weber et al., 2005, Tahiliani et al., 2009, Manrao et al., 2011), 
with  the  gold  standard  being  bisulphite  sequencing.  However,  bisulphite  sequencing 
requires μgs of DNA as 80 – 95% degradation usually occurs during the reaction process.  
It is therefore difficult to investigate the methylation status of cytosines in single cells or in 
a small sample size. The average methylation state of each cytosine is therefore generated, 
preventing the detection of weakly or highly regulated/modified methylated sites. All of 
the methods have their disadvantages (as discussed in section 1.4) with another common 
one being the sequence dependency of the detection techniques. One example is the use of 
methylation sensitive restriction enzymes (Cedar et al., 1979, McClelland et al., 1994) 
which  are  necessarily  limited  to  probe  the  recognition  sequence  of  the  methylation 
sensitive  restriction  enzyme(s),  e.g.  HpaII  for  CCGG.  This  has  been  useful  for 
investigation of CpG methylation sites (the main sites for cytosine methylation relating to 
gene expression), though CpG islands are generally unmethylated. Cytosine methylation 
can also occur at other (non-CpG) sites, i.e. CpN (Grafstrom et al., 1985, Ramsahoye et al., 
2000, Guo et al., 2014a, Guo et al., 2014b), which may be of unrealised importance in 
gene regulation, and therefore cannot be investigated by sequence dependant methods. 
Here we propose a new method for detecting the presence of 5-methylcytosine that should 
enable its detection in both fully methylated or hemi-methylated DNA sites, as well as 
being applicable to non-CpG sequences. By utilising the abilities of CDGs to distinguish 
between cytosine and 5-methylcytosine, combined with real-time PCR, the methylation (or 
other modified) state of any cytosine can be determined, regardless of its sequence context. 
It is hoped that this could be developed into a simple detection assay. 
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6.2 Experimental Design 
We propose using CDG to discriminate between cytosine and 5-methylcytosine with a 
simple assay in which the cleavage (at C) or no cleavage (at 
MC) of a target sequence is 
detected by real-time PCR. No PCR amplification will occur if the template DNA has been 
cleaved. 
To  test  the  viability  of  the  proposed  assay  we  designed  an  80mer  oligonucleotide 
containing  a  central  cytosine  or  5-methylcytosine  in  a  C/
MCpG  context,  flanked  by 
sequences that are similar to those in the A.C(AG) substrate that was used for determining 
the  cleavage  rates  in  Chapter  3.  This  synthetic  template  also  contained  sites  for  PCR 
primers  at  the  5′  and  3′  primer  ends.  This  80mer  is  hereafter  known  as  the  ‘target’ 
oligonucleotide. A complementary 20mer oligonucleotide (hereafter known as the ‘probe’ 
oligonucleotide) is annealed to the centre of this target, covering the cytosine to be probed, 
and generating a C.X mismatch at this location. This generates a dsDNA substrate for 
efficient cleavage by CDG if the target base is unmethylated cytosine. The sequences of 
the oligonucleotides are shown in Table 6.1. 
Oligonucleotide  Sequence 
Target  5′-TAGCGTAGGGAGATATACCATGGGCAGCAGCCAGTGCGCAC/
MCG 
GTCGGTATTCTGAGATCCGGCTGCTAACAAAGTTGATCAT-3′ 
Probe  5′-GGCTAAATACCGACTHTGCGCACTGATTCGG-propyl-3′ 
 
Table 6.1 Oligonucleotides used in the cytosine detection assay. H; HEG. 
The target-probe complex (with or without annealing) was incubated with eCYDG for 24 
hours to allow cleavage to occur, followed by cleavage of the backbone with hot alkali or 
AP endonuclease. The resulting products were subjected to PCR; amplification should only 
occur if the substrate contained 5-methylcytosine, but not with cytosine at this position as 
the template will have been cleaved in two (Figure 6.1). 139 
 
 
Figure 6.1 Proposed method for detecting 5-methylcytosine using eCYDG. The target DNA (black) and 
probe oligonucleotide (green) are reacted with eCYDG. The target base (X) will be excised if it is a cytosine, 
but not if it is5-methylcytosine. The reaction products are then treated with Apurinic Endonuclease 1 (APE1) 
or alkali conditions in order to break the phosphodiester backbone at the abasic site. The products are then 
subjected to PCR using flanking primers (blue). A PCR product will only be generated if the target contained 
a5-methylcytosine, since the cleaved cytosine-containing substrate will not be amplified. 
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6.3 Results 
6.3.1 Designing the Assay 
A 20mer probe was designed with a central A to generate an A.C mismatch with the target 
cytosine, as this produced a good rate of excision, as shown in Chapter 3. To demonstrate 
the feasibility of the process we first prepared two synthetic oligonucleotides to mimic a 
cleaved  cytosine-containing  substrate  (as  illustrated  in  Figure  6.2;  full  sequences  in 
Appendix III). 
Cytosine Target 
5′-…GCAGCCAGTGCGCACGGTCGGTATTCTGA…-3′ 
 
Cleaved Cytosine Mimics 
5′-…GCAGCCAGTGCGCA GGTCGGTATTCTGA…-3′ 
1               2 
Figure 6.2 Oligonucleotide sequences of the cytosine target and cleaved cytosine product mimics The target 
C is indicated in red bold. The full sequences of these oligonucleotides are shown in Appendix III. 
The  real-time  accumulation  of  the  PCR  product  was  detected  using  SYBR  Green 
(conditions  described  in  section  2.3.14.3).  The  first  assay,  performed  in  this  format, 
showed  no  discrimination  between  the  cleaved  mimics  and  the  full  length  target 
oligonucleotides. At this point we realised that the probe oligonucleotide could act as a 
bridge between the two cleavage products, enabling PCR read-through to produce the full 
length product. The probe oligonucleotide was therefore redesigned to include a central 
hexaethylene glycol (HEG), in place of A, generating a HEG.C pair, instead of A.C. The 
HEG  cannot  be  read-though  by  DNA  polymerase,  thereby  preventing  the  probe  from 
acting as a bridge in the PCR amplification. A 3′ propyl group was also included to prevent 
any polymerase extension of the probe oligonucleotide. The PCR was then repeated with 
the new probe (Figure 6.3). A clear difference between full length targets containing C or 
MC  and  the  cleaved  cytosine  mimics,  while  the  control  (no  template)  showed  no 
amplification.  To  confirm  that  this  system  is  concentration  dependent  and  that  small 
quantities of DNA can be detected, a standard concentration gradient of the template was 
performed between 1 nM to 0.1 fM in 10-fold dilutions. The results are shown in Figure 
6.4, which shows a consistent right shift of approximately 3 ct values per 10-fold reduction 
in concentration. The concentration range was then narrowed to between 10 pM and 10 fM 
in approximately 2-fold dilutions (Figure 6.5), to determine whether the assay would be 
able to detect small differences in DNA concentrations. 141 
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Figure 6.3 Real-time PCR analysis of a 1 nM C, 
MC, and a cleaved C mimic, target oligonucleotide with a 10 
nM HEG probe. 
 
 
Figure 6.4 Real-time PCR concentration gradient analysis of 10 nM to 0.1 fM C. 
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Figure 6.5 Real-time PCR concentration gradient analysis of 10 pM to 10 fM C. 
Though the lower concentrations used in Figure 6.5 are slightly more right shifted than 
comparable concentrations in Figure 6.4 (e.g. 10 pM, 100/150 fM and 10 fM), there is still 
a consistent right shift for each 2-fold dilution, showing the assay’s sensitivity to small 
differences in concentration. 
6.3.2 eCYDG:PCR Assay 
As there was  discrimination between the synthetic cleaved mimics  and the full  length 
substrates, we proceeded to test the assay with cleavage by eCYDG. The template-probe 
mixture was incubated with eCYDG for 24 hours and then subjected to PCR. We expected 
amplification with the5-methylcytosine-containing template, and at least a shift to the right 
with the cytosine-containing template, similar to the curves shown in Figure 6.3. However, 
initial  experiments  using  piperidine  to  cleave  at  the  basic  site,  showed  no  clear 
discrimination  between  amplification  of  the  cytosine  and5-methylcytosine-containing 
templates. This was also attempted with the more reactive hCDG but still no discrimination 
was observed. 
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6.3.3 eCYDG Reaction Analysis  
As the PCR showed no clear discrimination between the C and 
MC containing targets after 
reaction  with  eCYDG,  we  decided  to  analyse  the  cleavage  reaction  itself,  using  the 
standard radiolabelled cleavage assays  (Chapters 3 and 5) with these substrates. These 
assays were also used to investigate the effect of annealing conditions on the reaction and 
to examine different methods of backbone cleavage at the basic site. As shown in Figure 
6.7  eCYDG  efficiently  cleaves  the  cytosine-containing  template  and  very  little  intact 
substrate is left after 24 hours incubation. The reaction does not depend on whether the 
probe and template are properly annealed (slow cooling from 95°C) or simply mixed. This 
suggests that under the reaction conditions with eCYDG, the target and probe are able to 
hybridise to allow for efficient C excision. Most importantly no 
MC activity was detected. 
We can assume that activity is due to cleavage of duplex DNA, rather than unannealed 
single strands as the previous cleavage assays (Figure 3.21) showed there was little or no 
ssC activity with eCYDG. Despite this, other cleavage products were generated for both 
the C and 
MC containing substrates (Figure 6.7) showing low ssC activity in the single 
stranded flanking regions of the duplex. This is most apparent with the5-methylcytosine-
containing  substrate  as  the  reactivity  of  cytosine-containing  substrate  only  generates 
products of half length (from the position of the target C) or smaller. Products can also be 
seen within the duplex region at Cs (where the probe is annealed) suggesting G.C activity, 
but previous results discussed in Chapter 3 clearly show that eCYDG has no G.C activity. 
Therefore,  these  products  must  be  due  to  ssC  activity  from  a  small  amount  of  an 
unannealed or partially annealed probe:target substrate. 
To investigate this further, the PCR assay was also designed so the primers could also act 
as protection oligonucleotides on either side of the probe to reduce the likelihood of any 
single-stranded activity (Table 6.2 and as illustrated in Figure 6.6).  
Description  Sequence 
For Primer  5′-GGAGATATACCATGGGCAGCAGC-3′ 
Rev 
Primer/Protection 
5′-CTTTGTTAGCAGCCGGATCTCAG-3′ 
Rev Protection  5′-GCTGCTGCCCATGGTATATCTCC-3′ 
 
Table 6.2 Primers and protection oligonucleotides used in the cytosine detection assay. 
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Figure 6.6 Binding of protection oligonucleotides to the target DNA. The target DNA (black) hybridised with 
the probe oligonucleotide (green), protection oligonucleotide (red) and by the PCR primer (blue). 
This should minimise the production of non-specific products, and provide the greatest 
difference between C and 
MC for discrimination by PCR. Figure 6.8 shows that single 
stranded activity, with eCYDG incubation, is reduced by the addition of the protection 
oligonucleotides; as with the previous results activity is seen with the cytosine-containing 
substrate (arrow) but not with the 5-methylcytosine-containing substrate. 
Finally  we  investigated  the  effects  of  different  backbone  cleavage  agents  as  shown  in 
Figure 6.9. As expected piperidine, NaOH (10 mM) and the use of APE1 (1 μl; approx. 10 
u/μl) all acted to cleave the phosphodiester backbone. However, this Figure also shows 
efficient cleavage after simply heating the enzyme cleavage products at 95°C (Figure 6.9; 
arrow). This was surprising as backbone cleavage is expected to require alkaline conditions 
and the sample is in a slightly acidic reaction buffer (pH 6.3). However, this would make 
any PCR-based assay simpler as this can simply be included as the first heating step of the 
reaction. Again, no activity was observed at the central 5-methylcytosine. 
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Figure 6.7 eCYDG cleavage of the C- and 
MC-containing substrates. The 
32P labelled target (~50 nM) was 
incubated  with  ~1.25  μM  eCYDG  for  24  hours  and  the  backbone  cleaved  by  heating  at  95°C  in  10% 
piperidine  for  20  minutes.  The  products  were  resolved  on  a  12.5%  denaturing  polyacrylamide  gel  and 
analysed by phosphorimaging. The arrow indicates the 39mer product produced by cleavage at the target 
cytosine.  GA  corresponds  to  a  GA  tract  for  sequence  determination.  No  enzyme  is  a  control  without 
incubation with eCYDG. 
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Figure  6.8  eCYDG  cleavage  of  C-  and 
MC-containing  substrates  in  the  presence  of  protecting 
oligonucleotides.The 
32P labelled target (~50 nM) was incubated with ~1.25 μM eCYDG for 24 hours and the 
backbone cleaved by heating at 95°C in 10% piperidine for 20 minutes. The products were resolved on a 12.5% 
denaturing polyacrylamide gel and analysed by phosphorimaging. The arrow indicates the 39mer product 
produced by cleavage at the target cytosine. GA corresponds to a GA tract for sequence determination. No 
enzyme is a control without incubation with eCYDG. 
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Figure 6.9 eCYDG cleavage of C- and 
MC-containing oligonucleotide templates with different backbone 
cleavage agents. The 
32P labelled target (~50 nM) was incubated with ~1.25 μM eCYDG for 24 hours and the 
backbone cleaved by heating at 95°C without and with 10% (v/v) piperidine or 10 mM NaOH for 20 minutes, 
or reacted with APE1 (1 μl; approx. 10 u/μl) for 1 hour. The products were resolved on a 12.5% denaturing 
polyacrylamide gel and analysed by phosphorimaging. The arrow indicates the 39mer product produced by 
cleavage at the target cytosine. GA corresponds to a GA tract for sequence determination. No enzyme is a 
control without incubation with eCYDG. 
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6.4 Discussion 
The use of synthetic oligonucleotides to mimic the cleavage reaction of target DNA by 
eCYDG clearly shows that real time PCR should be able to distinguish between cleaved 
(cytosine-containing) and uncleaved (5-methylcytosine-containing) oligonucleotides. The 
concentration dependence of the signal confirms, as expected, that the assay should be able 
to detect small differences in DNA concentration. This is important since the concentration 
of DNA obtained from cellular extracts may be very low, and the differences between 
samples when analysing their cytosine methylation state may be very small. These controls 
highlight  that  the  proposed  assay  could  be  used  effectively  for  the  detection  of  5-
methylcytosine,  despite  the  lack  of  discrimination  seen  when  the  target  DNA  was 
incubated with eCYDG followed by PCR analysis. This requires further investigation and 
optimisation. 
The experiments in Chapter 3 showed that a HEG.C pair is one of the best substrates for 
eCYDG  and  allowed  excision  of  cytosine  within  the  sequence  context  ACG.  This  is 
superior to that seen with a simple AC mismatch at the same position. Although the use of 
HEG  overcomes  the  limitations  of  eCYDG  within  the  sequence  context  ACG,  further 
experiments will be needed for optimisation and to increase the reaction efficiency in other 
stable sequence combinations, such as GCA and GCG. This may be overcome by the use 
of longer incubation times with eCYDG. Alternatively hCDG might be used due to its 
greater  activity,  though  this  will  be  accompanied  by  other  disadvantages.  hCDG  has 
greater activity at G.C and ssC that could lead to fragmentation of the DNA, reducing the 
ability  to  discriminate  via  PCR.  However,  this  might  allow  the  detection  of  5-
methylcytosine  in  any  sequence  context.  The  single-stranded  cleavage  activity  can  be 
reduced by using protection oligonucleotides (that may also serve as primers as with our 
assay),  increasing  the  amount  of  full  length  target  (for 
MC)  that  is  available  for 
amplification and enhancing the assay’s discriminatory ability between cytosine and 5-
methylcytosine containing DNA. 
These  results  also  showed  that  it  is  possible  to  obtain  full  phosphodiester  backbone 
cleavage  merely  by  heating  the  sample  for  20  minutes  at  95°C.  This  will  be  a  real 
advantage for development of a simple 5-methylcytosine detection assay, as the initial 
heating step can be programmed into the PCR protocol. 149 
 
We anticipate that if the problems described above can be overcome then the assay could 
be  developed  into  a  96-well  plate  format  to  allow  for  higher  throughput.  This  would 
involve  each  well  containing  a  different  probe,  providing  the  ability  to  examine  the 
methylation state of different cytosines over a larger region. Alternatively, the methylation 
status of the complementary strand could also be examined to determine whether any CpG 
site  is  fully  or  hemi-methylated;  such  detection  of  hemi-methylated  DNA  is  often  not 
possible within other assays for 
MC. We therefore hope that this assay can be developed to 
produce an accurate and quick way of determining the methylation state of cytosine. 
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Chapter 7: General Discussion 
This thesis has investigated the ability of an enzyme to discriminate between cytosine and 
5-methylcytosine  and  to  assess  the  feasibility  of  using  them  in  an  assay  for  5-
methylcytosine  detection.  hUDG  was  generated  by  complete  gene  synthesis,  using  an 
oligonucleotide-stitching-PCR based method, followed by successful N204D mutagenesis 
to generate hCDG. This also highlights the viability of this method to generate whole 
genes. The equivalent  mutation in E. coli UDG (N123D) generated a highly cytotoxic 
protein that couldn’t be expressed, even in the cloning vector pUC19 and when out of 
frame with the LacZ gene. Since L191 aids base flipping by forcing the target base into an 
extrahelical conformation, while also preventing the base from reinserting into the duplex 
(Krokan  et  al.,  1997,  Parikh  et  al.,  1998),  mutation  to  alanine  (L191A)  significantly 
reduces the enzyme’s activity (Jiang et al., 2001, Jiang and Stivers, 2002). This effect can 
be rescued by placing  a large bulky  synthetic nucleoside opposite the target  base that 
occupies the space of the base pair forcing the base into a permanent extrahelical formation. 
This mutation was performed first to generate eUYDG (Jiang et al., 2001, Jiang et al., 
2002b) followed by N123D to generate eCYDG (Kwon et al., 2003), a functional eCDG.  
By exploiting UDG’s natural ability to discriminate between uracil and thymine, due to the 
presence of the 5-methyl group being sterically excluded by Y66, we have shown that 
these CDGs have the ability to excise cytosine when it is unpaired, mispaired or placed 
opposite a non-nucleosidic linker, while showing no activity towards 5-methylcytosine in 
any context. The excision efficiency of CDGs is affected by the stability of the base pair. 
This  is  shown  by  faster  rates  of  excision  being  obtained  with  HEG  or  anthraquinone 
pyrrolidine opposite cytosine compared to an A.C mismatch or a normal G.C base pair. 
Investigation into the effect of the flanking base pairs led us to conclude that base stacking 
interactions are more important in base stability, and have a greater effect on excision 
efficiency. To reduce this effect the flanking bases were mismatched or left unpaired to 
attempt  to  reduce  base  stacking  interactions  with  the  target  cytosine.  This  proved 
unsuccessful though further investigation with the use of DMSO or DNA destabilising 
compounds  (e.g.  betaine)  may  be  able  to  reduce  the  local  stability,  providing  more 
applicable cleavage rates for use in 5-methylcytosine detection assay. 
The extremely slow cleavage rates of ssDNA substrates strongly suggest that the major 
role of leucine is to “plug” the space left by the target base becoming extrahelical, rather 152 
 
than base flipping (Krokan et al., 1997, Parikh et al., 1998). This would suggest that the 
destabilisation of the base to allow it to become extrahelical occurs by the distortion of the 
DNA by 45° upon enzyme binding, with base flipping only being aided by leucine. The 
activity of the enzymes was determined as hCDG > eCYDG > hCYDG, and therefore it 
would be reasonable to predict that an eCDG would be even more active. Experiments into 
producing eCDG would be of potential benefit to the 5-methylcytosine detection assay by 
reducing the cleavage reaction time. Though this can be prepared via in vitro transcription 
translation systems (Handa et al., 2002), it would more efficient if the enzyme could be 
produced  using  E.  coli  (or  other  amenable  cell  types  such  as  yeast),  as  with  our 
investigation into generating a fusion enzyme with Ugi. As Ugi binds strongly to UDG and 
is even stable in 8 M urea (Acharya et al., 2002), a strategy would need to be developed to 
release the Ugi from the UDG/CDG if an expressible fusion construct was produced. 
Analysis of 5-methylcytosine is important in the understanding of gene regulation and is an 
area of great interest. All current methods suffer from two main limitations of having to 
undergo  a  reaction  with  bisulphite  and/or  are  dependent  on  sequence  context  (e.g. 
restriction enzymes). A method that overcomes these limitations while being fast, reliable, 
accurate  and  easy  to  perform  would  be  of  great  benefit.  Real-time  PCR  is  one  such 
technique that satisfies these requirements. We proposed an assay whereby DNA would 
first be reacted with a CDG, with the use of a probing oligonucleotide to form a duplex 
with the target cytosine, followed by real-time PCR to detect the presence or absence of a 
product indicating the presence of 5-methylcytosine or cytosine respectively. CDG is able 
to  fully  excise  cytosine  in  this  context  as  shown  by  PAGE  assays  with  radiolabelled 
substrates, however, this proved unsuccessful when analysed by PCR and reproducible and 
significant  discrimination  was  not  observed.  Further  investigation  will  be  required  for 
potential assay commercialisation. One solution may be to use molecular HyBeacons with 
melt analysis to detect the difference in one base pair. This is because upon amplification a 
guanine will be  incorporated  opposite a 5-methylcytosine, while  any base, most  likely 
adenine, will be incorporated opposite an AP site produced by excision of cytosine by 
CDG. 
Another  possibility  as  to  why  the  eCYDG:PCR  assay  failed  to  produce  any  clear 
discrimination between a cytosine and 5-methylcytosine substrate could be associated with 
the purity of the enzyme, due to contaminants during the purification. As no DNases were 
added  and  since  our  enzymes  bind  DNA,  it  is  conceivable  that  the  purified  enzymes 153 
 
contained traces of DNA. Furthermore, Figure 5.4 shows possible exonuclease (most likely 
exonuclease III) due to the laddering effect seen for the ssC and ss
MC substrates. Figure 
5.6E also shows potential phosphatase activity due to a radioactive signal, most likely from 
free radiolabelled phosphate, being apparent at the dye front at the bottom of the gel. It 
would therefore be appropriate for future work to include further purification steps, e.g. the 
addition of DNases and ion exchange, to yield purer enzymes. 
Initial experiments have been performed to assess the activity of Y66 UDG and CDG 
mutants in their ability to accept 5-methylcytosine into their active site. Further studies will 
be  required  to  fully  determine  their  activity,  including  their  activity  against  5-
hydroxymethylcytosine (5hmC),  5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). 
Further Y66 mutants will need to be generated to alter the activity and/or specificity, which 
may be aided by other active site mutations. The same mutations will also be compared to 
and examined in hCDG; hUDG Y147A has already been shown to excise thymine and it is 
effectively a TDG (Kavli et al., 1996). Obtaining crystal structures of the CDGs bound to a 
DNA substrate will show what residues form interactions, or where favourable interactions 
could form with the substrate, allowing better determination of residues for mutagenesis. 
Random mutagenesis may also be used and active enzymes characterised to determine 
favourable mutations. These studies would further develop the 5-methylcytosine detection 
assay for detection of hmC, fC and caC. 
In  conclusion  we  have  successfully  generated  fully  functional  CDGs  that  are  able  to 
discriminate between cytosine and 5-methylcytosine, providing a potential new method for 
5-methylcytosine detection. 
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Appendix I - List of General Oligonucleotides used 
Description  Sequence 
N123D For  5′-GCGTCAGGGCGTTCTGCTACTCGATACTGTGTTGACGGTACGCGC-3′ 
N123D Rev  5′-GCGCGTACCGTCAACACAGTATCGAGTAGCAGAACGCCCTGACGC-3′ 
L191A For  5′-GCACCGCATCCGTCGCCGGCGTCGGCGCATCGTGGATTC-3′  
L191A Rev  5′-GAATCCACGATGCGCCGACGCCGGCGACGGATGCGGTGC-3′ 
A191L For  5′-GCACCGCATCCGTCGCCGCTTTCGGCGCATCGTGGATTC-3′ 
A191L Rev  5′ GAATCCACGATGCGCCGAAAGCGGCGACGGATGCGGTGC 3′ 
pET28a For  5′-GGAGATATACCATGGGCAGCAGC-3′ 
pET28a Rev  5′-CTTTGTTAGCAGCCGGATCTCAG-3′ 
N204D For  5′-GGTGTTCTCCTTCTCGACGCTGTCCTCACGG-3′ 
N204D Rev  5′-CCGTGAGGACAGCGTCGAGAAGGAGAACACC-3′ 
L272A For  5′-GCTCATCCCTCCCCTGCCTCAGTGTATAGAGGG-3′ 
L272A Rev  5′-CCCTCTATACACTGAGGCAGGGGAGGGATGAGC-3′ 
A  5′-GGCTAAATACCGACTATGCGCACTGATTCGG-3′ 
G  5′-GGCTAAATACCGACTGTGCGCACTGATTCGG-3′ 
AP  5′-GGCTAAATACCGACTAPTGCGCACTGATTCGG-3′ 
U  5′-CCGAATCAGTGCGCAUAGTCGGTATTTAGCC-3′ 
T  5′-CCGAATCAGTGCGCATAGTCGGTATTTAGCC-3′ 
C  5′-CCGAATCAGTGCGCACAGTCGGTATTTAGCC-3′ 
MC  5′-CCGAATCAGTGCGCA
MCAGTCGGTATTTAGCC-3′ 
A2  5′-GGCTAAATACCGACCACGCGCACTGATTCGG-3′ 
C3  5′-CCGAATCAGTGCGCGCGGTCGGTATTTAGCC-3′ 
Z 
5′-GGCTAAATACCGACTZTGCGCACTGATTCGG-3′ 
where Z = anthraquinone pyrrolidine 
ssC(GAT)  5′-GGATAAATAGGGAGTCTGAGAAGTGATTAGG-3′ 
ss
MC  5′-GGATAAATAGGGAGT
MCTGAGAAGTGATTAGG-3′ 
ssC(polyA)  5′-AAAAAAAAAAAAAAACAAAAAAAAAAAAAAA-3′ 
G2  5′-GCTAAATATATATATGTTATATAATTATTCG-3′ 
C2  5′-CGAATAATTATATAACATATATATATTTAGC-3′ 
Long C  5′-CCGTACTGAATCAGTGCGCACAGTCGGTATTTACGATAGCC-3′ 
Long Gap 1  5′-GGCTATCGTAAATACCGACT-3′ 
Long Gap 2  5′-TGCGCACTGATTCAGTACGG-3′ 
I 
5′-GGCTAAATACCGACTITGCGCACTGATTCGG-3′ 
where I = Inosine 
Gap 1  5′-GGCTAAATACCGACTG-3′ 
Gap 2  5′-GCGCACTGATTCGG-3′ 
HEG  5′-GGCTAAATACCGACTHTGCGCACTGATTCGG-3′ 
where H = Hexaethylene glycol 
Long HEG  5′-GGCTAAATACCGACHGCGCACTGATTCGG-3′ 
where H = Hexaethylene glycol 
pBADA For  5′-GATCTGTACGACGATGACGATAAGG-3′ 
pBADA Rev  5′-GGCTGAAAATCTTCTCTCATCCGCC-3′ 
IRES Linker 1 
5′-AGCTACGTAAGATCTTATACTCGAGCAAGGATATCGACTGCTCGA 
GCCAGATCTTCC-3′ 
IRES Linker 2 
5′-AGCTGGAAGATCTGGCTCGAGCAGTCGATATCCTTGATCGAGTAT 
AAGATCTTACGT-3′ 
Stop Codon  5′-CATGATTACGCCAAGTAACATATGGCTAACGAA-3′ 166 
 
(UDG) 
Stop Codon 
(UDG)  5′-TTCGTTAGCCATATGTTACTTGGCGTAATCATG-3′ 
Stop Codon 
(LacZ)  5′-ACCATGATTACGCCATAATTCATATGGCTAACG-3′ 
Stop Codon 
(LacZ)  5′-CGTTAGCCATATGAATTATGGCGTAATCATGGT-3′ 
Ugi For  5′-CTGTAGAGCTCCATATGACAAATTTATCTGACAT-3′ 
Ugi Rev  5′-AATCGAATTCAAGCTTATAACATTTTAATTTTATT-3′ 
UDGUgi For 
5′-TCAGCTGAATTCCTGGTGCCGCGCGGCAGCATGACAAATTTATCT 
GACATCATTG-3′ 
UDGUgi Rev  5′-TAGTACAAGCTTATAACATTTTAATT-3′ 
Stop Codons For  5′-TTACCGGCAGAGAGTGAGGGAGGAGAATTCCTGGTGCCGCGC-3′ 
Stop Codons Rev  5′-GCGCGGCACCAGGAATTCTCCTCCCTCACTCTCTGCCGGTAA-3′ 
Thrombin For  5′-AGCGGCCTGGTGCCGGGCGGCAGCCATATGG-3′ 
Thrombin Rev  5′-CCATATGGCTGCCGCCCGGCACCAGGCCGCT-3′ 
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Appendix II - List of Oligonucleotides used for the Generation of hUDGΔ81 and 
hUDGΔ81Ugi 
Description  Sequence 
hUDG1  5′-AGCTCAGTCATATGGGCGGCTTTGGAGAGAGCTGGAAGAA-3′ 
hUDG2 
5′-CTTGATAAAATACGGTTTCCCGAACTCCCCGCTGAGGTGCTTCTTCCAG 
CTCTCTCCAAA-3′ 
hUDG3 
5′-GGAAACCGTATTTTATCAAGCTAATGGGATTTGTTGCAGAAGAAAGAAA 
GCATTACACTG-3′ 
hUDG4 
5′-ATCTGGGTCCAGGTGAAGACTTGGTGTGGGGGTGGATAAACAGTGTAAT 
GCTTTCTTTCT-3′ 
hUDG5 
5′-GTCTTCACCTGGACCCAGATGTGTGACATAAAAGATGTGAAGGTTGTCA 
TCCTGGGACAG-3′ 
hUDG6 
5′-GCAGAGCCCGTGAGCTTGATTAGGTCCATGATATGGATCCTGTCCCAGG 
ATGACAACCT-3′ 
hUDG7 
5′-TCAAGCTCACGGGCTCTGCTTTAGTGTTCAAAGGCCTGTTCCGCCTCCG 
CCCAGTTTGGA-3′ 
hUDG8 
5′-AAAATCCTCTATGTCTGTAGACAACTCTTTATAAATGTTCTCCAAACTG 
GGCGGAGGCGG-3′ 
hUDG9 
5′-CTACAGACATAGAGGATTTTGTTCATCCTGGCCATGGAGATTTATCTGG 
GTGGGCCAAGC-3′ 
hUDG10 
5′-GCACGAACCGTGAGGACAGCGTTGAGAAGGAGAACACCTTGCTTGGCCC 
ACCCAGATAAA-3′ 
hUDG11 
5′-GCTGTCCTCACGGTTCGTGCCCATCAAGCCAACTCTCATAAGGAGCGAG 
GCTGGGAGCAG-3′ 
hUDG12 
5′-TCGAGTTCTGATTTAGCCAGGACACAACTGCATCAGTGAACTGCTCCCA 
GCCTCGCTCCT-3′ 
hUDG13 
5′-CTGGCTAAATCAGAACTCGAATGGCCTTGTTTTCTTGCTCTGGGGCTCT 
TATGCTCAGAA-3′ 
hUDG14 
5′-TAGTACATGGTGCCGCTTCCTATCAATGGCACTGCCCTTCTTCTGAGCA 
TAAGAGCCCCA-3′ 
hUDG15 
5′-GGAAGCGGCACCATGTACTACAGACGGCTCATCCCTCCCCTTTGTCAGT 
GTATAGAGGGTTC-3′ 
hUDG16 
5′-AGCAGCTCATTGGTCTTTGAAAAGTGTCTACATCCAAAGAACCCTCTAT 
ACACTGA-3′ 
hUDG17 
5′-TCAAAGACCAATGAGCTGCTGCAGAAGTCTGGCAAGAAGCCCATTGACT 
GGAAGGAGCTG-3′ 
hUDG18  5′-TCCGAGTCGAATTCTCACAGCTCCTTCCAGTCAATGG-3′ 
Ugi1 
5′-CGGACAAGTTGGTCATGCTGCCGCGCGGCACCAGTTCTTCCAGCTCCTT 
CCAGTCAATGG-3′ 
Ugi2 
5′-CAGCATGACCAACTTGTCCGACATCATCGAAAAAGAGACCGGCAAGCAA 
CTGGTT-3′ 
Ugi3 
5′-ACTTCTTCAGGGAGCATCAAGATAGATTCTTGAATAACCAGTTGCTTGC 
CGGTCT-3′ 
Ugi4 
5′-TTGATGCTCCCTGAAGAAGTAGAAGAGGTTATCGGTAATAAGCCGGAGT 
CCGACA-3′ 
Ugi5 
5′-ATCAGTAGATTCGTCATAAGCAGTGTGCACCAGAATGTCGGACTCCGGC 
TTATTA-3′ 
Ugi6  5′-CTTATGACGAATCTACTGATGAGAACGTAATGCTGCTGACTAGCGACGC 168 
 
TCCGGA-3′ 
Ugi7 
5′-TAGAGTCTTGAATTACCAGAGCCCACGGTTTGTATTCCGGAGCGTCGCT 
AGTCAG-3′ 
Ugi8 
5′-TCTGGTAATTCAAGACTCTAACGGCGAAAACAAAATCAAGATGCTGTAA 
GAATTC-3′ 
Ugi9  5′-TCCGAGTCGAATTCTTACAGCATCTTGA-3′  
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Appendix IIIa - List of Oligonucleotides used for the PCR assay 
Description  Sequence 
Target  5′-TAGCGTAGGGAGATATACCATGGGCAGCAGCCAGTGCGCA[C/
MC] 
GGTCGGTATTCTGAGATCCGGCTGCTAACAAAGTTGATCAT-3′ 
Probe  5′-GGCTAAATACCGACTATGCGCACTGATTCGG-3′ 
C Mimic 1  5′-TAGCGTAGGGAGATATACCATGGGCAGCAGCCAGTGCGCA-3′ 
C Mimic 2  5′-GGTCGGTATTCTGAGATCCGGCTGCTAACAAAGTTGATCAT-3′ 
HEG Probe  5′-GGCTAAATACCGACTHTGCGCACTGATTCGG-Propyl-3′ 
Where H = Hexaethylene glycol 
 
Appendix IIIb - List of Primers/Protection Oligonucleotides used for the 
eCYDG:rtPCR Assay 
Description  Sequence 
For 
Primer/Protection 
5′-GGAGATATACCATGGGCAGCAGC-3′ 
Rev 
Primer/Protection 
5′-CTTTGTTAGCAGCCGGATCTCAG-3′ 
Rev Protection  5′-GCTGCTGCCCATGGTATATCTCC-3′ 
For Protection  5′-CTGAGATCCGGCTGCTAACAAAG-3′ 
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Appendix IV – Cleavage Assay Interpretation 
To determine the rate of reaction for the enzymes investigated against a range of different 
substrates the following procedure was used, using eCYDG A.C as an example. 
The  cleavage  assay  was  performed  and  the  samples  were  run  on  a  denaturing 
polyacrylamide gel to separate out substrate from product. The gel can be seen below. 
Boxes were then drawn around each band (Red Boxes) to analyse the intensity of each 
band. This was performed using the analysis software ImageQuantTL. 
 
The percentage product for each time point was calculated using the equation: 
% P =     PI      x 100 
           PI + SI 
 
% P = Percentage Product 
PI = Product Intensity 
SI = Substrate Intensity 
The percentage product was plotted against time to generate a graph (using SigmaPlot) 
allowing the rate of reaction to be calculated (0.0072 min
-1) by fitting a curve (see graph 
below). This was calculated by using the “exponential rise to maximum” equation given as: 
y = a(1-e
-bx) 
y = y axis value 
x = x axis value 
a = maximum amplitude of the curve (highlighted on the graph) 
b = initial velocity/rate of reaction (highlighted on the graph) 171 
 
 
This process was repeated for a further two gels and graphs (see below) to give rates of 
0.0061 and 0.0052 min
-1. This generates a triplicate of rates that were then averaged and 
the error calculated (by standard deviation) giving 0.0062 ± 0.001 min
-1. Rates were then 
compiled into Table 3.2, Table 5.2 and Table 5.3. 
 
   172 
 
Appendix V – DNA Sequences of the ORFs of eUDG and hUDGΔ81 
eUDG 
ATGGCTAACGAATTAACCTGGCATGACGTGCTGGCTGAAGAGAAGCAGCAACCCTATTTTC
TTAATACCCTTCAGACCGTCGCCAGCGAGCGGCAGTCCGGCGTCACTATCTACCCACCACA
AAAAGATGTCTTTAACGCGTTCCGCTTTACAGAGTTGGGTGACGTTAAAGTGGTGATTCTC
GGCCAGGATCCTTATCACGGACCGGGACAGGCGCATGGTCTGGCATTTTCCGTTCGTCCCG
GCATTGCCATTCCTCCGTCATTATTGAATATGTATAAAGAGCTGGAAAATACTATTCCGGG
CTTCACCCGCCCTAATCATGGTTATCTTGAAAGCTGGGCGCGTCAGGGCGTTCTGCTACTC
AATACTGTGTTGACGGTACGCGCAGGTCAGGCGCATTCCCACGCCAGCCTCGGCTGGGAAA
CCTTCACCGATAAAGTGATCAGCCTGATTAACCAGCATCGCGAAGGCGTGGTGTTTTTGTT
GTGGGGATCGCATGCGCAAAAGAAAGGGGCGATTATAGATAAGCAACGCCATCATGTACTG
AAAGCACCGCATCCGTCGCCGCTTTCGGCGCATCGTGGATTCTTTGGCTGCAACCATTTTG
TGCTGGCAAATCAGTGGCTGGAACAACGTGGCGAGACGCCGATTGACTGGATGCCAGTATT
ACCGGCAGAGAGTGAGTAA 
 
Y66A/L/T/W/H/S/C: TAT → GCG/CTG/ACC/TGG/CAT/AGC/TGC 
F77W/Y/H: TTT → TGG/TAT/CAT 
N123D: AAT → GAT 
L191A: CTT → GCG 
 
hUDG 
ATGGGCGTCTTCTGCCTTGGGCCGTGGGGGTTGGGCCGGAAGCTGCGGACGCCTGGGAAGG
GGCCGCTGCAGCTCTTGAGCCGCCTCTGCGGGGACCACTTGCAGGCCATCCCAGCCAAGAA
GGCCCCGGCTGGGCAGGAGGAGCCTGGGACGCCGCCCTCCTCGCCGCTGAGTGCCGAGCAG
TTGGACCGGATCCAGAGGAACAAGGCCGCGGCCCTGCTCAGACTCGCGGCCCGCAACGTGC
CCGTGGGCTTTGGAGAGAGCTGGAAGAAGCACCTCAGCGGGGAGTTCGGGAAACCGTATTT
TATCAAGCTAATGGGATTTGTTGCAGAAGAAAGAAAGCATTACACTGTTTATCCACCCCCA
CACCAAGTCTTCACCTGGACCCAGATGTGTGACATAAAAGATGTGAAGGTTGTCATCCTGG
GACAGGATCCATATCATGGACCTAATCAAGCTCACGGGCTCTGCTTTAGTGTTCAAAGGCC
TGTTCCGCCTCCGCCCAGTTTGGAGAACATTTATAAAGAGTTGTCTACAGACATAGAGGAT
TTTGTTCATCCTGGCCATGGAGATTTATCTGGGTGGGCCAAGCAAGGTGTTCTCCTTCTCA
ACGCTGTCCTCACGGTTCGTGCCCATCAAGCCAACTCTCATAAGGAGCGAGGCTGGGAGCA
GTTCACTGATGCAGTTGTGTCCTGGCTAAATCAGAACTCGAATGGCCTTGTTTTCTTGCTC
TGGGGCTCTTATGCTCAGAAGAAGGGCAGTGCCATTGATAGGAAGCGGCACCATGTACTAC
AGACGGCTCATCCCTCCCCTTTGTCAGTGTATAGAGGGTTCTTTGGATGTAGACACTTTTC
AAAGACCAATGAGCTGCTGCAGAAGTCTGGCAAGAAGCCCATTGACTGGAAGGAGCTGTGA 
 
N204D: AAC → GAC 
L272A: TTG → GCC 
 
Orange: Deleted sequence of residues 3 - 83   173 
 
Appendix VI - Sequencing Chromatograms 
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